,Country (ISO3 Code),WHO-CHOICE Region,World Bank Geographical Region,World Health Organization Region,World Bank Income Status,Gram stain,Antibiotic Class,Syndrome,Regional Level of MA for LOS,Number of Studies in MA for LOS,Mean Cost - from Excess LOS,Low 95% UI Bound - from Excess LOS,High 95% UI Bound - from Excess LOS,Regional Level of MA for Extracted Costs,Number of Studies in MA for Extracted Costs,Mean Cost - from Extracted Costs,Low 95% UI Bound - from Exctraced Costs,High 95% UI Bound - from Extraced Costs,Mean Cost - Across Both,Low 95% UI Bound - Across Both,High 95% UI Bound - Across Both
1,AFG,EMRO D,South Asia,EMRO,Low income,gn,3g cephalosporins,BSI,global,3,9,4,19,global,2,591,-581,1727,300,-356,1501
2,AFG,EMRO D,South Asia,EMRO,Low income,gn,carbapenems,BSI,global,4,12,3,27,NA,NA,NA,NA,NA,12,3,27
3,AFG,EMRO D,South Asia,EMRO,Low income,gp,glycopeptides,BSI,global,3,16,5,36,global,2,23797,-18192,62622,11906,-8585,56204
4,AFG,EMRO D,South Asia,EMRO,Low income,gp,penicillins,BSI,global,5,14,5,28,global,3,987,-691,2835,500,-448,2494
5,AFG,EMRO D,South Asia,EMRO,Low income,gn,3g cephalosporins,COL/INF,global,5,13,3,31,global,2,1755,-915,4247,884,-497,3898
6,AFG,EMRO D,South Asia,EMRO,Low income,gn,carbapenems,COL/INF,global,9,12,4,25,NA,NA,NA,NA,NA,12,4,25
7,AFG,EMRO D,South Asia,EMRO,Low income,gp,glycopeptides,COL/INF,global,3,13,0,36,global,5,13255,-1380,27433,6634,-2,25424
8,AFG,EMRO D,South Asia,EMRO,Low income,gp,penicillins,COL/INF,global,7,19,8,42,global,4,32810,-2351,66224,16414,7,61992
9,AFG,EMRO D,South Asia,EMRO,Low income,gp,glycopeptides,IAI,global,1,3,0,8,global,1,35818,-34293,107860,17911,-24762,96537
10,AFG,EMRO D,South Asia,EMRO,Low income,gn,carbapenems,RTI,global,1,21,-87,145,global,1,5264,-4646,15624,2643,-3445,13964
11,AFG,EMRO D,South Asia,EMRO,Low income,gp,penicillins,SSI,global,3,20,7,43,global,2,84457,-33705,200178,42239,-15699,180392
12,AFG,EMRO D,South Asia,EMRO,Low income,gp,penicillins,SSTI,global,1,22,5,53,NA,NA,NA,NA,NA,22,5,53
13,AFG,EMRO D,South Asia,EMRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9494,-11081,29075,9494,-11081,29075
14,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,266,102,583,global,2,596,-549,1697,431,-281,1517
15,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,344,80,867,NA,NA,NA,NA,NA,344,80,867
16,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,463,147,1094,global,2,24130,-14978,63132,12297,-8027,57932
17,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,397,152,889,global,3,1026,-778,2819,711,-417,2564
18,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,265,101,567,global,2,1808,-611,4250,1036,-231,3944
19,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,332,123,763,NA,NA,NA,NA,NA,332,123,763
20,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,350,9,968,global,5,13237,242,27326,6793,11,25029
21,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,550,208,1229,global,4,32424,-3109,68868,16487,164,64241
22,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,86,-1,240,global,1,33041,-32535,94540,16564,-23374,84630
23,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,674,-2163,4089,global,1,5075,-3870,14460,2875,-3288,13164
24,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,582,198,1371,global,2,82658,-32117,192758,41620,-12046,177144
25,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,636,149,1671,NA,NA,NA,NA,NA,636,149,1671
26,AGO,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10069,-9720,29394,10069,-9720,29394
27,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,366,141,774,income,2,615,-529,1667,490,-275,1535
28,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,1492,54,3908,NA,NA,NA,NA,NA,1492,54,3908
29,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,646,199,1512,global,2,22720,-15662,62005,11683,-10031,56332
30,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,517,196,1086,income,2,949,-658,2686,733,-429,2375
31,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,818,60,2081,income,2,1772,-858,4350,1295,-472,3915
32,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,308,123,629,NA,NA,NA,NA,NA,308,123,629
33,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,469,-42,1305,global,5,13297,-143,27300,6883,-45,25388
34,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,421,127,937,global,4,32765,-2114,69587,16593,104,61592
35,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,118,-5,325,global,1,34739,-29477,98705,17428,-20791,89497
36,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,1002,-3106,5944,income,1,5215,-4460,15272,3108,-4067,13298
37,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,512,99,1216,global,2,78838,-31496,195948,39675,-18186,174817
38,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,864,223,2119,NA,NA,NA,NA,NA,864,223,2119
39,ALB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10497,-9279,28539,10497,-9279,28539
40,AND,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,8227,163,24026,income,2,600,-510,1685,4414,-395,19863
41,AND,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,8680,-1935,26608,NA,NA,NA,NA,NA,8680,-1935,26608
42,AND,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,11999,3771,29139,income,2,23702,-13089,65337,17851,-8349,58356
43,AND,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,16441,4361,41926,income,3,1003,-634,2671,8722,-360,34892
44,AND,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,903,-2347,5253,global,2,1759,-801,4355,1331,-1801,4702
45,AND,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,6981,-5668,24973,NA,NA,NA,NA,NA,6981,-5668,24973
46,AND,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,9159,209,26291,income,5,13071,-832,27622,11115,-231,26798
47,AND,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,7878,2312,17967,income,4,33166,-1764,66532,20522,1840,62565
48,AND,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,2222,-39,6643,income,1,33981,-34852,102678,18102,-24170,93969
49,AND,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,20267,-55251,118841,global,1,5015,-5300,14722,12641,-38392,88844
50,AND,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,9490,1796,23209,income,2,84491,-30587,192650,46991,-13516,180278
51,AND,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,16146,3507,38756,NA,NA,NA,NA,NA,16146,3507,38756
52,AND,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10212,-8877,29549,10212,-8877,29549
53,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,BSI,income,3,3052,1127,7037,income,2,614,-570,1742,1833,-350,5852
54,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,BSI,income,3,3561,841,8628,NA,NA,NA,NA,NA,3561,841,8628
55,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,BSI,income,3,5383,1603,12977,income,2,23893,-16678,64895,14638,-8341,57948
56,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,BSI,income,5,4539,1691,9932,income,3,985,-779,2757,2762,-521,8753
57,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,COL/INF,income,1,454,-957,2394,global,2,1839,-760,4390,1147,-892,4117
58,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,COL/INF,whoc,1,2554,940,5696,NA,NA,NA,NA,NA,2554,940,5696
59,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,COL/INF,income,3,4060,-54,12150,income,5,13181,-635,27323,8621,-208,24947
60,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,COL/INF,income,7,6336,2297,13999,income,4,32394,-4238,68722,19365,1576,62054
61,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,IAI,income,1,960,-16,2690,income,1,35324,-33432,102472,18142,-23613,91671
62,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,RTI,global,1,8440,-26637,51396,global,1,5044,-4601,14836,6742,-18701,41211
63,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSI,income,3,6706,2214,14922,income,2,80405,-41438,196205,43556,-18102,174622
64,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSTI,income,1,7237,1547,18358,NA,NA,NA,NA,NA,7237,1547,18358
65,ARE,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10037,-10653,28331,10037,-10653,28331
66,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,1009,387,2137,income,2,582,-455,1678,795,-339,1978
67,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,4221,37,11638,NA,NA,NA,NA,NA,4221,37,11638
68,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,1748,518,4006,global,2,23724,-16180,63572,12736,-10422,57901
69,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,1430,514,3160,income,2,897,-876,2701,1164,-538,2833
70,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,2255,151,6101,income,2,1769,-615,4178,2012,-337,5109
71,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,850,325,1809,NA,NA,NA,NA,NA,850,325,1809
72,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1352,25,3784,global,5,13376,-1536,27680,7364,-92,25151
73,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,2103,774,4548,global,4,32166,-3489,69971,17135,628,64117
74,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,332,1,922,global,1,34915,-31033,103825,17623,-24769,94793
75,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,2625,-8284,18524,income,1,5167,-4239,15601,3896,-6749,16578
76,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,2209,739,5106,global,2,83913,-28516,190788,43061,-9845,177274
77,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,2400,547,6444,NA,NA,NA,NA,NA,2400,547,6444
78,ARG,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10084,-9131,27824,10084,-9131,27824
79,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,215,81,448,income,2,589,-468,1573,402,-305,1424
80,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,892,51,2437,NA,NA,NA,NA,NA,892,51,2437
81,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,378,124,870,global,2,23117,-13935,61933,11747,-8281,55240
82,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,307,111,677,income,2,951,-803,2672,629,-536,2408
83,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,491,36,1283,income,2,1831,-649,4221,1161,-396,3907
84,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,182,69,385,NA,NA,NA,NA,NA,182,69,385
85,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,292,19,779,global,5,13150,-1439,27132,6721,-20,24647
86,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,252,75,582,global,4,32323,-2380,68161,16287,60,62092
87,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,70,0,206,global,1,33896,-33603,97861,16983,-21627,89824
88,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,555,-1793,3452,income,1,4894,-5617,14668,2725,-3889,13061
89,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,304,60,778,global,2,79845,-37749,197845,40075,-14913,179567
90,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,512,113,1231,NA,NA,NA,NA,NA,512,113,1231
91,ARM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10571,-9936,30109,10571,-9936,30109
92,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,BSI,income,3,1566,638,3324,income,2,589,-540,1692,1078,-321,2971
93,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,BSI,income,3,1859,470,4860,NA,NA,NA,NA,NA,1859,470,4860
94,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,BSI,income,3,2773,910,6131,income,2,24340,-14819,64687,13556,-7693,56364
95,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,BSI,income,5,2341,938,5027,income,3,985,-718,2706,1663,-412,4416
96,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,COL/INF,income,1,209,-511,1215,global,2,1797,-789,4312,1003,-602,3886
97,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,COL/INF,income,8,2533,365,6768,NA,NA,NA,NA,NA,2533,365,6768
98,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,COL/INF,income,3,2109,26,5701,income,5,13449,-543,27032,7779,-43,25021
99,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,COL/INF,income,7,3241,1306,6913,income,4,32496,-3629,67973,17869,863,62840
100,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,IAI,income,1,529,-20,1486,income,1,34346,-38282,103526,17438,-24273,91363
101,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,RTI,global,1,4619,-12560,27150,global,1,4764,-5269,14527,4691,-8938,20159
102,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSI,income,3,3425,1232,7607,income,2,82407,-35085,204296,42916,-17486,181955
103,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSTI,income,1,3706,839,9174,NA,NA,NA,NA,NA,3706,839,9174
104,ATG,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10398,-9958,29091,10398,-9958,29091
105,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,BSI,income,3,6971,2683,15641,income,2,595,-460,1698,3783,-361,13013
106,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,BSI,income,3,8094,1761,21226,NA,NA,NA,NA,NA,8094,1761,21226
107,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,BSI,income,3,12229,3715,29507,income,2,23502,-15924,63798,17866,-9833,57484
108,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,BSI,income,5,10362,3907,22917,income,3,1011,-784,2742,5687,-504,19637
109,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,COL/INF,income,1,967,-2643,5500,wbregion,2,1705,-928,4270,1336,-1943,4794
110,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,COL/INF,income,8,11218,2180,29361,NA,NA,NA,NA,NA,11218,2180,29361
111,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,COL/INF,income,3,9330,-158,25953,income,5,13141,-1220,27694,11236,-489,27303
112,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,COL/INF,whoc,1,15502,5956,34482,income,4,33835,-2736,68398,24668,3609,63908
113,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,IAI,income,1,2294,-205,6488,income,1,34789,-32365,102179,18542,-22289,91960
114,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,RTI,wbregion,1,19566,-55944,106774,wbregion,1,5268,-3896,14937,12417,-41627,89079
115,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,SSI,income,3,15212,5395,35283,income,2,80081,-41276,194265,47647,-12662,178340
116,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,SSTI,income,1,16442,3863,39095,NA,NA,NA,NA,NA,16442,3863,39095
117,AUS,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9936,-8797,30145,9936,-8797,30145
118,AUT,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,6653,329,17808,income,2,575,-480,1595,3614,-358,15401
119,AUT,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,7408,-1573,23121,NA,NA,NA,NA,NA,7408,-1573,23121
120,AUT,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,10031,2997,24414,income,2,24622,-14813,64427,17327,-7630,56544
121,AUT,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,13936,3382,35054,income,3,1057,-632,2774,7497,-392,30403
122,AUT,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,799,-2552,4938,global,2,1801,-740,4412,1300,-1770,4631
123,AUT,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,5678,-6711,25896,NA,NA,NA,NA,NA,5678,-6711,25896
124,AUT,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,7682,12,23395,income,5,12988,-675,27071,10335,-241,26645
125,AUT,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,6624,1840,15073,income,4,33822,-1078,70086,20223,1513,64521
126,AUT,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1829,-142,5344,income,1,33668,-33329,97704,17749,-20263,87688
127,AUT,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,14776,-53387,97645,global,1,4970,-4618,14431,9873,-37205,82350
128,AUT,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,8188,1360,21054,income,2,82434,-40127,201370,45311,-12289,179135
129,AUT,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,13655,3343,34419,NA,NA,NA,NA,NA,13655,3343,34419
130,AUT,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9904,-9652,29626,9904,-9652,29626
131,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,312,125,679,income,2,602,-465,1703,457,-293,1520
132,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,1324,16,3751,NA,NA,NA,NA,NA,1324,16,3751
133,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,549,173,1250,global,2,23693,-16005,61948,12121,-8752,55551
134,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,440,164,950,income,2,967,-772,2616,704,-522,2369
135,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,726,35,1955,income,2,1738,-747,4324,1232,-411,3847
136,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,263,103,560,NA,NA,NA,NA,NA,263,103,560
137,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,417,5,1139,global,5,13280,-845,26691,6849,-29,24377
138,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,368,110,865,global,4,33435,-3721,69985,16902,101,64023
139,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,99,1,276,global,1,33040,-31466,97347,16569,-22782,89404
140,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,809,-2768,4916,income,1,4980,-5317,14509,2895,-4370,12705
141,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,438,94,1083,global,2,79499,-26326,195629,39968,-10222,179962
142,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,745,173,1811,NA,NA,NA,NA,NA,745,173,1811
143,AZE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9794,-9326,30103,9794,-9326,30103
144,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,14,5,30,global,2,624,-506,1751,319,-310,1513
145,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,18,4,43,NA,NA,NA,NA,NA,18,4,43
146,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,25,8,58,global,2,24051,-13384,62623,12038,-7063,56354
147,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,21,8,46,global,3,985,-768,2831,503,-471,2455
148,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,54,20,122,global,2,1737,-663,4214,895,-274,3766
149,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,17,6,37,NA,NA,NA,NA,NA,17,6,37
150,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,19,0,54,global,5,13828,-436,28316,6923,-1,25912
151,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,29,11,63,global,4,31482,-8017,71386,15755,-74,61275
152,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,4,0,12,global,1,34885,-34593,102697,17445,-23293,87458
153,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,38,-114,221,global,1,5124,-4257,15420,2581,-2809,13739
154,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,30,10,68,global,2,85503,-25015,208853,42767,-8718,188836
155,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,34,8,84,NA,NA,NA,NA,NA,34,8,84
156,BDI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9734,-9169,30125,9734,-9169,30125
157,BEL,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,6441,179,19204,income,2,588,-476,1644,3514,-401,15530
158,BEL,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,7044,-1806,21641,NA,NA,NA,NA,NA,7044,-1806,21641
159,BEL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,9638,3065,24089,income,2,24304,-16796,63087,16971,-8761,57515
160,BEL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,13250,3460,33473,income,3,1050,-717,2745,7150,-440,27785
161,BEL,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,715,-2056,4327,global,2,1813,-740,4499,1264,-1620,4444
162,BEL,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,5520,-4943,20573,NA,NA,NA,NA,NA,5520,-4943,20573
163,BEL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,7156,162,18756,income,5,13113,-1351,27544,10135,-462,25781
164,BEL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,6231,1993,15643,income,4,33192,-2714,69762,19711,1461,63354
165,BEL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1782,-54,5143,income,1,32791,-31457,96496,17286,-20671,87687
166,BEL,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,14888,-46379,89682,global,1,4705,-4754,14691,9797,-32838,72262
167,BEL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,7547,1495,18013,income,2,81544,-31030,194630,44545,-12532,174370
168,BEL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,12722,3138,32700,NA,NA,NA,NA,NA,12722,3138,32700
169,BEL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10389,-9853,28700,10389,-9853,28700
170,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,45,18,98,global,2,576,-552,1661,310,-375,1477
171,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,59,15,145,NA,NA,NA,NA,NA,59,15,145
172,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,80,27,185,global,2,24053,-16618,63748,12066,-8608,57552
173,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,67,27,144,global,3,983,-702,2688,525,-358,2399
174,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,45,19,95,global,2,1819,-769,4431,932,-284,3921
175,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,57,22,127,NA,NA,NA,NA,NA,57,22,127
176,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,60,-1,157,global,5,13453,-1067,28322,6756,-8,25838
177,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,93,37,203,global,4,33062,2004,67311,16577,37,62462
178,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,15,0,40,global,1,34211,-36260,103568,17113,-21211,92282
179,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,121,-385,702,global,1,4956,-5156,14483,2538,-3133,13132
180,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,98,36,217,global,2,86480,-33052,205493,43289,-12315,185007
181,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,107,27,279,NA,NA,NA,NA,NA,107,27,279
182,BEN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10011,-8876,28778,10011,-8876,28778
183,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,35,13,72,global,2,590,-510,1655,313,-343,1532
184,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,46,12,107,NA,NA,NA,NA,NA,46,12,107
185,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,63,19,135,global,2,24505,-14831,63075,12284,-8140,57120
186,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,53,19,106,global,3,1044,-716,2701,548,-461,2523
187,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,35,13,68,global,2,1796,-587,4266,915,-208,3857
188,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,44,15,98,NA,NA,NA,NA,NA,44,15,98
189,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,47,1,125,global,5,13166,81,27478,6606,1,24889
190,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,73,26,147,global,4,33400,-2513,69671,16737,25,64271
191,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,12,-1,33,global,1,32923,-32154,102526,16467,-24981,91852
192,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,95,-278,595,global,1,5047,-4248,14733,2571,-3189,13309
193,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,78,25,166,global,2,81785,-37581,198016,40931,-19920,185320
194,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,84,19,208,NA,NA,NA,NA,NA,84,19,208
195,BFA,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9490,-9536,29503,9490,-9536,29503
196,BGD,SEARO D,South Asia,SEARO,Lower middle income,gn,3g cephalosporins,BSI,global,3,53,21,111,global,2,594,-485,1734,324,-327,1526
197,BGD,SEARO D,South Asia,SEARO,Lower middle income,gn,carbapenems,BSI,global,4,69,18,164,NA,NA,NA,NA,NA,69,18,164
198,BGD,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,BSI,global,3,93,29,208,global,2,23655,-20085,63603,11874,-10808,59180
199,BGD,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,BSI,global,5,79,31,168,global,3,1045,-647,2865,562,-386,2564
200,BGD,SEARO D,South Asia,SEARO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,53,21,109,global,2,1806,-755,4273,929,-305,3822
201,BGD,SEARO D,South Asia,SEARO,Lower middle income,gn,carbapenems,COL/INF,global,9,67,25,146,NA,NA,NA,NA,NA,67,25,146
202,BGD,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,COL/INF,global,3,71,3,189,global,5,13013,-1873,27276,6542,-8,25133
203,BGD,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,COL/INF,global,7,110,42,239,global,4,33505,-2424,69217,16807,40,63396
204,BGD,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,IAI,global,1,17,-1,46,global,1,34412,-31262,99250,17215,-23484,90381
205,BGD,SEARO D,South Asia,SEARO,Lower middle income,gn,carbapenems,RTI,global,1,129,-443,814,global,1,4953,-5112,15311,2541,-3744,13610
206,BGD,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,SSI,global,3,118,42,252,global,2,84990,-26455,198832,42554,-8079,182298
207,BGD,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,SSTI,global,1,125,28,291,NA,NA,NA,NA,NA,125,28,291
208,BGD,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9524,-10303,29492,9524,-10303,29492
209,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,763,269,1654,income,2,612,-451,1657,688,-274,1657
210,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,3211,68,9110,NA,NA,NA,NA,NA,3211,68,9110
211,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,1353,397,3145,global,2,23890,-15280,61881,12622,-9733,56912
212,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,1077,402,2318,income,2,913,-693,2502,995,-449,2447
213,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1723,202,4517,income,2,1783,-771,4197,1753,-383,4366
214,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,642,238,1361,NA,NA,NA,NA,NA,642,238,1361
215,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1012,36,2869,global,5,13582,-1440,28838,7297,-54,26114
216,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,895,257,2154,global,4,33230,-1065,67256,17062,228,62704
217,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,250,-9,716,global,1,35088,-35304,102099,17669,-23133,91158
218,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,2092,-6884,11942,income,1,5233,-5108,14531,3663,-5595,13664
219,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,1068,186,2647,global,2,84171,-36881,197246,42620,-13938,184899
220,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,1809,380,4425,NA,NA,NA,NA,NA,1809,380,4425
221,BGR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10340,-9100,30145,10340,-9100,30145
222,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,BSI,income,3,1146,436,2638,income,2,600,-495,1669,873,-315,2231
223,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,BSI,income,3,1314,337,3296,NA,NA,NA,NA,NA,1314,337,3296
224,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,BSI,income,3,2006,595,4700,income,2,23007,-16429,62102,12506,-9680,55621
225,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,BSI,income,5,1708,628,3808,income,3,998,-778,2746,1353,-441,3418
226,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,COL/INF,income,1,167,-446,896,global,2,1766,-888,4341,966,-574,4042
227,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,COL/INF,whoc,1,962,373,2111,NA,NA,NA,NA,NA,962,373,2111
228,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,COL/INF,income,3,1567,33,4361,income,5,13470,203,27302,7518,36,24969
229,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,COL/INF,income,7,2377,875,5175,income,4,33079,-619,70063,17728,844,62570
230,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,IAI,income,1,365,-1,993,income,1,35401,-30562,103376,17883,-21329,96053
231,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,RTI,global,1,2832,-8665,18259,global,1,5352,-4248,16018,4092,-7330,16938
232,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSI,income,3,2531,923,6074,income,2,84270,-33136,205766,43401,-13747,185553
233,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSTI,income,1,2757,676,7099,NA,NA,NA,NA,NA,2757,676,7099
234,BHR,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9769,-9850,29388,9769,-9850,29388
235,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,BSI,income,3,4101,1669,8899,income,2,587,-532,1647,2344,-363,7788
236,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,BSI,income,3,4855,1256,11994,NA,NA,NA,NA,NA,4855,1256,11994
237,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,BSI,income,3,7157,2432,16335,income,2,24165,-13885,64228,15661,-6281,56232
238,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,BSI,income,5,6128,2448,13926,income,3,1033,-684,2761,3581,-414,11657
239,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,COL/INF,income,1,558,-1422,3416,global,2,1816,-915,4372,1187,-1286,4103
240,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,COL/INF,income,8,6562,1236,16381,NA,NA,NA,NA,NA,6562,1236,16381
241,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,COL/INF,income,3,5547,-210,15239,income,5,13087,-25,26930,9317,-198,25009
242,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,COL/INF,income,7,8507,3410,18916,income,4,32547,-2422,65166,20527,2615,60913
243,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,IAI,income,1,1347,-79,3859,income,1,37732,-30489,106038,19539,-21994,95571
244,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,RTI,global,1,11680,-29325,64221,global,1,5020,-5297,14248,8350,-23429,52708
245,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSI,income,3,8945,3168,19809,income,2,84278,-27348,193526,46611,-15315,175740
246,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSTI,income,1,9790,2038,24864,NA,NA,NA,NA,NA,9790,2038,24864
247,BHS,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10321,-10361,29167,10321,-10361,29167
248,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,391,150,804,income,2,595,-451,1699,493,-309,1540
249,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,1578,27,4477,NA,NA,NA,NA,NA,1578,27,4477
250,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,685,213,1580,global,2,22471,-15715,61494,11578,-10014,55194
251,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,552,203,1189,income,2,962,-923,2706,757,-594,2419
252,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,873,71,2223,income,2,1684,-865,4276,1278,-461,3877
253,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,330,127,665,NA,NA,NA,NA,NA,330,127,665
254,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,530,-3,1423,global,5,13238,-99,27778,6884,-3,25420
255,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,457,136,1036,global,4,32934,-1565,68689,16696,121,61326
256,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,129,-3,365,global,1,33327,-30865,103418,16728,-20476,91915
257,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,1035,-2987,6324,income,1,5103,-5181,15013,3069,-4479,13403
258,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,552,117,1341,global,2,82374,-32510,193688,41463,-12681,181811
259,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,932,201,2180,NA,NA,NA,NA,NA,932,201,2180
260,BIH,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9877,-9029,30783,9877,-9029,30783
261,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,589,231,1280,income,2,583,-473,1716,586,-344,1563
262,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,2469,39,6895,NA,NA,NA,NA,NA,2469,39,6895
263,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,1035,317,2342,global,2,23477,-15737,63647,12256,-10477,56629
264,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,833,299,1842,income,2,947,-682,2628,890,-461,2414
265,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1344,138,3570,income,2,1731,-784,4289,1538,-340,4102
266,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,496,192,1069,NA,NA,NA,NA,NA,496,192,1069
267,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,810,25,2212,global,5,13287,84,26594,7048,25,24336
268,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,679,205,1600,global,4,32120,-3124,66644,16400,154,62390
269,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,195,0,530,global,1,37085,-25445,104342,18640,-19030,92514
270,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,1728,-4736,9358,income,1,5024,-4266,14458,3376,-4615,13798
271,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,831,164,2065,global,2,87507,-34340,198844,44169,-8986,185279
272,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,1386,310,3384,NA,NA,NA,NA,NA,1386,310,3384
273,BLR,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9885,-9855,31324,9885,-9855,31324
274,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,459,189,922,income,2,621,-424,1620,540,-262,1529
275,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,1998,141,5482,NA,NA,NA,NA,NA,1998,141,5482
276,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,795,259,1808,global,2,25267,-12979,63280,13031,-7054,58511
277,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,648,246,1398,income,2,964,-717,2719,806,-425,2386
278,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1055,119,2805,income,2,1793,-669,4304,1424,-218,3933
279,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,385,154,795,NA,NA,NA,NA,NA,385,154,795
280,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,624,34,1763,global,5,13129,-973,26836,6877,-50,24495
281,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,941,375,1948,global,4,33643,-2196,68308,17292,348,63475
282,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,151,3,398,global,1,32570,-35116,95353,16361,-24795,86080
283,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,1196,-4373,7094,income,1,5296,-4150,15210,3246,-4312,13899
284,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,1008,351,2093,global,2,86427,-27208,196775,43717,-7072,180308
285,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,1093,258,2556,NA,NA,NA,NA,NA,1093,258,2556
286,BLZ,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10203,-10080,31492,10203,-10080,31492
287,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gn,3g cephalosporins,BSI,global,3,214,79,486,global,2,605,-419,1668,410,-281,1507
288,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,BSI,global,4,276,68,684,NA,NA,NA,NA,NA,276,68,684
289,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,BSI,global,3,376,112,963,global,2,24106,-14067,63509,12241,-9591,57381
290,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,BSI,global,5,318,120,729,global,3,1041,-699,2844,680,-419,2507
291,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,213,80,471,global,2,1802,-695,4533,1007,-314,3940
292,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,COL/INF,global,9,267,94,625,NA,NA,NA,NA,NA,267,94,625
293,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,COL/INF,global,3,287,-2,836,global,5,13205,-956,26092,6746,-20,24326
294,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,COL/INF,global,7,442,166,991,global,4,33079,-1268,68441,16760,155,63049
295,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,IAI,global,1,72,0,207,global,1,35947,-30326,107749,18010,-22821,94396
296,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,RTI,global,1,538,-1711,3283,global,1,4953,-5077,14951,2746,-3328,13163
297,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,SSI,global,3,467,160,1032,global,2,85453,-26569,198270,42960,-6738,180946
298,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,SSTI,global,1,510,115,1314,NA,NA,NA,NA,NA,510,115,1314
299,BOL,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10003,-9689,28921,10003,-9689,28921
300,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,136,57,299,income,2,596,-476,1593,366,-276,1470
301,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,567,1,1572,NA,NA,NA,NA,NA,567,1,1572
302,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,240,80,547,global,2,23689,-16538,61302,11965,-8020,55515
303,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,192,78,421,income,2,947,-732,2677,570,-511,2335
304,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,308,24,862,income,2,1796,-687,4333,1052,-340,3898
305,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,115,47,248,NA,NA,NA,NA,NA,115,47,248
306,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,179,0,480,global,5,13559,-330,28150,6869,-5,25731
307,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,279,114,618,global,4,32894,-4315,65576,16586,104,61567
308,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,43,-2,124,global,1,35763,-31488,105162,17903,-17788,92453
309,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,352,-1017,2200,income,1,4773,-5107,14584,2563,-3314,13163
310,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,301,112,630,global,2,83750,-24763,193570,42025,-6224,175706
311,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,325,77,794,NA,NA,NA,NA,NA,325,77,794
312,BRA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9901,-9823,29794,9901,-9823,29794
313,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,BSI,income,3,2946,1131,6440,income,2,589,-460,1742,1767,-340,5569
314,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,BSI,income,3,3428,932,8467,NA,NA,NA,NA,NA,3428,932,8467
315,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,BSI,income,3,5223,1650,11819,income,2,23242,-12414,61472,14233,-7850,55499
316,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,BSI,income,5,4397,1668,9707,income,3,1011,-774,2732,2704,-458,8535
317,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,COL/INF,income,1,415,-1082,2290,global,2,1774,-861,4147,1095,-996,3824
318,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,COL/INF,income,8,4758,878,12201,NA,NA,NA,NA,NA,4758,878,12201
319,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,COL/INF,income,3,4164,200,11539,income,5,13190,-1967,27715,8677,-258,25492
320,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,COL/INF,income,7,6076,2384,13667,income,4,32880,-2227,67690,19478,1589,60513
321,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,IAI,income,1,961,35,2874,income,1,34066,-33125,98390,17514,-21576,89153
322,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,RTI,global,1,7482,-25163,48503,global,1,5153,-4763,15232,6317,-16122,38859
323,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSI,income,3,6518,2180,15414,income,2,82353,-33122,195752,44436,-8874,180318
324,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSTI,income,1,7006,1663,17474,NA,NA,NA,NA,NA,7006,1663,17474
325,BRB,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10069,-9401,29451,10069,-9401,29451
326,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,BSI,income,3,2964,1133,6414,income,2,586,-452,1643,1775,-267,5611
327,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,BSI,income,3,3434,842,8468,NA,NA,NA,NA,NA,3434,842,8468
328,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,BSI,income,3,5216,1603,12318,income,2,22589,-16742,60200,13902,-9904,53784
329,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,BSI,income,5,4432,1621,9928,income,3,992,-887,2667,2712,-541,8434
330,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,COL/INF,income,1,470,-1164,2493,wbregion,2,1761,-600,4300,1115,-933,3925
331,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,COL/INF,income,8,4832,665,11610,NA,NA,NA,NA,NA,4832,665,11610
332,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,COL/INF,income,3,4043,90,10940,income,5,13663,-1291,28191,8853,-343,25834
333,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,COL/INF,whoc,1,6600,2572,14292,income,4,33422,-2354,67631,20011,1744,61063
334,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,IAI,income,1,979,-35,2736,income,1,35363,-33577,105148,18171,-23144,96346
335,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,RTI,wbregion,1,6957,-25333,45026,wbregion,1,4899,-4762,15032,5928,-18881,36054
336,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,SSI,income,3,6494,2265,14837,income,2,84738,-23482,200321,45616,-10331,181979
337,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,SSTI,income,1,6965,1485,17785,NA,NA,NA,NA,NA,6965,1485,17785
338,BRN,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10383,-9117,29757,10383,-9117,29757
339,BTN,SEARO D,South Asia,SEARO,Lower middle income,gn,3g cephalosporins,BSI,global,3,594,230,1288,global,2,594,-519,1693,594,-334,1559
340,BTN,SEARO D,South Asia,SEARO,Lower middle income,gn,carbapenems,BSI,global,4,766,166,1973,NA,NA,NA,NA,NA,766,166,1973
341,BTN,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,BSI,global,3,1047,316,2442,global,2,24077,-14665,63612,12562,-7355,55863
342,BTN,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,BSI,global,5,881,327,1926,global,3,1000,-792,2765,941,-437,2525
343,BTN,SEARO D,South Asia,SEARO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,591,229,1264,global,2,1694,-778,4224,1143,-362,3875
344,BTN,SEARO D,South Asia,SEARO,Lower middle income,gn,carbapenems,COL/INF,global,9,751,274,1618,NA,NA,NA,NA,NA,751,274,1618
345,BTN,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,COL/INF,global,3,804,30,2237,global,5,13099,-1485,26708,6951,-133,24599
346,BTN,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,COL/INF,global,7,1227,471,2754,global,4,33513,-2865,69070,17370,443,63175
347,BTN,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,IAI,global,1,194,1,531,global,1,35288,-31617,98486,17741,-22209,88374
348,BTN,SEARO D,South Asia,SEARO,Lower middle income,gn,carbapenems,RTI,global,1,1761,-5010,10101,global,1,4877,-5102,15226,3319,-5102,13504
349,BTN,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,SSI,global,3,1309,484,2953,global,2,80973,-34829,197787,41141,-16773,179271
350,BTN,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,SSTI,global,1,1399,291,3410,NA,NA,NA,NA,NA,1399,291,3410
351,BTN,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10001,-8744,28559,10001,-8744,28559
352,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,716,264,1494,income,2,595,-500,1670,656,-246,1621
353,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,BSI,income,1,2986,223,8620,NA,NA,NA,NA,NA,2986,223,8620
354,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,BSI,global,3,1279,397,2869,global,2,24396,-15514,63283,12838,-10116,56539
355,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,BSI,income,2,1012,370,2161,income,2,944,-709,2723,978,-464,2450
356,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,COL/INF,whoc,1,2775,965,5971,income,2,1734,-878,4267,2255,-376,5201
357,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,COL/INF,income,1,606,221,1240,NA,NA,NA,NA,NA,606,221,1240
358,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,926,4,2495,global,5,13349,-671,27707,7137,-25,25518
359,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,COL/INF,global,7,1482,541,3039,global,4,32256,-2258,69228,16869,483,62413
360,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,IAI,global,1,228,-12,661,global,1,31897,-34524,100519,16063,-23561,86386
361,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,RTI,income,1,1892,-6173,12407,income,1,5160,-4528,14503,3526,-5140,13775
362,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSI,global,3,1578,531,3346,global,2,81631,-32360,193624,41605,-17360,174144
363,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSTI,global,1,1671,348,4047,NA,NA,NA,NA,NA,1671,348,4047
364,BWA,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9865,-9950,29017,9865,-9950,29017
365,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,32,12,72,global,2,591,-526,1737,311,-330,1507
366,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,41,11,105,NA,NA,NA,NA,NA,41,11,105
367,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,57,18,140,global,2,23650,-13836,63050,11854,-8926,56423
368,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,48,18,106,global,3,1017,-668,2727,533,-394,2426
369,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,124,46,281,global,2,1757,-813,4260,941,-386,3860
370,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,40,14,90,NA,NA,NA,NA,NA,40,14,90
371,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,42,1,121,global,5,12664,-1796,27150,6353,-6,24652
372,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,66,24,147,global,4,33893,126,66834,16979,24,62431
373,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,11,-1,34,global,1,32210,-33431,97039,16111,-23336,88029
374,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,87,-278,529,global,1,5090,-4134,14613,2588,-2485,12926
375,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,70,25,161,global,2,82970,-34866,187631,41520,-15132,176031
376,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,77,20,193,NA,NA,NA,NA,NA,77,20,193
377,CAF,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9802,-9847,30439,9802,-9847,30439
378,CAN,AMRO A,North America,PAHO,High income,gn,3g cephalosporins,BSI,income,3,5468,2020,11406,income,2,596,-480,1662,3032,-316,10234
379,CAN,AMRO A,North America,PAHO,High income,gn,carbapenems,BSI,income,3,6365,1449,15031,NA,NA,NA,NA,NA,6365,1449,15031
380,CAN,AMRO A,North America,PAHO,High income,gp,glycopeptides,BSI,whoc,3,9693,2978,21323,whoc,2,23143,-14678,61091,16418,-9229,55404
381,CAN,AMRO A,North America,PAHO,High income,gp,penicillins,BSI,income,5,8162,3073,17128,income,3,969,-760,2736,4565,-357,15348
382,CAN,AMRO A,North America,PAHO,High income,gn,3g cephalosporins,COL/INF,income,1,761,-2372,4241,global,2,1801,-832,4292,1281,-1728,4253
383,CAN,AMRO A,North America,PAHO,High income,gn,carbapenems,COL/INF,whoc,3,14234,1472,40470,NA,NA,NA,NA,NA,14234,1472,40470
384,CAN,AMRO A,North America,PAHO,High income,gp,glycopeptides,COL/INF,whoc,3,7413,278,19715,whoc,5,13231,-1489,26904,10322,-561,25280
385,CAN,AMRO A,North America,PAHO,High income,gp,penicillins,COL/INF,whoc,4,13401,5033,28907,whoc,4,32349,-337,67191,22875,3699,61470
386,CAN,AMRO A,North America,PAHO,High income,gp,glycopeptides,IAI,whoc,1,1800,-15,5260,whoc,1,34717,-30690,104245,18258,-19387,90448
387,CAN,AMRO A,North America,PAHO,High income,gn,carbapenems,RTI,global,1,14714,-45663,87913,global,1,4990,-5162,14698,9852,-34608,73949
388,CAN,AMRO A,North America,PAHO,High income,gp,penicillins,SSI,whoc,2,13467,4812,30285,whoc,2,83038,-35733,197395,48252,-16021,176623
389,CAN,AMRO A,North America,PAHO,High income,gp,penicillins,SSTI,income,1,13050,3307,30864,NA,NA,NA,NA,NA,13050,3307,30864
390,CAN,AMRO A,North America,PAHO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,whoc,1,9733,-10933,29151,9733,-10933,29151
391,CHE,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,11311,492,33598,income,2,592,-492,1684,5951,-390,26466
392,CHE,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,12210,-2504,39810,NA,NA,NA,NA,NA,12210,-2504,39810
393,CHE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,17134,5340,41460,income,2,23578,-13755,64253,20356,-8766,60095
394,CHE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,23510,6275,58166,income,3,995,-789,2771,12253,-499,49845
395,CHE,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,1303,-4101,7269,global,2,1828,-637,4426,1566,-2742,6069
396,CHE,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,9793,-8065,34623,NA,NA,NA,NA,NA,9793,-8065,34623
397,CHE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,12726,305,35679,income,5,12999,-1702,27729,12862,-633,32023
398,CHE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,11236,3458,26406,income,4,32192,-5571,67729,18221,2203,58126
399,CHE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,3163,-185,9137,income,1,34652,-33229,101741,18908,-22977,91607
400,CHE,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,26575,-64035,153193,global,1,4934,-4899,15097,15755,-49462,123572
401,CHE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,13594,2304,34013,income,2,83113,-27306,198694,48354,-12044,182423
402,CHE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,22933,4735,58526,NA,NA,NA,NA,NA,22933,4735,58526
403,CHE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10590,-8927,29849,10590,-8927,29849
404,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,BSI,income,3,1478,560,3216,income,2,599,-424,1723,1039,-283,2627
405,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,BSI,income,3,1755,448,4260,NA,NA,NA,NA,NA,1755,448,4260
406,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,BSI,income,3,2601,842,6000,income,2,24936,-12146,63177,13768,-6881,56733
407,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,BSI,income,5,2210,813,4891,income,3,1008,-697,2778,1609,-372,3977
408,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,COL/INF,income,1,216,-545,1163,global,2,1816,-644,4195,1016,-606,3826
409,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,COL/INF,income,8,2405,399,5823,NA,NA,NA,NA,NA,2405,399,5823
410,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,COL/INF,income,3,1962,45,5346,income,5,13232,-662,27794,7597,-63,25006
411,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,COL/INF,income,7,3052,1122,6491,income,4,31851,-3641,65565,17452,859,61269
412,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,IAI,income,1,479,-4,1332,income,1,32636,-34159,106220,16558,-24484,91605
413,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,RTI,global,1,3900,-10573,20901,global,1,4860,-4529,14392,4380,-8604,18049
414,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSI,income,3,3220,1135,7037,income,2,82703,-30576,198747,42962,-11405,179698
415,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSTI,income,1,3565,812,9615,NA,NA,NA,NA,NA,3565,812,9615
416,CHL,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10430,-8122,29970,10430,-8122,29970
417,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,419,159,841,income,2,606,-488,1765,512,-295,1539
418,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,BSI,whoc,1,378,142,827,NA,NA,NA,NA,NA,378,142,827
419,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,BSI,global,3,738,258,1668,global,2,24005,-16530,59976,12372,-9813,53834
420,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,BSI,whoc,1,680,212,1540,whoc,1,11779,-11097,34946,6230,-7596,30989
421,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,948,95,2558,income,2,1835,-627,4381,1392,-306,3927
422,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,COL/INF,income,1,353,135,713,NA,NA,NA,NA,NA,353,135,713
423,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,564,-4,1423,global,5,13622,-1113,27199,7093,-14,25723
424,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,COL/INF,wbregion,1,934,351,1894,global,4,32614,-3003,66865,16774,279,62457
425,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,IAI,global,1,133,-6,367,global,1,34607,-33886,102237,17370,-22598,90471
426,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,RTI,income,1,1052,-3743,6990,income,1,5272,-4950,15500,3162,-4401,13919
427,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSI,global,3,923,325,2015,global,2,84183,-23830,204113,42553,-12877,181436
428,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSTI,global,1,1014,218,2395,NA,NA,NA,NA,NA,1014,218,2395
429,CHN,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9763,-10506,28764,9763,-10506,28764
430,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,93,34,215,global,2,594,-491,1629,343,-315,1485
431,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,118,29,298,NA,NA,NA,NA,NA,118,29,298
432,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,162,48,398,global,2,23223,-16074,64332,11692,-9258,56394
433,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,139,50,308,global,3,1029,-761,2812,584,-471,2608
434,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,359,125,819,global,2,1805,-676,4215,1082,-385,3878
435,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,116,39,258,NA,NA,NA,NA,NA,116,39,258
436,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,121,-4,359,global,5,13639,219,27732,6880,-3,25665
437,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,193,67,443,global,4,33035,-2217,68399,16614,63,62804
438,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,31,-2,88,global,1,32050,-37186,99353,16041,-23324,89537
439,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,272,-740,1649,global,1,4831,-5041,14797,2551,-3539,13480
440,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,205,68,485,global,2,80818,-33438,188364,40512,-22456,169959
441,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,219,45,576,NA,NA,NA,NA,NA,219,45,576
442,CIV,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10136,-9079,31464,10136,-9079,31464
443,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,77,29,171,global,2,589,-478,1619,333,-303,1441
444,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,100,22,257,NA,NA,NA,NA,NA,100,22,257
445,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,133,37,305,global,2,23730,-14348,62392,11932,-7103,56354
446,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,114,43,248,global,3,991,-724,2867,553,-422,2432
447,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,77,28,162,global,2,1748,-784,4219,912,-305,3791
448,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,96,34,218,NA,NA,NA,NA,NA,96,34,218
449,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,103,0,281,global,5,13382,-508,27130,6743,-3,25431
450,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,158,60,353,global,4,32962,-1441,68521,16560,56,62542
451,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,25,-1,70,global,1,33645,-34676,101308,16835,-24313,91728
452,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,197,-649,1317,global,1,5082,-4496,14297,2639,-2706,13026
453,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,170,58,391,global,2,82617,-21698,196069,41393,-8056,174579
454,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,180,42,436,NA,NA,NA,NA,NA,180,42,436
455,CMR,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9934,-9876,31289,9934,-9876,31289
456,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,13,5,28,global,2,587,-515,1619,300,-362,1467
457,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,17,4,44,NA,NA,NA,NA,NA,17,4,44
458,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,23,7,56,global,2,24146,-14884,63856,12085,-8569,57432
459,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,20,7,42,global,3,1032,-665,2849,526,-454,2616
460,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,52,18,114,global,2,1714,-761,4279,883,-375,3857
461,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,17,6,35,NA,NA,NA,NA,NA,17,6,35
462,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,18,1,50,global,5,13226,-589,27764,6622,0,25102
463,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,27,10,59,global,4,31902,-4320,70374,15965,9,63379
464,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,4,0,13,global,1,35485,-32567,100758,17745,-22352,91714
465,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,32,-112,202,global,1,5074,-4780,15019,2553,-3336,13372
466,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,30,10,70,global,2,84347,-38019,204991,42188,-16294,183321
467,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,31,7,81,NA,NA,NA,NA,NA,31,7,81
468,COD,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10239,-10148,29865,10239,-10148,29865
469,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,153,57,327,global,2,571,-491,1676,362,-355,1485
470,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,196,47,488,NA,NA,NA,NA,NA,196,47,488
471,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,272,89,623,global,2,23561,-14710,60224,11916,-8625,55837
472,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,228,87,492,global,3,979,-836,2654,603,-559,2416
473,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,594,213,1327,global,2,1761,-803,4217,1177,-324,3741
474,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,193,72,418,NA,NA,NA,NA,NA,193,72,418
475,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,202,9,528,global,5,12994,-1195,26462,6598,-13,24209
476,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,317,119,681,global,4,31582,-3903,68331,15949,110,60096
477,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,50,-4,142,global,1,33590,-30634,102885,16820,-16980,90549
478,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,362,-1352,2286,global,1,5043,-4943,15029,2702,-3402,13427
479,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,333,119,740,global,2,84214,-31879,206093,42273,-6656,182612
480,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,366,86,934,NA,NA,NA,NA,NA,366,86,934
481,COG,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10063,-10543,30852,10063,-10543,30852
482,COK,WPRO B,NA,WPRO,NA,gn,3g cephalosporins,BSI,global,3,1083,411,2410,global,2,630,-406,1700,856,-246,2081
483,COK,WPRO B,NA,WPRO,NA,gn,carbapenems,BSI,whoc,1,971,345,2222,NA,NA,NA,NA,NA,971,345,2222
484,COK,WPRO B,NA,WPRO,NA,gp,glycopeptides,BSI,global,3,1884,541,4310,global,2,24441,-15443,64855,13163,-9815,57804
485,COK,WPRO B,NA,WPRO,NA,gp,penicillins,BSI,whoc,1,1710,489,4117,whoc,1,12221,-12560,34442,6966,-7562,30761
486,COK,WPRO B,NA,WPRO,NA,gn,3g cephalosporins,COL/INF,global,5,1518,369,3738,global,2,1821,-758,4383,1670,-289,4216
487,COK,WPRO B,NA,WPRO,NA,gn,carbapenems,COL/INF,global,9,1363,486,3055,NA,NA,NA,NA,NA,1363,486,3055
488,COK,WPRO B,NA,WPRO,NA,gp,glycopeptides,COL/INF,global,3,1445,105,4289,global,5,13551,-339,27388,7498,59,25417
489,COK,WPRO B,NA,WPRO,NA,gp,penicillins,COL/INF,global,7,2218,813,4864,global,4,33017,-2065,68340,17617,783,62053
490,COK,WPRO B,NA,WPRO,NA,gp,glycopeptides,IAI,global,1,340,-31,980,global,1,31975,-35127,99727,16157,-26864,88478
491,COK,WPRO B,NA,WPRO,NA,gn,carbapenems,RTI,global,1,3132,-9940,18719,global,1,4983,-4988,14863,4057,-7015,16366
492,COK,WPRO B,NA,WPRO,NA,gp,penicillins,SSI,global,3,2355,814,5694,global,2,84453,-35087,195706,43404,-15225,178563
493,COK,WPRO B,NA,WPRO,NA,gp,penicillins,SSTI,global,1,2549,575,6790,NA,NA,NA,NA,NA,2549,575,6790
494,COK,WPRO B,NA,WPRO,NA,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9772,-9127,29574,9772,-9127,29574
495,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,449,168,973,income,2,599,-475,1633,524,-281,1509
496,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,1865,66,4966,NA,NA,NA,NA,NA,1865,66,4966
497,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,793,259,1914,global,2,23121,-15308,63277,11957,-9436,56809
498,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,637,237,1413,income,2,924,-759,2657,781,-524,2432
499,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,981,38,2689,income,2,1781,-773,4312,1381,-432,3843
500,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,379,145,836,NA,NA,NA,NA,NA,379,145,836
501,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,612,36,1683,global,5,13287,-1114,26478,6950,-16,24259
502,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,927,353,1966,global,4,33301,-1871,69496,17114,330,62990
503,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,151,-5,453,global,1,35030,-28898,99506,17590,-21682,89662
504,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,1055,-3703,6974,income,1,4806,-4862,14343,2931,-4248,12793
505,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,1002,346,2363,global,2,83928,-38800,189148,42465,-15362,174203
506,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,1100,253,2950,NA,NA,NA,NA,NA,1100,253,2950
507,COL,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9840,-9249,29966,9840,-9249,29966
508,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,175,70,363,global,2,562,-624,1647,368,-419,1465
509,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,224,59,516,NA,NA,NA,NA,NA,224,59,516
510,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,311,98,695,global,2,23680,-17063,63223,11996,-9222,56565
511,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,262,104,543,global,3,955,-833,2635,609,-477,2441
512,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,175,69,363,global,2,1763,-683,4116,969,-329,3844
513,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,221,81,474,NA,NA,NA,NA,NA,221,81,474
514,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,243,17,632,global,5,12968,-1613,27604,6606,-10,25506
515,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,362,144,769,global,4,33234,-2640,69512,16798,135,63577
516,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,58,0,161,global,1,35323,-29189,99329,17691,-18227,89925
517,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,442,-1471,2740,global,1,5016,-4321,15198,2729,-3162,13196
518,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,384,133,812,global,2,82386,-33289,200520,41385,-16767,179868
519,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,417,99,990,NA,NA,NA,NA,NA,417,99,990
520,CPV,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9853,-9456,30180,9853,-9456,30180
521,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,927,358,2011,income,2,571,-511,1707,749,-400,1833
522,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,3877,93,10573,NA,NA,NA,NA,NA,3877,93,10573
523,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,1637,490,3722,global,2,23788,-15869,66091,12713,-10442,57508
524,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,1318,503,2859,income,2,933,-817,2624,1125,-559,2730
525,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,2091,141,5781,income,2,1761,-729,4260,1926,-451,5096
526,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,785,308,1651,NA,NA,NA,NA,NA,785,308,1651
527,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1265,75,3399,global,5,12739,-1944,26901,7002,-170,24688
528,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,1918,733,4110,global,4,33510,-2202,71196,17714,654,64691
529,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,305,-12,862,global,1,32519,-35880,100559,16412,-22946,90126
530,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,2766,-7428,16204,income,1,4963,-5493,14480,3865,-6432,15160
531,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,2039,739,4555,global,2,83787,-26859,195349,42913,-11574,174733
532,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,2221,466,5670,NA,NA,NA,NA,NA,2221,466,5670
533,CRI,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10157,-9887,29597,10157,-9887,29597
534,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,383,146,797,income,2,577,-454,1675,480,-341,1516
535,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,1629,68,4276,NA,NA,NA,NA,NA,1629,68,4276
536,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,whoc,3,683,222,1531,whoc,2,24022,-14425,63105,12352,-8529,57270
537,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,544,194,1164,income,2,890,-893,2540,717,-572,2290
538,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,868,68,2184,income,2,1765,-641,4262,1316,-298,3932
539,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,whoc,3,977,27,2510,NA,NA,NA,NA,NA,977,27,2510
540,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,whoc,3,516,5,1399,whoc,5,13176,316,28245,6846,7,26030
541,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,whoc,4,957,350,1987,whoc,4,32929,-1652,67816,16943,315,62932
542,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,whoc,1,127,-9,357,whoc,1,34283,-33118,102396,17205,-22565,92364
543,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,932,-3559,5776,income,1,4936,-5440,14450,2934,-4577,13032
544,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,whoc,2,951,328,2162,whoc,2,84736,-23673,203716,42844,-10013,186661
545,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,922,191,2269,NA,NA,NA,NA,NA,922,191,2269
546,CUB,AMRO A,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,whoc,1,10044,-8390,30213,10044,-8390,30213
547,CYP,EMRO E,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,income,3,3134,1113,7048,income,2,588,-483,1688,1861,-345,5937
548,CYP,EMRO E,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,income,3,3766,871,9232,NA,NA,NA,NA,NA,3766,871,9232
549,CYP,EMRO E,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,5537,1706,12912,income,2,25247,-15529,62666,15392,-6857,55918
550,CYP,EMRO E,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,income,5,4649,1629,9924,income,3,1007,-702,2715,2828,-430,8841
551,CYP,EMRO E,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,income,1,406,-1124,2536,global,2,1739,-927,4203,1073,-1090,3914
552,CYP,EMRO E,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,1,2636,955,5727,NA,NA,NA,NA,NA,2636,955,5727
553,CYP,EMRO E,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,4261,306,11808,income,5,12914,-975,26523,8588,174,24224
554,CYP,EMRO E,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,income,7,6483,2265,14424,income,4,32164,-3949,69429,19323,1259,64001
555,CYP,EMRO E,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1019,5,2867,income,1,34351,-34107,104565,17685,-22284,92027
556,CYP,EMRO E,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,8833,-22971,50147,global,1,5091,-4085,14665,6962,-17161,40609
557,CYP,EMRO E,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,income,3,6895,2212,15704,income,2,82638,-27487,196929,44766,-12495,179064
558,CYP,EMRO E,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,income,1,7305,1697,18796,NA,NA,NA,NA,NA,7305,1697,18796
559,CYP,EMRO E,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9997,-9509,28200,9997,-9509,28200
560,CZE,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,2376,99,6488,income,2,594,-490,1698,1485,-374,5451
561,CZE,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,2541,-627,7472,NA,NA,NA,NA,NA,2541,-627,7472
562,CZE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,3553,1087,8857,income,2,23245,-16972,64617,13399,-9849,58385
563,CZE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,4864,1193,12427,income,3,1020,-839,2730,2942,-460,10113
564,CZE,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,280,-771,1475,global,2,1762,-751,4330,1021,-771,3852
565,CZE,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,2143,-1830,8037,NA,NA,NA,NA,NA,2143,-1830,8037
566,CZE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,2715,86,7359,income,5,13279,-938,28090,7997,-134,25340
567,CZE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,2352,691,6137,income,4,32041,-4148,67623,17196,483,63161
568,CZE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,674,8,1991,income,1,33141,-33435,98254,16908,-23522,89333
569,CZE,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,5382,-17274,34090,global,1,5041,-3995,14672,5212,-12576,25116
570,CZE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,2871,539,7469,income,2,83546,-30692,197410,43208,-10697,179626
571,CZE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,4832,1026,12424,NA,NA,NA,NA,NA,4832,1026,12424
572,CZE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10036,-9872,32693,10036,-9872,32693
573,DEU,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,5912,268,15698,income,2,578,-479,1635,3245,-380,13631
574,DEU,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,6483,-1799,19877,NA,NA,NA,NA,NA,6483,-1799,19877
575,DEU,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,8976,2862,20186,income,2,23480,-15380,62279,16228,-8952,57651
576,DEU,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,12249,3162,29613,income,3,1036,-709,2700,6643,-429,26056
577,DEU,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,634,-2007,3680,global,2,1744,-959,4313,1189,-1634,4101
578,DEU,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,5005,-5384,19046,NA,NA,NA,NA,NA,5005,-5384,19046
579,DEU,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,6711,129,18284,income,5,13297,-1028,27713,10004,-344,25473
580,DEU,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,6027,1879,13552,income,4,31803,-2726,64893,18915,1514,60458
581,DEU,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1711,28,4663,income,1,35976,-36886,106621,18843,-25212,91846
582,DEU,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,14777,-37006,87222,global,1,4947,-5109,15139,9862,-29027,69262
583,DEU,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,7199,1258,17972,income,2,80530,-35257,196127,43865,-14965,176318
584,DEU,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,12169,2701,29229,NA,NA,NA,NA,NA,12169,2701,29229
585,DEU,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10012,-9271,30688,10012,-9271,30688
586,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,201,79,432,global,2,619,-453,1636,410,-279,1504
587,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,BSI,wbregion,1,-21,-587,575,NA,NA,NA,NA,NA,-21,-587,575
588,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,BSI,global,3,355,114,818,global,2,23770,-11888,65464,12063,-7383,57289
589,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,BSI,global,5,298,109,664,global,3,1006,-707,2744,652,-407,2474
590,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,200,76,431,global,2,1712,-738,4070,956,-368,3738
591,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,COL/INF,wbregion,3,169,64,359,NA,NA,NA,NA,NA,169,64,359
592,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,268,1,749,global,5,13126,-1136,27363,6697,-20,25483
593,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,COL/INF,global,7,415,154,921,global,4,32835,-1829,65604,16625,144,60469
594,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,IAI,global,1,67,-2,188,global,1,34398,-31602,97640,17232,-22067,89372
595,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,RTI,global,1,544,-1710,3405,global,1,5049,-4745,14769,2797,-3377,13770
596,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,SSI,global,3,440,157,1017,global,2,85547,-19095,206023,42993,-3766,187157
597,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,SSTI,global,1,471,115,1122,NA,NA,NA,NA,NA,471,115,1122
598,DJI,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10154,-9304,29975,10154,-9304,29975
599,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,1076,426,2237,income,2,605,-478,1676,840,-329,1990
600,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,4580,75,11575,NA,NA,NA,NA,NA,4580,75,11575
601,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,1887,594,4264,global,2,24224,-15211,63523,13056,-7485,57216
602,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,1526,576,3176,income,2,976,-703,2770,1251,-466,3011
603,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,2491,204,6282,income,2,1787,-671,4167,2139,-371,5601
604,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,907,354,1891,NA,NA,NA,NA,NA,907,354,1891
605,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1415,-12,3923,global,5,13024,-1262,28430,7220,-174,25112
606,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,2217,849,4562,global,4,32322,-5256,69001,17269,711,62247
607,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,347,-32,977,global,1,36128,-31436,106476,18238,-20961,96948
608,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,2697,-9046,15757,income,1,4878,-5194,14883,3788,-7352,15180
609,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,2353,858,4868,global,2,83604,-24873,190679,42979,-9297,174554
610,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,2551,591,5772,NA,NA,NA,NA,NA,2551,591,5772
611,DMA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9813,-8889,29633,9813,-8889,29633
612,DNK,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,8008,486,21370,income,2,586,-443,1589,4297,-368,18068
613,DNK,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,8272,-2226,25059,NA,NA,NA,NA,NA,8272,-2226,25059
614,DNK,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,12123,3708,29158,income,2,23114,-16527,61718,17619,-10695,56570
615,DNK,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,16253,4450,39924,income,3,1056,-717,2737,8655,-419,33852
616,DNK,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,937,-2344,5320,global,2,1731,-708,4268,1334,-1794,4572
617,DNK,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,6416,-7550,25894,NA,NA,NA,NA,NA,6416,-7550,25894
618,DNK,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,9299,-260,25760,income,5,12886,-1127,26908,11093,-549,26828
619,DNK,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,7940,2323,18993,income,4,33694,-684,69411,20817,1847,62461
620,DNK,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,2272,-173,6819,income,1,34760,-34107,102313,18516,-19730,89786
621,DNK,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,15687,-64956,97974,global,1,5255,-4458,14557,10471,-46407,84122
622,DNK,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,9737,1483,24824,income,2,83430,-34025,203686,46583,-16787,179282
623,DNK,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,16345,3578,41492,NA,NA,NA,NA,NA,16345,3578,41492
624,DNK,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10075,-8776,28581,10075,-8776,28581
625,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,458,168,1010,income,2,612,-443,1663,535,-261,1499
626,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,1927,36,4986,NA,NA,NA,NA,NA,1927,36,4986
627,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,812,256,1899,global,2,24049,-16022,60913,12431,-8033,54166
628,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,647,228,1469,income,2,938,-772,2624,793,-521,2328
629,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1045,117,2750,income,2,1776,-683,4274,1411,-310,3827
630,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,385,139,848,NA,NA,NA,NA,NA,385,139,848
631,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,627,17,1809,global,5,13579,-781,27902,7103,-15,25431
632,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,945,324,2085,global,4,33499,-3868,70978,17222,244,63821
633,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,152,-3,453,global,1,31718,-35758,96087,15935,-25581,88071
634,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,1273,-3820,7729,income,1,4866,-4909,14631,3070,-4408,13213
635,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,997,342,2214,global,2,81155,-34618,199037,41076,-15764,181393
636,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,1100,268,2721,NA,NA,NA,NA,NA,1100,268,2721
637,DOM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9562,-9956,29476,9562,-9956,29476
638,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,899,338,1983,income,2,598,-478,1700,749,-321,1818
639,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gn,carbapenems,BSI,income,1,3744,-73,10185,NA,NA,NA,NA,NA,3744,-73,10185
640,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gp,glycopeptides,BSI,global,3,1575,493,3724,global,2,23396,-17276,60786,12486,-10279,55205
641,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gp,penicillins,BSI,income,2,1278,444,2791,income,2,930,-804,2737,1104,-569,2757
642,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gn,3g cephalosporins,COL/INF,whoc,1,899,330,1972,income,2,1783,-847,4249,1341,-339,3945
643,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gn,carbapenems,COL/INF,income,1,758,279,1731,NA,NA,NA,NA,NA,758,279,1731
644,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1210,42,3240,global,5,13217,-778,28884,7213,-77,25283
645,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gp,penicillins,COL/INF,global,7,1858,644,4232,global,4,32589,-4975,68677,17223,549,62956
646,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gp,glycopeptides,IAI,global,1,298,-24,855,global,1,34771,-31994,101491,17535,-21655,92133
647,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gn,carbapenems,RTI,income,1,2343,-8393,15775,income,1,4973,-4357,14524,3658,-6280,14701
648,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gp,penicillins,SSI,global,3,1990,694,4719,global,2,84726,-31000,197100,43358,-9779,180762
649,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gp,penicillins,SSTI,global,1,2103,513,5390,NA,NA,NA,NA,NA,2103,513,5390
650,DZA,AFRO D,Middle East & North Africa,AFRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9716,-8846,29139,9716,-8846,29139
651,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,528,209,1108,income,2,563,-460,1721,546,-318,1502
652,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,2191,6,5827,NA,NA,NA,NA,NA,2191,6,5827
653,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,933,294,2185,global,2,22700,-16618,59008,11816,-10948,54186
654,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,760,298,1685,income,2,908,-802,2647,834,-547,2397
655,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1203,68,3240,income,2,1858,-627,4260,1531,-327,4035
656,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,447,179,942,NA,NA,NA,NA,NA,447,179,942
657,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,720,26,1881,global,5,13484,-795,28274,7102,-47,25833
658,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,1092,407,2275,global,4,32168,-6994,66312,16630,-242,61349
659,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,178,-8,498,global,1,35339,-29561,99853,17759,-20534,89225
660,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,1384,-4782,8690,income,1,5091,-5091,14710,3237,-4889,13216
661,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,1160,418,2574,global,2,82038,-29140,197276,41599,-17619,174388
662,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,1268,289,3112,NA,NA,NA,NA,NA,1268,289,3112
663,ECU,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9904,-9524,29771,9904,-9524,29771
664,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,165,63,357,global,2,587,-512,1641,376,-347,1481
665,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,BSI,wbregion,1,-17,-501,493,NA,NA,NA,NA,NA,-17,-501,493
666,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,BSI,global,3,290,95,680,global,2,24049,-13433,63698,12169,-8621,57960
667,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,BSI,global,5,247,97,535,global,3,1030,-774,2845,639,-517,2505
668,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,165,64,366,global,2,1830,-697,4178,998,-340,3811
669,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,COL/INF,wbregion,3,139,54,303,NA,NA,NA,NA,NA,139,54,303
670,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,222,13,579,global,5,13046,-1034,27300,6634,-7,24506
671,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,COL/INF,global,7,341,132,757,global,4,31697,-4880,65644,16019,101,61421
672,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,IAI,global,1,53,-1,149,global,1,34133,-40751,102503,17093,-23886,85958
673,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,RTI,global,1,383,-1515,2686,global,1,5096,-4519,15116,2739,-3233,13071
674,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,SSI,global,3,361,128,782,global,2,85685,-30151,204354,43023,-11333,184166
675,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,SSTI,global,1,398,89,1003,NA,NA,NA,NA,NA,398,89,1003
676,EGY,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10300,-9331,30149,10300,-9331,30149
677,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,32,12,71,global,2,593,-535,1714,312,-375,1584
678,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,41,9,102,NA,NA,NA,NA,NA,41,9,102
679,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,56,17,134,global,2,23725,-17868,65574,11891,-10070,58284
680,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,48,18,109,global,3,987,-851,2659,517,-560,2408
681,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,122,42,272,global,2,1828,-882,4280,975,-444,3889
682,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,40,13,89,NA,NA,NA,NA,NA,40,13,89
683,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,41,1,117,global,5,13081,-702,27433,6561,-1,25395
684,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,66,24,145,global,4,32986,-2893,68210,16526,22,63290
685,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,10,0,30,global,1,32894,-33627,99307,16452,-23831,90250
686,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,92,-282,583,global,1,5156,-4116,14647,2624,-2881,13562
687,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,70,23,163,global,2,80232,-35826,195295,40151,-22144,176076
688,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,75,18,197,NA,NA,NA,NA,NA,75,18,197
689,ERI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10537,-7331,29277,10537,-7331,29277
690,ESP,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,3932,142,10286,income,2,596,-485,1691,2264,-388,8946
691,ESP,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,4260,-869,12859,NA,NA,NA,NA,NA,4260,-869,12859
692,ESP,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,5890,1841,13229,income,2,24260,-12251,63809,15075,-9541,56313
693,ESP,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,7984,1984,19243,income,3,1027,-795,2785,4505,-422,16253
694,ESP,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,468,-1291,2536,global,2,1777,-796,4137,1123,-1128,3912
695,ESP,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,3135,-3207,11543,NA,NA,NA,NA,NA,3135,-3207,11543
696,ESP,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,4474,42,12253,income,5,13224,-639,27952,8849,-188,25113
697,ESP,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,3868,1187,9175,income,4,32351,-3566,66133,18109,868,61716
698,ESP,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1108,2,3031,income,1,36638,-32339,106430,18873,-19685,93170
699,ESP,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,8965,-27656,58275,global,1,5065,-3962,14802,7015,-20039,44017
700,ESP,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,4756,776,12078,income,2,82529,-35647,195274,43642,-9906,176607
701,ESP,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,7901,1549,19124,NA,NA,NA,NA,NA,7901,1549,19124
702,ESP,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10199,-9514,29329,10199,-9514,29329
703,EST,EURO C,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,income,3,1770,725,3615,income,2,600,-453,1702,1185,-309,3210
704,EST,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,income,3,2074,495,4741,NA,NA,NA,NA,NA,2074,495,4741
705,EST,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,3138,1071,6812,income,2,23520,-16848,63379,13329,-9577,56089
706,EST,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,income,5,2635,1083,5485,income,3,1011,-752,2785,1823,-452,4815
707,EST,EURO C,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,income,1,254,-639,1394,global,2,1756,-614,4248,1005,-639,3916
708,EST,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,income,8,2843,515,7028,NA,NA,NA,NA,NA,2843,515,7028
709,EST,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,2399,189,6312,income,5,13222,-477,27388,7811,61,24360
710,EST,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,income,7,3668,1432,7379,income,4,32289,-4873,66053,17979,1005,60838
711,EST,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,569,-15,1617,income,1,34561,-35452,96732,17565,-24543,88805
712,EST,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,4889,-15620,30299,global,1,5037,-4512,14599,4963,-11178,22234
713,EST,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,income,3,3840,1441,7949,income,2,80683,-35746,202474,42262,-17448,183742
714,EST,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,income,1,4247,1061,9659,NA,NA,NA,NA,NA,4247,1061,9659
715,EST,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10089,-9520,28946,10089,-9520,28946
716,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,29,11,63,global,2,595,-567,1687,312,-360,1514
717,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,37,9,90,NA,NA,NA,NA,NA,37,9,90
718,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,51,16,114,global,2,23184,-17630,63211,11618,-10326,56103
719,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,43,16,96,global,3,1013,-854,2790,528,-518,2530
720,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,112,40,254,global,2,1788,-775,4248,950,-320,3876
721,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,36,13,80,NA,NA,NA,NA,NA,36,13,80
722,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,39,3,103,global,5,13319,-1100,27324,6679,-3,25512
723,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,59,22,132,global,4,33238,-692,65980,16649,21,61794
724,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,10,0,27,global,1,35196,-29265,103540,17603,-22089,90339
725,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,81,-240,475,global,1,5017,-5111,14470,2549,-3467,12910
726,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,63,23,146,global,2,84103,-36387,209655,42083,-19645,184788
727,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,70,17,172,NA,NA,NA,NA,NA,70,17,172
728,ETH,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10068,-10239,29948,10068,-10239,29948
729,FIN,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,6453,192,18477,income,2,604,-479,1657,3528,-437,14799
730,FIN,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,6946,-1818,21228,NA,NA,NA,NA,NA,6946,-1818,21228
731,FIN,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,9521,3152,21666,income,2,24005,-17190,61273,16763,-8476,56286
732,FIN,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,12964,3537,30598,income,3,1025,-573,2796,6995,-409,26459
733,FIN,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,699,-2153,3778,global,2,1764,-508,4117,1231,-1613,4068
734,FIN,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,5690,-5254,20731,NA,NA,NA,NA,NA,5690,-5254,20731
735,FIN,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,7563,175,20643,income,5,13455,-1675,27126,10509,-661,25846
736,FIN,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,6271,1864,14806,income,4,33656,-2269,69122,19964,1109,63358
737,FIN,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1780,-82,4965,income,1,34915,-33708,103413,18348,-22834,92970
738,FIN,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,13678,-44806,92668,global,1,5091,-4792,15045,9384,-31643,69568
739,FIN,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,7769,1354,19066,income,2,84051,-25615,199043,45910,-6346,184214
740,FIN,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,12983,2934,32840,NA,NA,NA,NA,NA,12983,2934,32840
741,FIN,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10469,-9436,29608,10469,-9436,29608
742,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,237,95,479,income,2,606,-439,1695,422,-271,1487
743,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,BSI,whoc,1,215,82,443,NA,NA,NA,NA,NA,215,82,443
744,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,BSI,global,3,418,141,926,global,2,24486,-14437,62292,12452,-7086,56926
745,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,BSI,whoc,1,376,127,810,whoc,1,12430,-10997,35806,6403,-6741,31364
746,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,539,56,1316,income,2,1733,-623,4200,1136,-234,3847
747,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,COL/INF,income,1,200,80,390,NA,NA,NA,NA,NA,200,80,390
748,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,318,5,871,global,5,13195,-931,27859,6756,-42,25479
749,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,COL/INF,wbregion,1,530,211,1062,global,4,33582,-1570,68187,17056,205,62237
750,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,IAI,global,1,79,1,222,global,1,35648,-31125,103360,17863,-19842,92491
751,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,RTI,income,1,657,-1857,3923,income,1,5257,-3944,14945,2957,-3161,13797
752,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSI,global,3,525,199,1120,global,2,82800,-35237,199283,41663,-21617,177488
753,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSTI,global,1,557,127,1284,NA,NA,NA,NA,NA,557,127,1284
754,FJI,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10281,-11152,29817,10281,-11152,29817
755,FRA,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,5456,162,14815,income,2,610,-490,1666,3033,-407,12399
756,FRA,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,5867,-1474,18095,NA,NA,NA,NA,NA,5867,-1474,18095
757,FRA,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,8029,2586,18367,income,2,24210,-14746,64850,16120,-8424,57513
758,FRA,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,10934,2631,25846,income,3,1034,-709,2797,5984,-379,22811
759,FRA,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,653,-1729,3523,global,2,1771,-661,4150,1212,-1331,3969
760,FRA,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,4528,-4566,17590,NA,NA,NA,NA,NA,4528,-4566,17590
761,FRA,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,6185,111,17957,income,5,13106,-414,26932,9646,-18,24999
762,FRA,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,5266,1568,12042,income,4,33007,-3298,66646,19136,1169,61639
763,FRA,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1474,-200,4374,income,1,34493,-35775,104842,17984,-23431,91635
764,FRA,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,12141,-34504,71535,global,1,4963,-4973,14528,8552,-25937,57966
765,FRA,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,6507,1344,17623,income,2,87047,-25204,211296,46777,-4698,189322
766,FRA,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,10697,2988,27096,NA,NA,NA,NA,NA,10697,2988,27096
767,FRA,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9608,-10845,28676,9608,-10845,28676
768,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,341,134,773,global,2,599,-560,1605,470,-343,1442
769,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,BSI,whoc,1,302,110,665,NA,NA,NA,NA,NA,302,110,665
770,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,BSI,global,3,601,193,1416,global,2,22217,-16678,62907,11409,-10669,53778
771,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,BSI,whoc,1,552,163,1312,whoc,1,12169,-11422,34709,6361,-6109,31074
772,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,340,135,738,wbregion,2,1792,-689,4298,1066,-286,3943
773,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,COL/INF,global,9,427,164,946,NA,NA,NA,NA,NA,427,164,946
774,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,449,-4,1290,global,5,13524,-747,26278,6987,-47,24845
775,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,759,301,1642,global,4,32390,-1848,67458,16575,262,60933
776,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,IAI,global,1,115,-1,302,global,1,34165,-32458,101358,17140,-23002,89071
777,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,RTI,wbregion,1,821,-2652,5582,wbregion,1,5136,-3590,14674,2978,-3142,13169
778,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSI,global,3,749,281,1699,global,2,83629,-37187,204972,42189,-18011,179870
779,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSTI,global,1,807,205,1974,NA,NA,NA,NA,NA,807,205,1974
780,FSM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10264,-8639,29932,10264,-8639,29932
781,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,768,283,1720,income,2,616,-439,1719,692,-267,1720
782,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,BSI,income,1,3096,70,8625,NA,NA,NA,NA,NA,3096,70,8625
783,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,BSI,global,3,1359,415,3429,global,2,23902,-15490,63824,12631,-8601,56930
784,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,BSI,income,2,1084,386,2416,income,2,936,-694,2708,1010,-442,2590
785,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,COL/INF,whoc,1,765,272,1762,income,2,1743,-684,4391,1254,-308,3893
786,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,COL/INF,income,1,647,230,1489,NA,NA,NA,NA,NA,647,230,1489
787,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1014,0,2866,global,5,13157,-1435,27341,7085,-172,25090
788,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,COL/INF,global,7,1599,578,3807,global,4,33510,-2034,67125,17554,509,61861
789,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,IAI,global,1,251,-9,710,global,1,34187,-34917,102126,17219,-21240,91410
790,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,RTI,income,1,1974,-6315,12724,income,1,4854,-5114,14944,3414,-5835,14533
791,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSI,global,3,1704,559,4122,global,2,82640,-32230,192147,42172,-20111,180739
792,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSTI,global,1,1838,426,4866,NA,NA,NA,NA,NA,1838,426,4866
793,GAB,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9400,-9752,29625,9400,-9752,29625
794,GBR,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,5432,118,15574,income,2,570,-507,1701,3001,-410,12823
795,GBR,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,5681,-2138,18352,NA,NA,NA,NA,NA,5681,-2138,18352
796,GBR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,8166,2752,18643,income,2,22956,-17090,60148,15561,-9397,55145
797,GBR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,11334,3085,27883,income,3,1053,-655,2764,6194,-416,23591
798,GBR,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,652,-1673,3784,global,2,1828,-677,4298,1240,-1272,4207
799,GBR,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,4941,-4469,17757,NA,NA,NA,NA,NA,4941,-4469,17757
800,GBR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,6228,-55,17077,income,5,13443,-638,26824,9835,-412,25023
801,GBR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,5381,1388,13016,income,4,32582,-1867,67669,18981,1101,61750
802,GBR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1519,9,4184,income,1,34101,-33339,99609,17810,-22760,92906
803,GBR,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,13165,-40439,79252,global,1,4982,-5136,14651,9073,-29671,64429
804,GBR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,6518,1277,16764,income,2,84447,-37906,202702,45482,-19746,184326
805,GBR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,11075,2696,27417,NA,NA,NA,NA,NA,11075,2696,27417
806,GBR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10002,-9595,30847,10002,-9595,30847
807,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,187,76,411,income,2,611,-450,1730,399,-282,1519
808,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,786,34,2310,NA,NA,NA,NA,NA,786,34,2310
809,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,331,108,783,global,2,23665,-14353,64258,11998,-8655,56033
810,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,266,104,602,income,2,875,-728,2557,570,-481,2266
811,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,431,43,1172,income,2,1766,-816,4283,1099,-472,3915
812,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,158,63,337,NA,NA,NA,NA,NA,158,63,337
813,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,253,14,758,global,5,12899,-949,26164,6576,0,24175
814,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,217,69,542,global,4,33293,-759,67607,16755,65,61963
815,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,61,-5,164,global,1,34471,-29294,102777,17266,-19856,91113
816,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,469,-1646,2862,income,1,4975,-4477,14967,2722,-3123,13160
817,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,271,42,720,global,2,81396,-27032,190384,40834,-9955,173209
818,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,446,97,1174,NA,NA,NA,NA,NA,446,97,1174
819,GEO,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10069,-11667,28850,10069,-11667,28850
820,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,60,23,123,global,2,593,-577,1734,327,-369,1591
821,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,76,18,172,NA,NA,NA,NA,NA,76,18,172
822,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,105,33,235,global,2,23529,-14732,63146,11817,-9530,56523
823,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,89,34,187,global,3,1029,-642,2728,559,-421,2532
824,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,60,23,120,global,2,1823,-595,4332,941,-280,3889
825,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,75,28,161,NA,NA,NA,NA,NA,75,28,161
826,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,78,4,213,global,5,13501,-269,26632,6789,3,24630
827,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,123,46,261,global,4,31565,-3123,64909,15844,43,60060
828,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,19,-1,57,global,1,32449,-30542,100242,16234,-23624,89479
829,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,157,-411,858,global,1,5104,-4477,15650,2630,-3230,13667
830,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,131,47,292,global,2,82720,-29212,195666,41426,-9101,178771
831,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,141,32,339,NA,NA,NA,NA,NA,141,32,339
832,GHA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10030,-10006,29156,10030,-10006,29156
833,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,30,12,60,global,2,610,-488,1692,320,-311,1502
834,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,39,10,93,NA,NA,NA,NA,NA,39,10,93
835,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,53,18,120,global,2,23959,-13612,65360,12006,-7606,57468
836,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,44,18,90,global,3,1034,-629,2652,539,-341,2356
837,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,30,12,61,global,2,1789,-644,4359,909,-267,3835
838,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,38,14,83,NA,NA,NA,NA,NA,38,14,83
839,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,40,2,105,global,5,13141,-189,26836,6591,2,24585
840,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,61,25,126,global,4,33629,-31,67466,16845,25,62385
841,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,10,0,25,global,1,34163,-30191,104829,17086,-22282,91361
842,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,84,-221,489,global,1,5097,-4667,15201,2591,-3477,13294
843,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,65,24,148,global,2,85607,-34191,204054,42836,-15432,185511
844,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,70,16,166,NA,NA,NA,NA,NA,70,16,166
845,GIN,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9687,-11466,28585,9687,-11466,28585
846,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,47,19,97,global,2,578,-426,1617,313,-312,1451
847,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,61,16,151,NA,NA,NA,NA,NA,61,16,151
848,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,84,28,195,global,2,22845,-12115,61668,11464,-5910,55540
849,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,71,30,151,global,3,1041,-587,2693,556,-287,2439
850,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,47,19,100,global,2,1790,-805,4222,919,-348,3876
851,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,60,23,135,NA,NA,NA,NA,NA,60,23,135
852,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,65,-1,186,global,5,13184,54,26819,6625,-1,24457
853,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,98,38,203,global,4,32710,-1807,66428,16404,34,61511
854,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,15,-1,44,global,1,35834,-37654,105394,17925,-23640,93026
855,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,157,-371,912,global,1,4912,-4363,14521,2535,-3432,13150
856,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,104,37,233,global,2,85605,-27210,202776,42855,-9726,178883
857,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,113,21,274,NA,NA,NA,NA,NA,113,21,274
858,GMB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10254,-8727,29778,10254,-8727,29778
859,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,35,13,82,global,2,603,-523,1701,319,-333,1533
860,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,44,11,102,NA,NA,NA,NA,NA,44,11,102
861,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,62,17,156,global,2,22824,-15673,61609,11443,-9507,56441
862,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,53,19,116,global,3,1022,-640,2683,537,-436,2452
863,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,35,13,78,global,2,1794,-828,4194,915,-430,3750
864,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,44,16,97,NA,NA,NA,NA,NA,44,16,97
865,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,47,2,132,global,5,13209,-772,27424,6628,0,25503
866,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,73,26,170,global,4,33030,-2009,68090,16551,24,62345
867,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,12,0,35,global,1,33938,-32128,100934,16975,-23359,91782
868,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,84,-310,552,global,1,4837,-4990,14003,2461,-3252,13027
869,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,77,26,181,global,2,84682,-38015,196886,42380,-18356,182878
870,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,84,20,218,NA,NA,NA,NA,NA,84,20,218
871,GNB,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10118,-8084,28709,10118,-8084,28709
872,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,1623,614,3506,income,2,589,-527,1592,1106,-324,3106
873,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,BSI,income,1,6925,148,19467,NA,NA,NA,NA,NA,6925,148,19467
874,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,BSI,global,3,2837,890,6733,global,2,23879,-14421,62626,13358,-8705,57448
875,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,BSI,income,2,2327,862,5204,income,2,962,-858,2697,1644,-455,4480
876,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,COL/INF,whoc,1,1622,639,3504,income,2,1840,-702,4418,1731,-274,4149
877,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,COL/INF,income,1,1374,534,2945,NA,NA,NA,NA,NA,1374,534,2945
878,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,2163,8,6332,global,5,13088,-622,26060,7625,-150,23988
879,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,COL/INF,global,7,3385,1264,7288,global,4,33374,-1891,70190,18379,1092,64566
880,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,IAI,global,1,517,-53,1426,global,1,33422,-34406,104638,16969,-23030,92740
881,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,RTI,income,1,4427,-14846,27510,income,1,5070,-4495,14459,4748,-10253,22755
882,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSI,global,3,3582,1255,8100,global,2,83850,-30864,196406,43716,-10616,176633
883,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSTI,global,1,3820,945,9817,NA,NA,NA,NA,NA,3820,945,9817
884,GNQ,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9885,-10423,29210,9885,-10423,29210
885,GRC,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,3291,291,9339,income,2,610,-413,1641,1950,-309,7916
886,GRC,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,3594,-445,11640,NA,NA,NA,NA,NA,3594,-445,11640
887,GRC,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,4881,1392,11227,income,2,24620,-11341,64931,14750,-6967,59018
888,GRC,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,6644,1519,16498,income,3,1043,-777,2772,3843,-522,14372
889,GRC,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,425,-1044,2242,global,2,1774,-810,4329,1099,-988,3969
890,GRC,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,2782,-2586,9823,NA,NA,NA,NA,NA,2782,-2586,9823
891,GRC,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,3694,81,10381,income,5,13386,-1110,27736,8540,-330,25873
892,GRC,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,3121,914,7557,income,4,32867,-3668,68373,17994,738,63382
893,GRC,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,872,-31,2468,income,1,35328,-29162,103999,18100,-19738,91676
894,GRC,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,6949,-22838,45473,global,1,4905,-5775,15042,5927,-17283,35142
895,GRC,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,3905,617,10178,income,2,84564,-27208,195748,44234,-9437,176651
896,GRC,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,6386,1488,16264,NA,NA,NA,NA,NA,6386,1488,16264
897,GRC,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9733,-9282,30844,9733,-9282,30844
898,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,837,316,1752,income,2,615,-474,1700,726,-291,1745
899,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,3473,24,9187,NA,NA,NA,NA,NA,3473,24,9187
900,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,1470,478,3322,global,2,23642,-16437,66424,12556,-10532,59240
901,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,1181,430,2452,income,2,948,-846,2787,1065,-525,2666
902,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1876,78,4919,income,2,1777,-581,4163,1827,-254,4605
903,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,703,281,1430,NA,NA,NA,NA,NA,703,281,1430
904,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1091,-13,2893,global,5,13403,-135,26793,7247,-28,24268
905,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,1733,677,3677,global,4,33229,-2340,68730,17481,604,62976
906,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,271,-25,702,global,1,33817,-34279,103088,17044,-22062,92799
907,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,2254,-7018,13490,income,1,4896,-4636,14938,3575,-5720,14278
908,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,1838,644,3971,global,2,85018,-31692,196404,43428,-10119,178631
909,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,1952,375,4836,NA,NA,NA,NA,NA,1952,375,4836
910,GRD,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10607,-8952,30313,10607,-8952,30313
911,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,247,97,516,income,2,604,-508,1715,425,-336,1525
912,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,1030,75,2669,NA,NA,NA,NA,NA,1030,75,2669
913,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,430,135,985,global,2,23746,-12994,61281,12088,-7494,55004
914,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,351,132,754,income,2,918,-902,2731,635,-578,2385
915,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,558,47,1416,income,2,1794,-731,4462,1176,-274,3923
916,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,208,85,447,NA,NA,NA,NA,NA,208,85,447
917,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,334,18,931,global,5,13291,-1616,27768,6813,-40,25258
918,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,511,202,1089,global,4,33146,-834,68038,16828,194,61071
919,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,80,-4,216,global,1,34071,-30883,103251,17075,-21014,89686
920,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,652,-2139,4166,income,1,4655,-5112,14214,2653,-3978,12676
921,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,547,190,1230,global,2,83172,-30747,203544,41860,-11825,180995
922,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,589,143,1460,NA,NA,NA,NA,NA,589,143,1460
923,GTM,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9941,-9526,30124,9941,-9526,30124
924,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,148,57,312,income,2,578,-521,1672,363,-344,1533
925,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,625,24,1576,NA,NA,NA,NA,NA,625,24,1576
926,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,261,88,609,global,2,24418,-15024,65156,12339,-9297,58398
927,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,210,80,442,income,2,961,-773,2743,585,-457,2418
928,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,332,30,843,income,2,1792,-775,4380,1062,-357,3932
929,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,125,49,256,NA,NA,NA,NA,NA,125,49,256
930,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,200,2,574,global,5,13036,-1981,27854,6618,-15,24976
931,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,306,118,641,global,4,32978,-3961,66743,16642,101,62386
932,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,48,-4,134,global,1,33883,-35004,100913,16965,-24528,91396
933,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,400,-1095,2122,income,1,5171,-4264,15140,2785,-3021,13033
934,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,327,116,737,global,2,83544,-36222,200056,41936,-13019,183055
935,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,356,86,852,NA,NA,NA,NA,NA,356,86,852
936,GUY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9954,-9698,28927,9954,-9698,28927
937,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gn,3g cephalosporins,BSI,global,3,185,73,411,global,2,619,-436,1671,402,-244,1520
938,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,BSI,global,4,234,61,581,NA,NA,NA,NA,NA,234,61,581
939,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,BSI,global,3,329,107,758,global,2,23191,-14519,61726,11760,-9235,53695
940,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,BSI,global,5,274,108,607,global,3,1027,-660,2816,651,-376,2500
941,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,183,70,403,global,2,1775,-715,4207,979,-232,3691
942,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,COL/INF,global,9,231,86,525,NA,NA,NA,NA,NA,231,86,525
943,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,COL/INF,global,3,248,10,666,global,5,13161,-982,27256,6704,-31,24619
944,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,COL/INF,global,7,380,142,820,global,4,34401,-786,69584,17390,137,63952
945,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,IAI,global,1,61,2,176,global,1,34965,-31436,101158,17513,-22301,89021
946,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,RTI,global,1,489,-1567,2829,global,1,5147,-5011,15059,2818,-3129,13075
947,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,SSI,global,3,407,144,954,global,2,85127,-28451,200935,42767,-9316,182093
948,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,SSTI,global,1,430,110,1114,NA,NA,NA,NA,NA,430,110,1114
949,HND,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10098,-8088,29545,10098,-8088,29545
950,HRV,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,1591,4,4506,income,2,571,-535,1673,1081,-394,3648
951,HRV,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,1730,-465,5288,NA,NA,NA,NA,NA,1730,-465,5288
952,HRV,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,2457,737,6251,income,2,23471,-15047,61204,12964,-10545,55844
953,HRV,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,3355,856,8261,income,3,1009,-731,2634,2182,-454,6913
954,HRV,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,190,-507,1105,global,2,1797,-806,4281,994,-653,3891
955,HRV,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,1355,-1241,4779,NA,NA,NA,NA,NA,1355,-1241,4779
956,HRV,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,1898,82,5636,income,5,13544,-981,27195,7721,-76,25504
957,HRV,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,1601,490,3939,income,4,33044,-4095,69187,17323,376,62940
958,HRV,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,454,4,1283,income,1,36273,-29256,104014,18363,-18686,91129
959,HRV,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,3388,-12063,20070,global,1,4665,-4652,14229,4027,-8981,17437
960,HRV,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,1990,360,5046,income,2,83941,-35479,207642,42966,-14189,186564
961,HRV,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,3247,738,7885,NA,NA,NA,NA,NA,3247,738,7885
962,HRV,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10022,-9292,28611,10022,-9292,28611
963,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gn,3g cephalosporins,BSI,global,3,32,12,68,global,2,550,-509,1668,291,-343,1486
964,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gn,carbapenems,BSI,global,4,41,9,105,NA,NA,NA,NA,NA,41,9,105
965,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gp,glycopeptides,BSI,global,3,56,17,132,global,2,23188,-17265,61791,11622,-9267,55970
966,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gp,penicillins,BSI,global,5,48,18,104,global,3,1070,-500,2686,559,-338,2422
967,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gn,3g cephalosporins,COL/INF,global,5,45,9,104,global,2,1761,-861,4389,903,-397,3875
968,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gn,carbapenems,COL/INF,global,9,40,13,87,NA,NA,NA,NA,NA,40,13,87
969,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gp,glycopeptides,COL/INF,global,3,44,2,123,global,5,13066,-619,26862,6555,0,24156
970,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gp,penicillins,COL/INF,global,7,66,25,143,global,4,32635,-3014,66482,16351,21,63127
971,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gp,glycopeptides,IAI,global,1,11,0,33,global,1,36006,-32239,109667,18008,-20488,96561
972,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gn,carbapenems,RTI,global,1,80,-309,494,global,1,5044,-4635,14910,2562,-3490,13735
973,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gp,penicillins,SSI,global,3,72,24,165,global,2,81790,-29611,188752,40931,-11275,173121
974,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gp,penicillins,SSTI,global,1,76,17,198,NA,NA,NA,NA,NA,76,17,198
975,HTI,AMRO D,Latin America & Caribbean,PAHO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9465,-9894,28944,9465,-9894,28944
976,HUN,EURO C,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,income,3,1325,502,2792,income,2,596,-532,1758,961,-318,2577
977,HUN,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,income,3,1540,408,3731,NA,NA,NA,NA,NA,1540,408,3731
978,HUN,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,2312,753,5252,income,2,22904,-13545,64350,12608,-9266,57613
979,HUN,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,income,5,1966,756,4152,income,3,1047,-593,2853,1507,-384,3690
980,HUN,EURO C,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,income,1,198,-504,1005,global,2,1783,-697,4230,991,-610,3772
981,HUN,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,income,8,2131,318,5443,NA,NA,NA,NA,NA,2131,318,5443
982,HUN,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,1782,-17,4796,income,5,13327,-777,27785,7555,-44,25526
983,HUN,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,income,7,2740,968,6020,income,4,32353,1280,64459,17547,992,59625
984,HUN,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,443,-5,1312,income,1,35789,-35080,101602,18116,-23675,93329
985,HUN,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,3356,-12386,22810,global,1,5235,-4335,15254,4295,-8969,17717
986,HUN,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,income,3,2927,954,6423,income,2,83958,-25268,200691,43442,-14267,182304
987,HUN,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,income,1,3136,724,7645,NA,NA,NA,NA,NA,3136,724,7645
988,HUN,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10023,-9944,30898,10023,-9944,30898
989,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gn,3g cephalosporins,BSI,global,3,125,46,266,global,2,606,-436,1658,366,-285,1489
990,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gn,carbapenems,BSI,whoc,1,515,21,1406,NA,NA,NA,NA,NA,515,21,1406
991,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,BSI,global,3,217,65,513,global,2,23004,-14653,61571,11610,-8845,54251
992,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,BSI,wbregion,1,199,57,454,wbregion,1,12164,-11563,36622,6182,-7608,32459
993,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,2,152,12,411,whoc,2,1750,-523,4237,951,-157,3815
994,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gn,carbapenems,COL/INF,global,9,158,58,354,NA,NA,NA,NA,NA,158,58,354
995,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,COL/INF,global,3,169,4,433,global,5,13328,-819,27513,6748,-2,25283
996,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,279,105,598,global,4,31898,-222,64964,16089,104,59403
997,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,IAI,global,1,42,0,114,global,1,35635,-31474,104187,17838,-21263,95079
998,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gn,carbapenems,RTI,whoc,1,334,-1030,1974,whoc,1,5385,-4097,14995,2860,-2698,13326
999,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,SSI,global,3,274,94,650,global,2,83659,-30802,197310,41967,-14724,180110
1000,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,SSTI,global,1,298,61,762,NA,NA,NA,NA,NA,298,61,762
1001,IDN,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10576,-8288,29555,10576,-8288,29555
1002,IND,SEARO D,South Asia,SEARO,Lower middle income,gn,3g cephalosporins,BSI,global,3,89,35,200,global,2,595,-533,1672,342,-309,1483
1003,IND,SEARO D,South Asia,SEARO,Lower middle income,gn,carbapenems,BSI,global,4,115,27,293,NA,NA,NA,NA,NA,115,27,293
1004,IND,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,BSI,global,3,158,52,394,global,2,24966,-12445,63813,12562,-7180,58100
1005,IND,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,BSI,global,5,133,51,308,global,3,1029,-868,2761,581,-493,2570
1006,IND,SEARO D,South Asia,SEARO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,89,35,196,global,2,1793,-780,4272,941,-245,3846
1007,IND,SEARO D,South Asia,SEARO,Lower middle income,gn,carbapenems,COL/INF,global,9,113,43,277,NA,NA,NA,NA,NA,113,43,277
1008,IND,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,COL/INF,global,3,120,8,336,global,5,13184,-832,28005,6652,-3,25778
1009,IND,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,COL/INF,global,7,184,74,412,global,4,32304,-1844,67986,16244,72,62772
1010,IND,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,IAI,global,1,29,-1,86,global,1,34859,-28565,102113,17444,-20619,90791
1011,IND,SEARO D,South Asia,SEARO,Lower middle income,gn,carbapenems,RTI,global,1,251,-755,1417,global,1,4796,-4503,14458,2524,-3393,12795
1012,IND,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,SSI,global,3,196,70,465,global,2,85272,-28715,201870,42734,-13178,182143
1013,IND,SEARO D,South Asia,SEARO,Lower middle income,gp,penicillins,SSTI,global,1,214,41,549,NA,NA,NA,NA,NA,214,41,549
1014,IND,SEARO D,South Asia,SEARO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9835,-10301,29166,9835,-10301,29166
1015,IRL,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,7250,347,19897,income,2,642,-484,1737,3946,-387,16813
1016,IRL,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,7397,-1979,24312,NA,NA,NA,NA,NA,7397,-1979,24312
1017,IRL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,10477,3266,24630,income,2,22775,-17176,64320,16626,-10981,57427
1018,IRL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,14343,3724,34893,income,3,1020,-645,2685,7681,-354,30316
1019,IRL,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,816,-2362,4881,global,2,1769,-785,4269,1292,-1822,4509
1020,IRL,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,5907,-5893,23111,NA,NA,NA,NA,NA,5907,-5893,23111
1021,IRL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,8204,394,23196,income,5,13133,-897,26573,10669,-163,25931
1022,IRL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,6938,2099,17251,income,4,32579,-2603,67338,19758,1666,63194
1023,IRL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1895,-217,5439,income,1,36048,-32895,103331,18971,-20836,91373
1024,IRL,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,15843,-50816,94536,global,1,4853,-4801,14814,10348,-35863,76001
1025,IRL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,8388,1507,20980,income,2,81020,-48564,198432,44704,-18559,175216
1026,IRL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,14240,2902,34790,NA,NA,NA,NA,NA,14240,2902,34790
1027,IRL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10429,-10017,30802,10429,-10017,30802
1028,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,1941,728,3999,income,2,611,-538,1644,1276,-383,3618
1029,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,BSI,income,1,8016,477,21578,NA,NA,NA,NA,NA,8016,477,21578
1030,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,BSI,global,3,3411,1024,7923,global,2,23617,-13827,61995,13514,-7670,56521
1031,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,BSI,income,2,2769,920,5775,income,2,946,-730,2578,1857,-490,5252
1032,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,4412,446,12463,income,2,1811,-671,4273,3112,-411,10141
1033,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,COL/INF,whoc,1,1637,610,3451,NA,NA,NA,NA,NA,1637,610,3451
1034,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,2649,193,7431,global,5,13535,-786,28115,8092,52,25150
1035,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,COL/INF,global,7,4039,1344,8734,global,4,32904,-3796,67932,18472,1172,63809
1036,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,IAI,global,1,638,-46,1703,global,1,31626,-38663,100103,16132,-28438,88181
1037,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,RTI,income,1,5510,-15259,32850,income,1,5110,-4037,14967,5310,-11205,25231
1038,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,SSI,global,3,4298,1398,9806,global,2,81522,-29819,192616,42910,-8558,172774
1039,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,SSTI,global,1,4599,1066,11171,NA,NA,NA,NA,NA,4599,1066,11171
1040,IRN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9119,-8971,28886,9119,-8971,28886
1041,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,122,49,264,income,2,579,-566,1746,350,-313,1531
1042,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,BSI,income,1,512,24,1358,NA,NA,NA,NA,NA,512,24,1358
1043,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,BSI,global,3,213,69,481,global,2,23690,-14393,62399,11952,-9201,57281
1044,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,BSI,income,2,172,65,380,income,2,937,-812,2727,555,-544,2316
1045,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,282,28,777,income,2,1723,-864,4168,1003,-508,3799
1046,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,COL/INF,income,1,103,42,222,NA,NA,NA,NA,NA,103,42,222
1047,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,164,6,428,global,5,13145,-771,28140,6654,-19,26066
1048,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,COL/INF,global,7,254,98,531,global,4,32377,-3651,67335,16315,88,61745
1049,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,IAI,global,1,40,-3,113,global,1,35368,-27177,106702,17704,-18629,94688
1050,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,RTI,income,1,293,-1113,2003,income,1,4815,-4923,14872,2554,-3521,13173
1051,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,SSI,global,3,270,101,568,global,2,82197,-28860,201852,41234,-15795,182662
1052,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,SSTI,global,1,289,74,701,NA,NA,NA,NA,NA,289,74,701
1053,IRQ,EMRO D,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10422,-10619,28920,10422,-10619,28920
1054,ISL,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,7853,28,21750,income,2,616,-536,1735,4234,-469,18028
1055,ISL,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,8667,-1092,26824,NA,NA,NA,NA,NA,8667,-1092,26824
1056,ISL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,11561,3918,25740,income,2,24745,-11165,62741,18153,-7326,57787
1057,ISL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,15890,3768,38994,income,3,1088,-646,2894,8489,-431,33758
1058,ISL,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,994,-2195,5224,global,2,1772,-780,4267,1383,-1614,4621
1059,ISL,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,6832,-6817,27060,NA,NA,NA,NA,NA,6832,-6817,27060
1060,ISL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,9058,273,24953,income,5,13156,-973,27003,11107,-434,26572
1061,ISL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,7715,2214,17528,income,4,32495,-2494,67216,20105,1738,63415
1062,ISL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,2030,-269,5759,income,1,33027,-37745,95184,17528,-23168,88496
1063,ISL,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,17264,-49282,105543,global,1,5129,-5339,14650,11197,-40335,85248
1064,ISL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,9326,1820,23568,income,2,83576,-26779,203132,46451,-12140,181469
1065,ISL,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,15083,3274,38788,NA,NA,NA,NA,NA,15083,3274,38788
1066,ISL,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9881,-10356,29016,9881,-10356,29016
1067,ISR,EURO A,Middle East & North Africa,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,5046,257,13433,income,2,596,-500,1662,2821,-386,11362
1068,ISR,EURO A,Middle East & North Africa,EURO,High income,gn,carbapenems,BSI,whoc,2,5605,-1096,18095,NA,NA,NA,NA,NA,5605,-1096,18095
1069,ISR,EURO A,Middle East & North Africa,EURO,High income,gp,glycopeptides,BSI,income,3,7703,2432,18256,income,2,23828,-15100,62155,15765,-8021,56347
1070,ISR,EURO A,Middle East & North Africa,EURO,High income,gp,penicillins,BSI,whoc,2,10539,2432,25762,income,3,1034,-801,2725,5786,-463,22271
1071,ISR,EURO A,Middle East & North Africa,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,544,-1588,2963,global,2,1805,-876,4404,1175,-1349,4047
1072,ISR,EURO A,Middle East & North Africa,EURO,High income,gn,carbapenems,COL/INF,whoc,5,4423,-4130,18060,NA,NA,NA,NA,NA,4423,-4130,18060
1073,ISR,EURO A,Middle East & North Africa,EURO,High income,gp,glycopeptides,COL/INF,income,3,5982,357,16165,income,5,13394,-517,27429,9688,175,25819
1074,ISR,EURO A,Middle East & North Africa,EURO,High income,gp,penicillins,COL/INF,whoc,2,5055,1475,12473,income,4,32731,-2368,67661,18893,1033,62117
1075,ISR,EURO A,Middle East & North Africa,EURO,High income,gp,glycopeptides,IAI,income,1,1442,84,4207,income,1,33477,-39291,100527,17459,-25671,89899
1076,ISR,EURO A,Middle East & North Africa,EURO,High income,gn,carbapenems,RTI,global,1,10929,-37624,71104,global,1,4901,-5054,14399,7915,-25090,55854
1077,ISR,EURO A,Middle East & North Africa,EURO,High income,gp,penicillins,SSI,whoc,1,6134,1217,15360,income,2,82078,-29367,203423,44106,-15936,183374
1078,ISR,EURO A,Middle East & North Africa,EURO,High income,gp,penicillins,SSTI,whoc,1,10339,2328,27500,NA,NA,NA,NA,NA,10339,2328,27500
1079,ISR,EURO A,Middle East & North Africa,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10172,-8708,31000,10172,-8708,31000
1080,ITA,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,4644,61,12863,income,2,592,-521,1660,2618,-408,11155
1081,ITA,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,5170,-919,16192,NA,NA,NA,NA,NA,5170,-919,16192
1082,ITA,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,7085,2249,17046,income,2,24747,-14314,64360,15916,-7098,58630
1083,ITA,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,9524,2469,22591,income,3,953,-804,2704,5239,-463,19164
1084,ITA,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,610,-1235,3235,global,2,1810,-651,4395,1210,-1079,4104
1085,ITA,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,3898,-3561,15661,NA,NA,NA,NA,NA,3898,-3561,15661
1086,ITA,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,5234,-190,14797,income,5,13494,230,27374,9364,-111,24827
1087,ITA,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,4605,1379,11560,income,4,33151,-1514,66498,18878,1218,61243
1088,ITA,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1294,-43,3864,income,1,35100,-37645,104058,18197,-22743,90357
1089,ITA,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,9529,-30258,57839,global,1,5067,-4277,14686,7298,-24576,48476
1090,ITA,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,5634,1115,14789,income,2,81525,-32391,199766,43580,-17156,178348
1091,ITA,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,9466,2025,25240,NA,NA,NA,NA,NA,9466,2025,25240
1092,ITA,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9996,-9848,28220,9996,-9848,28220
1093,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,470,177,973,income,2,581,-487,1707,525,-321,1525
1094,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,1960,110,5223,NA,NA,NA,NA,NA,1960,110,5223
1095,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,838,254,1901,global,2,23475,-13242,61611,12157,-9642,56291
1096,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,674,250,1447,income,2,967,-776,2657,821,-470,2385
1097,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1050,87,2823,income,2,1834,-798,4201,1442,-366,3878
1098,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,398,151,846,NA,NA,NA,NA,NA,398,151,846
1099,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,633,-1,1758,global,5,13145,-1091,26802,6889,-39,24624
1100,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,973,366,1985,global,4,33278,-1091,67003,17125,357,60386
1101,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,154,-5,433,global,1,33990,-34227,99042,17072,-24786,88326
1102,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,1277,-4009,7745,income,1,5110,-5211,15065,3193,-4501,13124
1103,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,1042,358,2308,global,2,81405,-44630,203489,41223,-19949,180071
1104,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,1105,232,2721,NA,NA,NA,NA,NA,1105,232,2721
1105,JAM,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10340,-9002,30913,10340,-9002,30913
1106,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,269,104,598,income,2,597,-492,1668,433,-282,1509
1107,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,BSI,income,1,1125,52,3325,NA,NA,NA,NA,NA,1125,52,3325
1108,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,BSI,global,3,475,145,1188,global,2,23409,-14316,65556,11942,-8846,57268
1109,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,BSI,income,2,384,142,865,income,2,959,-740,2631,672,-463,2386
1110,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,603,68,1618,income,2,1838,-510,4406,1221,-210,3962
1111,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,COL/INF,whoc,1,227,89,508,NA,NA,NA,NA,NA,227,89,508
1112,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,352,-15,1039,global,5,13301,-767,27900,6826,-45,24432
1113,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,COL/INF,global,7,559,212,1282,global,4,33467,-803,66684,17013,194,62822
1114,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,IAI,global,1,88,-1,254,global,1,34726,-39853,105538,17407,-23739,93159
1115,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,RTI,income,1,639,-2477,4425,income,1,5173,-4363,14784,2906,-3415,13305
1116,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,SSI,global,3,597,205,1406,global,2,83314,-36034,196063,41956,-17158,180594
1117,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,SSTI,global,1,637,157,1604,NA,NA,NA,NA,NA,637,157,1604
1118,JOR,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9906,-10506,28854,9906,-10506,28854
1119,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,BSI,income,3,4439,1848,9665,income,2,575,-509,1657,2507,-347,8136
1120,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,BSI,income,3,5254,1298,13604,NA,NA,NA,NA,NA,5254,1298,13604
1121,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,BSI,income,3,7762,2418,17419,income,2,24090,-15136,65257,15926,-8988,58162
1122,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,BSI,income,5,6630,2758,14121,income,3,1006,-793,2700,3818,-507,12363
1123,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,COL/INF,income,1,599,-1804,3360,wbregion,2,1788,-590,4210,1193,-1332,4007
1124,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,COL/INF,income,8,7344,1415,19291,NA,NA,NA,NA,NA,7344,1415,19291
1125,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,COL/INF,income,3,6043,90,16220,income,5,13182,-719,28451,9613,-153,26124
1126,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,COL/INF,whoc,1,9897,4154,21171,income,4,33707,-2035,70557,21802,2952,64382
1127,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,IAI,income,1,1398,-52,3976,income,1,32610,-37267,101525,17004,-27169,90525
1128,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,RTI,wbregion,1,12467,-34626,75178,wbregion,1,5137,-4839,15450,8802,-24193,60034
1129,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,SSI,income,3,9744,3643,22219,income,2,80688,-40965,192479,45216,-17883,176720
1130,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,SSTI,income,1,10377,2429,25497,NA,NA,NA,NA,NA,10377,2429,25497
1131,JPN,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9360,-10069,27677,9360,-10069,27677
1132,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,511,181,1171,income,2,607,-428,1711,559,-290,1555
1133,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,2101,11,5796,NA,NA,NA,NA,NA,2101,11,5796
1134,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,901,263,2184,global,2,23154,-16186,61981,12027,-9591,54236
1135,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,722,235,1734,income,2,969,-716,2650,845,-455,2441
1136,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1139,122,3160,income,2,1710,-891,4184,1424,-516,3896
1137,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,430,152,994,NA,NA,NA,NA,NA,430,152,994
1138,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,710,79,1910,global,5,13369,-729,27522,7040,27,25573
1139,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,596,154,1477,global,4,31939,-1007,68002,16268,140,62232
1140,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,168,-8,501,global,1,35202,-33587,107696,17685,-21104,92343
1141,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,1430,-4516,8436,income,1,4777,-4890,14533,3103,-4630,13033
1142,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,720,137,1882,global,2,87866,-27614,200797,44293,-10509,180847
1143,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,1220,268,3123,NA,NA,NA,NA,NA,1220,268,3123
1144,KAZ,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10241,-8489,29021,10241,-8489,29021
1145,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,72,27,151,global,2,608,-492,1642,340,-301,1491
1146,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,92,22,238,NA,NA,NA,NA,NA,92,22,238
1147,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,125,41,284,global,2,24097,-11362,62241,12111,-5456,57275
1148,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,106,41,226,global,3,1043,-728,2700,575,-443,2451
1149,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,278,97,621,global,2,1726,-699,4199,1002,-309,3832
1150,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,89,32,193,NA,NA,NA,NA,NA,89,32,193
1151,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,95,-2,266,global,5,13160,-2010,27444,6627,-23,25499
1152,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,148,55,330,global,4,33179,-2439,65314,16664,46,61614
1153,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,23,0,66,global,1,33007,-36647,101111,16515,-24303,89818
1154,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,180,-626,1240,global,1,5099,-4609,14897,2640,-2917,13454
1155,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,157,53,354,global,2,81686,-32209,196360,40922,-17059,175855
1156,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,169,38,412,NA,NA,NA,NA,NA,169,38,412
1157,KEN,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10234,-11081,29991,10234,-11081,29991
1158,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gn,3g cephalosporins,BSI,wbregion,3,57,23,119,wbregion,2,590,-452,1609,324,-237,1440
1159,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,BSI,wbregion,1,102,39,221,NA,NA,NA,NA,NA,102,39,221
1160,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,BSI,global,3,100,34,235,global,2,24903,-12511,61809,12502,-5667,54777
1161,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,BSI,wbregion,4,85,32,183,wbregion,2,989,-673,2768,537,-469,2521
1162,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,57,23,117,global,2,1839,-641,4298,948,-257,4017
1163,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,COL/INF,wbregion,3,63,-110,273,NA,NA,NA,NA,NA,63,-110,273
1164,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,COL/INF,global,3,75,1,207,global,5,13091,-1450,27600,6583,-14,24907
1165,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,COL/INF,wbregion,2,66,22,150,global,4,32608,-1419,71503,16337,17,64100
1166,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,IAI,global,1,18,-1,53,global,1,34322,-37296,101935,17170,-23652,87657
1167,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,RTI,global,1,159,-447,896,global,1,5123,-4676,14703,2641,-3029,13077
1168,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,SSI,wbregion,1,80,20,205,global,2,84635,-29156,202281,42357,-9630,183924
1169,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,SSTI,wbregion,1,136,34,337,NA,NA,NA,NA,NA,136,34,337
1170,KGZ,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10095,-8817,27380,10095,-8817,27380
1171,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,67,25,146,global,2,590,-475,1666,329,-347,1505
1172,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,BSI,whoc,1,61,22,130,NA,NA,NA,NA,NA,61,22,130
1173,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,BSI,global,3,119,41,290,global,2,24556,-15065,62010,12338,-8369,56978
1174,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,BSI,whoc,1,109,33,260,whoc,1,11769,-11779,34383,5939,-7282,31075
1175,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,67,24,140,wbregion,2,1817,-953,4399,942,-326,4052
1176,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,COL/INF,global,9,84,30,185,NA,NA,NA,NA,NA,84,30,185
1177,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,89,3,243,global,5,12875,-1161,27609,6482,-7,25386
1178,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,150,55,325,global,4,33115,-3423,67652,16632,53,62839
1179,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,IAI,global,1,22,0,62,global,1,33945,-39348,101523,16984,-28204,92315
1180,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,RTI,wbregion,1,177,-586,1041,wbregion,1,5282,-4777,14568,2730,-3137,13030
1181,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSI,global,3,148,51,328,global,2,84950,-27715,199473,42549,-13411,180522
1182,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSTI,global,1,160,36,388,NA,NA,NA,NA,NA,160,36,388
1183,KHM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9833,-8733,30187,9833,-8733,30187
1184,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,141,53,321,global,2,625,-538,1700,383,-314,1553
1185,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,BSI,whoc,1,127,45,293,NA,NA,NA,NA,NA,127,45,293
1186,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,BSI,global,3,245,83,580,global,2,24629,-12543,65708,12437,-7888,60016
1187,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,BSI,whoc,1,224,77,532,whoc,1,12622,-10061,35951,6423,-6851,31899
1188,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,140,53,316,wbregion,2,1847,-625,4260,994,-309,3940
1189,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,COL/INF,global,9,175,63,399,NA,NA,NA,NA,NA,175,63,399
1190,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,186,-9,556,global,5,13284,-581,26796,6735,-21,24560
1191,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,312,119,713,global,4,32490,-4976,68051,16401,99,63132
1192,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,IAI,global,1,45,-1,127,global,1,33747,-36741,104558,16896,-24935,90527
1193,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,RTI,wbregion,1,342,-1134,2266,wbregion,1,5020,-5236,15102,2681,-3644,13496
1194,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSI,global,3,309,106,708,global,2,83430,-28719,199363,41869,-11790,183036
1195,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSTI,global,1,337,74,813,NA,NA,NA,NA,NA,337,74,813
1196,KIR,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10172,-8562,30021,10172,-8562,30021
1197,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,BSI,income,3,1608,674,3167,income,2,586,-524,1715,1097,-381,2927
1198,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,BSI,income,3,1926,520,4791,NA,NA,NA,NA,NA,1926,520,4791
1199,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,BSI,income,3,2838,957,6485,income,2,24724,-14082,63522,13781,-9045,58090
1200,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,BSI,income,5,2404,1001,4941,income,3,1037,-635,2749,1721,-406,4410
1201,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,COL/INF,income,1,237,-599,1337,global,2,1785,-631,4434,1011,-608,3879
1202,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,COL/INF,income,8,2548,546,6087,NA,NA,NA,NA,NA,2548,546,6087
1203,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,COL/INF,income,3,2099,20,5632,income,5,13371,-441,27564,7735,-17,24950
1204,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,COL/INF,income,7,3345,1404,6851,income,4,32328,-1068,67994,17836,1327,61772
1205,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,IAI,income,1,522,-8,1411,income,1,33168,-36997,101993,16845,-27096,91441
1206,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,RTI,global,1,4418,-13179,26035,global,1,4988,-5025,15093,4703,-9955,20048
1207,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSI,income,3,3555,1287,7526,income,2,84684,-31916,200967,44119,-16336,179728
1208,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSTI,income,1,3825,920,9647,NA,NA,NA,NA,NA,3825,920,9647
1209,KNA,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10477,-8451,30293,10477,-8451,30293
1210,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,BSI,income,3,2877,1046,6402,income,2,590,-471,1720,1733,-347,5568
1211,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gn,carbapenems,BSI,whoc,1,2578,889,6054,NA,NA,NA,NA,NA,2578,889,6054
1212,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gp,glycopeptides,BSI,income,3,5058,1585,12395,income,2,22833,-16459,63521,13946,-9039,57024
1213,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gp,penicillins,BSI,whoc,1,4615,1355,10747,whoc,1,11713,-11383,35852,8164,-7429,31109
1214,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,COL/INF,income,1,413,-1039,2294,wbregion,2,1753,-810,4237,1083,-943,3982
1215,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gn,carbapenems,COL/INF,income,8,4640,926,11639,NA,NA,NA,NA,NA,4640,926,11639
1216,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gp,glycopeptides,COL/INF,income,3,3920,-167,11053,income,5,13386,-698,28113,8653,-296,25286
1217,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gp,penicillins,COL/INF,income,7,5957,2103,13471,income,4,31885,-1508,65659,18921,1729,61626
1218,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gp,glycopeptides,IAI,income,1,934,10,2758,income,1,35330,-30500,99887,18132,-21089,89221
1219,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gn,carbapenems,RTI,wbregion,1,8989,-22171,56080,wbregion,1,5181,-4450,15107,7085,-15195,41090
1220,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gp,penicillins,SSI,income,3,6297,2046,14693,income,2,84007,-32365,198469,45152,-17981,180603
1221,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gp,penicillins,SSTI,income,1,6747,1389,17010,NA,NA,NA,NA,NA,6747,1389,17010
1222,KOR,WPRO B,East Asia & Pacific,WPRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10329,-8145,30170,10329,-8145,30170
1223,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,BSI,income,3,2414,977,5060,income,2,564,-474,1727,1489,-309,4577
1224,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,BSI,income,3,2869,681,7196,NA,NA,NA,NA,NA,2869,681,7196
1225,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,BSI,income,3,4249,1442,9736,income,2,24203,-13677,60853,14226,-9184,56210
1226,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,BSI,income,5,3593,1444,7618,income,3,1011,-665,2727,2302,-441,6872
1227,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,COL/INF,income,1,354,-864,1965,global,2,1731,-556,4284,1042,-791,3815
1228,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,COL/INF,whoc,1,2037,839,4292,NA,NA,NA,NA,NA,2037,839,4292
1229,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,COL/INF,income,3,3283,189,8653,income,5,13427,-643,27949,8355,95,24440
1230,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,COL/INF,income,7,4996,1965,10794,income,4,33718,960,68532,19357,1933,63637
1231,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,IAI,income,1,774,-14,2111,income,1,33473,-31055,103518,17124,-22817,91012
1232,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,RTI,global,1,5528,-23289,38391,global,1,5165,-4308,14845,5347,-15899,31990
1233,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSI,income,3,5274,1891,11638,income,2,82895,-32193,199386,44085,-15970,182912
1234,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSTI,income,1,5777,1305,14151,NA,NA,NA,NA,NA,5777,1305,14151
1235,KWT,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10042,-9176,29661,10042,-9176,29661
1236,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,81,28,178,global,2,595,-467,1694,338,-356,1549
1237,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,BSI,whoc,1,73,25,157,NA,NA,NA,NA,NA,73,25,157
1238,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,BSI,global,3,144,47,338,global,2,24102,-15509,61460,12123,-10062,56412
1239,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,BSI,whoc,1,132,36,316,whoc,1,11548,-12168,36181,5840,-8875,31595
1240,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,81,29,176,wbregion,2,1779,-632,4351,930,-354,3924
1241,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,COL/INF,global,9,102,35,229,NA,NA,NA,NA,NA,102,35,229
1242,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,107,-3,297,global,5,13405,-577,26757,6756,-14,24784
1243,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,180,65,392,global,4,33234,-2525,67852,16707,62,62840
1244,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,IAI,global,1,27,-1,74,global,1,34433,-38548,101069,17230,-22766,89417
1245,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,RTI,wbregion,1,216,-685,1251,wbregion,1,5207,-4921,14807,2712,-3570,13068
1246,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSI,global,3,178,55,400,global,2,83991,-32610,210085,42084,-17764,185132
1247,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSTI,global,1,189,37,473,NA,NA,NA,NA,NA,189,37,473
1248,LAO,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9411,-9301,28432,9411,-9301,28432
1249,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,987,388,2183,income,2,570,-562,1609,778,-389,1885
1250,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,BSI,income,1,3970,-11,10844,NA,NA,NA,NA,NA,3970,-11,10844
1251,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,BSI,global,3,1762,566,4057,global,2,22574,-16837,60889,12168,-10481,55397
1252,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,BSI,income,2,1395,550,3106,income,2,947,-781,2661,1171,-458,2849
1253,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,2259,288,5880,income,2,1694,-698,4242,1976,-443,5287
1254,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,COL/INF,whoc,1,835,341,1774,NA,NA,NA,NA,NA,835,341,1774
1255,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1358,-79,3970,global,5,13152,-541,26788,7255,-119,25014
1256,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,COL/INF,global,7,2054,805,4627,global,4,32823,-2813,71837,17438,713,63074
1257,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,IAI,global,1,326,-19,916,global,1,34948,-33028,105435,17637,-21865,92753
1258,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,RTI,income,1,2452,-8913,16838,income,1,5067,-5153,15034,3760,-7358,15487
1259,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,SSI,global,3,2182,782,5029,global,2,83898,-36884,196737,43040,-6643,178743
1260,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,SSTI,global,1,2338,506,5596,NA,NA,NA,NA,NA,2338,506,5596
1261,LBN,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9792,-9220,30230,9792,-9220,30230
1262,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,0,0,0,global,2,601,-533,1647,301,-307,1499
1263,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,0,0,0,NA,NA,NA,NA,NA,0,0,0
1264,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,0,0,0,global,2,23439,-15443,63255,11719,-9050,54929
1265,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,0,0,0,global,3,988,-847,2719,494,-578,2506
1266,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,0,0,0,global,2,1735,-769,4211,868,-281,3818
1267,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,0,0,0,NA,NA,NA,NA,NA,0,0,0
1268,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,0,0,0,global,5,13459,151,26881,6730,0,25052
1269,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,0,0,0,global,4,32389,-2343,68916,16194,0,63377
1270,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,0,0,0,global,1,34426,-37304,107273,17213,-25277,97408
1271,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,0,-1,2,global,1,5309,-4705,15182,2655,-3101,13497
1272,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,0,0,1,global,2,83592,-30748,198093,41796,-9569,178906
1273,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,0,0,1,NA,NA,NA,NA,NA,0,0,1
1274,LBR,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10351,-9848,29345,10351,-9848,29345
1275,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,746,304,1534,income,2,563,-460,1655,655,-322,1620
1276,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,BSI,income,1,3216,206,8282,NA,NA,NA,NA,NA,3216,206,8282
1277,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,BSI,global,3,1325,450,2990,global,2,24292,-13760,62955,12809,-7371,56394
1278,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,BSI,income,2,1069,440,2232,income,2,971,-760,2671,1020,-494,2496
1279,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1714,132,4600,income,2,1820,-799,4300,1767,-361,4461
1280,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,COL/INF,whoc,1,633,264,1253,NA,NA,NA,NA,NA,633,264,1253
1281,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1022,11,2529,global,5,13384,-217,27580,7203,-15,26027
1282,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,COL/INF,global,7,1552,628,3162,global,4,33193,-1983,68696,17372,512,63638
1283,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,IAI,global,1,250,-15,687,global,1,34878,-31615,105265,17564,-22908,92434
1284,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gn,carbapenems,RTI,income,1,1729,-6761,12708,income,1,4958,-4310,15009,3344,-5408,14354
1285,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,SSI,global,3,1657,596,3559,global,2,83855,-38177,208673,42756,-10523,184403
1286,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,penicillins,SSTI,global,1,1810,520,4529,NA,NA,NA,NA,NA,1810,520,4529
1287,LBY,EMRO E,Middle East & North Africa,EMRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10556,-8161,30369,10556,-8161,30369
1288,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,959,369,1965,income,2,592,-536,1691,776,-372,1838
1289,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,4047,198,11587,NA,NA,NA,NA,NA,4047,198,11587
1290,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,1697,543,3702,global,2,23592,-14077,62887,12644,-10555,57720
1291,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,1361,515,2903,income,2,956,-854,2619,1158,-492,2765
1292,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,2188,285,6008,income,2,1767,-609,4303,1978,-353,5051
1293,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,809,310,1680,NA,NA,NA,NA,NA,809,310,1680
1294,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1268,21,3302,global,5,13061,-1470,26851,7165,-219,25247
1295,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,1983,741,4175,global,4,30919,-6034,66957,16451,575,61518
1296,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,312,-16,892,global,1,33661,-30391,103053,16986,-21759,88474
1297,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,2404,-7526,15731,income,1,4819,-4693,14014,3612,-6623,14598
1298,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,2118,784,4837,global,2,83355,-29227,195243,42736,-11841,178667
1299,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,2209,445,5178,NA,NA,NA,NA,NA,2209,445,5178
1300,LCA,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10181,-8811,29213,10181,-8811,29213
1301,LKA,SEARO B,South Asia,SEARO,Upper middle income,gn,3g cephalosporins,BSI,income,2,144,57,295,income,2,576,-570,1651,360,-293,1493
1302,LKA,SEARO B,South Asia,SEARO,Upper middle income,gn,carbapenems,BSI,whoc,1,633,41,1752,NA,NA,NA,NA,NA,633,41,1752
1303,LKA,SEARO B,South Asia,SEARO,Upper middle income,gp,glycopeptides,BSI,global,3,253,86,572,global,2,23647,-17585,62827,11950,-8593,56673
1304,LKA,SEARO B,South Asia,SEARO,Upper middle income,gp,penicillins,BSI,income,2,205,82,424,income,2,979,-779,2721,592,-563,2415
1305,LKA,SEARO B,South Asia,SEARO,Upper middle income,gn,3g cephalosporins,COL/INF,whoc,2,174,11,467,whoc,2,1818,-606,4339,996,-231,4009
1306,LKA,SEARO B,South Asia,SEARO,Upper middle income,gn,carbapenems,COL/INF,income,1,121,49,244,NA,NA,NA,NA,NA,121,49,244
1307,LKA,SEARO B,South Asia,SEARO,Upper middle income,gp,glycopeptides,COL/INF,global,3,200,11,522,global,5,12996,-688,27366,6598,-2,25385
1308,LKA,SEARO B,South Asia,SEARO,Upper middle income,gp,penicillins,COL/INF,global,7,299,118,611,global,4,33610,408,70334,16955,119,62053
1309,LKA,SEARO B,South Asia,SEARO,Upper middle income,gp,glycopeptides,IAI,global,1,49,-2,133,global,1,36589,-28916,105532,18319,-20111,94905
1310,LKA,SEARO B,South Asia,SEARO,Upper middle income,gn,carbapenems,RTI,whoc,1,373,-1189,2233,whoc,1,5019,-4588,14604,2696,-3102,13079
1311,LKA,SEARO B,South Asia,SEARO,Upper middle income,gp,penicillins,SSI,global,3,318,116,714,global,2,83368,-33866,201391,41843,-14739,178940
1312,LKA,SEARO B,South Asia,SEARO,Upper middle income,gp,penicillins,SSTI,global,1,337,80,835,NA,NA,NA,NA,NA,337,80,835
1313,LKA,SEARO B,South Asia,SEARO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9629,-10932,29864,9629,-10932,29864
1314,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,56,21,122,global,2,574,-500,1658,315,-381,1516
1315,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,72,19,181,NA,NA,NA,NA,NA,72,19,181
1316,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,98,31,224,global,2,24936,-14547,64731,12517,-8064,56825
1317,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,84,30,182,global,3,1008,-700,2824,546,-474,2450
1318,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,217,74,479,global,2,1802,-752,4325,1009,-354,4025
1319,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,71,24,162,NA,NA,NA,NA,NA,71,24,162
1320,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,77,4,208,global,5,13233,-680,27138,6655,1,24724
1321,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,116,44,252,global,4,33533,-4057,67633,16825,39,63258
1322,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,19,-2,53,global,1,35753,-30631,96515,17886,-19277,88642
1323,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,148,-435,940,global,1,5304,-4186,15059,2726,-2578,13662
1324,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,122,42,274,global,2,85000,-34340,199625,42561,-14698,184066
1325,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,135,33,331,NA,NA,NA,NA,NA,135,33,331
1326,LSO,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10395,-9796,30156,10395,-9796,30156
1327,LTU,EURO C,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,income,3,1277,486,2611,income,2,569,-462,1648,923,-351,2388
1328,LTU,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,income,3,1515,309,3716,NA,NA,NA,NA,NA,1515,309,3716
1329,LTU,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,2286,743,5110,income,2,23730,-16857,61153,13008,-9836,55630
1330,LTU,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,income,5,1911,716,4030,income,3,1012,-734,2723,1462,-450,3646
1331,LTU,EURO C,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,income,1,185,-470,966,global,2,1752,-750,4270,968,-580,3946
1332,LTU,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,income,8,2027,492,4866,NA,NA,NA,NA,NA,2027,492,4866
1333,LTU,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,1735,-3,4583,income,5,13592,-81,27864,7664,-8,25623
1334,LTU,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,income,7,2652,951,5765,income,4,32719,-3007,68687,17686,768,62694
1335,LTU,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,423,-36,1200,income,1,34916,-32109,100798,17669,-18593,91400
1336,LTU,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,3436,-11261,20105,global,1,5111,-5263,14896,4274,-8956,17071
1337,LTU,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,income,3,2832,945,6451,income,2,86209,-26625,203085,44521,-6073,183942
1338,LTU,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,income,1,3048,670,7152,NA,NA,NA,NA,NA,3048,670,7152
1339,LTU,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10484,-9726,30728,10484,-9726,30728
1340,LUX,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,19623,632,54447,income,2,586,-496,1706,10104,-462,45021
1341,LUX,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,21107,-6316,65897,NA,NA,NA,NA,NA,21107,-6316,65897
1342,LUX,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,28632,8656,64135,income,2,23375,-16397,59589,26004,-9507,62214
1343,LUX,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,39941,10024,96616,income,3,1018,-751,2798,20479,-419,84290
1344,LUX,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,2297,-6526,11953,global,2,1739,-880,4185,2018,-4668,9871
1345,LUX,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,17029,-13828,59649,NA,NA,NA,NA,NA,17029,-13828,59649
1346,LUX,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,22405,-488,58642,income,5,13622,-520,27625,18014,-518,49780
1347,LUX,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,19596,6216,46487,income,4,33548,-4833,70213,26572,2178,65634
1348,LUX,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,5364,-443,14424,income,1,35410,-35094,98373,20387,-19853,86336
1349,LUX,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,41421,-140073,247400,global,1,4971,-3971,14504,23196,-102449,200084
1350,LUX,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,23532,5308,58452,income,2,83545,-25841,197090,53538,-8559,179636
1351,LUX,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,38840,9025,91089,NA,NA,NA,NA,NA,38840,9025,91089
1352,LUX,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10000,-8962,30744,10000,-8962,30744
1353,LVA,EURO C,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,income,3,1370,549,2955,income,2,619,-403,1721,994,-270,2573
1354,LVA,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,income,3,1601,377,4067,NA,NA,NA,NA,NA,1601,377,4067
1355,LVA,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,2401,763,5555,income,2,23398,-15451,61244,12900,-7893,55477
1356,LVA,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,income,5,2025,789,4314,income,3,1049,-587,2703,1537,-316,3881
1357,LVA,EURO C,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,income,1,196,-521,1096,global,2,1753,-713,4341,974,-556,3891
1358,LVA,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,income,8,2213,353,5857,NA,NA,NA,NA,NA,2213,353,5857
1359,LVA,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,1874,66,5081,income,5,13426,-1253,27374,7650,-137,25325
1360,LVA,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,income,7,2829,1117,6260,income,4,33150,-2368,68382,17990,935,62412
1361,LVA,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,447,-1,1210,income,1,35284,-31019,100025,17866,-22248,92288
1362,LVA,EURO C,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,3789,-10062,22384,global,1,5038,-4957,14981,4414,-8105,18666
1363,LVA,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,income,3,3019,1044,6710,income,2,85150,-26458,200848,44084,-7588,184550
1364,LVA,EURO C,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,income,1,3277,867,8199,NA,NA,NA,NA,NA,3277,867,8199
1365,LVA,EURO C,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10184,-10071,30169,10184,-10071,30169
1366,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,172,67,374,global,2,611,-500,1649,391,-283,1497
1367,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,BSI,wbregion,1,-28,-553,528,NA,NA,NA,NA,NA,-28,-553,528
1368,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,BSI,global,3,302,99,713,global,2,23163,-14276,61715,11732,-8558,55573
1369,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,BSI,global,5,256,98,564,global,3,1020,-693,2742,638,-485,2470
1370,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,170,66,365,global,2,1818,-726,4296,994,-309,3972
1371,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,COL/INF,wbregion,3,144,55,309,NA,NA,NA,NA,NA,144,55,309
1372,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,227,-18,640,global,5,13339,-880,27244,6783,-33,25068
1373,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,COL/INF,global,7,353,132,809,global,4,33516,-1946,71381,16935,123,64622
1374,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,IAI,global,1,55,-1,160,global,1,35175,-31877,101093,17615,-21792,92257
1375,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,RTI,global,1,466,-1599,2682,global,1,4938,-5556,14861,2702,-3782,13521
1376,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,SSI,global,3,374,135,870,global,2,84097,-38426,195839,42236,-17817,177750
1377,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,SSTI,global,1,402,85,1020,NA,NA,NA,NA,NA,402,85,1020
1378,MAR,EMRO D,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10373,-10195,29769,10373,-10195,29769
1379,MCO,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,30474,1310,82600,income,2,631,-475,1706,15552,-373,67032
1380,MCO,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,30891,-6724,90073,NA,NA,NA,NA,NA,30891,-6724,90073
1381,MCO,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,44056,14139,104102,income,2,23116,-14624,63838,33586,-8500,90440
1382,MCO,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,60081,16917,147184,income,3,971,-693,2722,30526,-492,120495
1383,MCO,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,3107,-10763,18877,global,2,1808,-707,4288,2457,-7732,15381
1384,MCO,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,25746,-26871,102244,NA,NA,NA,NA,NA,25746,-26871,102244
1385,MCO,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,33892,-82,93106,income,5,13281,-1323,27687,23586,-1133,76835
1386,MCO,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,29287,9048,67643,income,4,33716,-1774,69085,31502,3135,68613
1387,MCO,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,8150,-397,22694,income,1,34983,-28628,101933,21567,-17940,90734
1388,MCO,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,55633,-211290,353063,global,1,5322,-4770,14552,30477,-158721,276821
1389,MCO,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,34151,5979,87516,income,2,80848,-43233,196057,57500,-15466,178784
1390,MCO,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,59010,12388,147197,NA,NA,NA,NA,NA,59010,12388,147197
1391,MCO,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10065,-9271,29550,10065,-9271,29550
1392,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gn,3g cephalosporins,BSI,wbregion,3,117,42,253,wbregion,2,567,-540,1738,342,-402,1525
1393,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,BSI,wbregion,1,207,72,453,NA,NA,NA,NA,NA,207,72,453
1394,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,BSI,global,3,208,63,506,global,2,24230,-12763,62686,12219,-6088,56913
1395,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,BSI,wbregion,4,173,59,399,wbregion,2,968,-744,2711,570,-496,2447
1396,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,117,42,257,global,2,1790,-671,4197,954,-236,3862
1397,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,COL/INF,wbregion,3,134,-206,544,NA,NA,NA,NA,NA,134,-206,544
1398,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,COL/INF,global,3,159,12,436,global,5,13235,-1800,27667,6697,-18,25584
1399,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,COL/INF,wbregion,2,137,40,331,global,4,32539,-4256,70352,16338,18,63813
1400,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,IAI,global,1,37,0,104,global,1,33989,-40438,100852,17013,-27167,91103
1401,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,RTI,global,1,330,-1073,1769,global,1,4871,-4609,14634,2601,-3346,12849
1402,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,SSI,wbregion,1,167,33,412,global,2,83569,-27823,198688,41868,-12178,181629
1403,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,SSTI,wbregion,1,272,60,697,NA,NA,NA,NA,NA,272,60,697
1404,MDA,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10241,-8869,31481,10241,-8869,31481
1405,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,19,7,42,global,2,598,-529,1707,308,-327,1559
1406,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,24,6,62,NA,NA,NA,NA,NA,24,6,62
1407,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,33,11,78,global,2,23414,-16047,60718,11724,-9497,55850
1408,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,28,10,63,global,3,1061,-596,2865,544,-280,2470
1409,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,19,7,40,global,2,1793,-753,4186,906,-361,3902
1410,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,24,8,53,NA,NA,NA,NA,NA,24,8,53
1411,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,25,0,72,global,5,13435,-1051,27368,6730,-1,25097
1412,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,39,14,85,global,4,33898,-1520,68580,16968,13,63153
1413,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,6,0,18,global,1,33556,-33132,105120,16781,-22107,91738
1414,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,53,-141,291,global,1,4858,-4196,14357,2456,-2918,12926
1415,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,42,14,96,global,2,83753,-31646,202137,41897,-12258,182438
1416,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,44,11,110,NA,NA,NA,NA,NA,44,11,110
1417,MDG,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10990,-8970,31575,10990,-8970,31575
1418,MDV,SEARO D,South Asia,SEARO,Upper middle income,gn,3g cephalosporins,BSI,income,2,571,213,1196,income,2,578,-544,1641,575,-340,1535
1419,MDV,SEARO D,South Asia,SEARO,Upper middle income,gn,carbapenems,BSI,income,1,2420,-44,6808,NA,NA,NA,NA,NA,2420,-44,6808
1420,MDV,SEARO D,South Asia,SEARO,Upper middle income,gp,glycopeptides,BSI,global,3,1004,327,2272,global,2,23756,-14973,61878,12380,-8275,56896
1421,MDV,SEARO D,South Asia,SEARO,Upper middle income,gp,penicillins,BSI,income,2,811,303,1745,income,2,932,-780,2705,872,-540,2425
1422,MDV,SEARO D,South Asia,SEARO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1283,121,3432,income,2,1774,-693,4351,1528,-342,4113
1423,MDV,SEARO D,South Asia,SEARO,Upper middle income,gn,carbapenems,COL/INF,income,1,483,183,1012,NA,NA,NA,NA,NA,483,183,1012
1424,MDV,SEARO D,South Asia,SEARO,Upper middle income,gp,glycopeptides,COL/INF,global,3,770,10,2119,global,5,13163,-927,28017,6966,-38,24946
1425,MDV,SEARO D,South Asia,SEARO,Upper middle income,gp,penicillins,COL/INF,global,7,1186,448,2552,global,4,31806,-4262,67396,16496,365,60494
1426,MDV,SEARO D,South Asia,SEARO,Upper middle income,gp,glycopeptides,IAI,global,1,186,-11,534,global,1,34613,-32262,104127,17400,-20379,92466
1427,MDV,SEARO D,South Asia,SEARO,Upper middle income,gn,carbapenems,RTI,income,1,1390,-4793,9565,income,1,4875,-4601,14040,3133,-4784,13383
1428,MDV,SEARO D,South Asia,SEARO,Upper middle income,gp,penicillins,SSI,global,3,1256,430,2810,global,2,84851,-26852,195738,43053,-8679,181646
1429,MDV,SEARO D,South Asia,SEARO,Upper middle income,gp,penicillins,SSTI,global,1,1374,322,3364,NA,NA,NA,NA,NA,1374,322,3364
1430,MDV,SEARO D,South Asia,SEARO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10688,-7960,29989,10688,-7960,29989
1431,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,1028,348,2277,income,2,588,-525,1687,808,-351,2031
1432,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,4410,264,11800,NA,NA,NA,NA,NA,4410,264,11800
1433,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,1812,508,4181,global,2,24819,-13138,63069,13316,-6834,56311
1434,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,1454,474,3373,income,2,961,-827,2769,1208,-442,2972
1435,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,2336,31,6179,income,2,1742,-874,4382,2039,-484,5297
1436,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,864,290,1924,NA,NA,NA,NA,NA,864,290,1924
1437,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1364,61,3653,global,5,13340,77,27394,7352,61,25156
1438,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,2120,677,4756,global,4,32436,-4771,68515,17278,450,62544
1439,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,337,-8,1007,global,1,33883,-30408,100299,17110,-21800,90859
1440,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,2853,-8058,16947,income,1,4994,-4714,15068,3924,-6737,16188
1441,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,2280,683,5374,global,2,82279,-39308,196990,42279,-13919,183043
1442,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,2454,525,6450,NA,NA,NA,NA,NA,2454,525,6450
1443,MEX,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10187,-9463,28488,10187,-9463,28488
1444,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,223,85,467,income,2,569,-637,1612,396,-378,1465
1445,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,BSI,whoc,1,203,77,425,NA,NA,NA,NA,NA,203,77,425
1446,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,BSI,global,3,399,123,917,global,2,24926,-11823,63825,12662,-6969,58044
1447,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,BSI,whoc,1,358,102,840,whoc,1,11284,-11431,33519,5821,-7317,30050
1448,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,512,30,1381,income,2,1754,-790,4326,1133,-401,3876
1449,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,COL/INF,income,1,188,72,387,NA,NA,NA,NA,NA,188,72,387
1450,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,308,12,839,global,5,13385,-567,27665,6847,-4,25118
1451,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,COL/INF,wbregion,1,498,197,1018,global,4,33203,582,67424,16850,199,61616
1452,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,IAI,global,1,74,-2,211,global,1,33744,-37863,104468,16909,-24671,89305
1453,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,RTI,income,1,572,-1859,3625,income,1,4944,-4883,14884,2758,-3544,13190
1454,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSI,global,3,491,174,1064,global,2,82800,-27229,198205,41645,-13299,178007
1455,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSTI,global,1,536,134,1323,NA,NA,NA,NA,NA,536,134,1323
1456,MHL,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10101,-10791,29330,10101,-10791,29330
1457,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,519,182,1191,income,2,580,-525,1675,550,-363,1557
1458,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,2249,220,6514,NA,NA,NA,NA,NA,2249,220,6514
1459,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,896,264,2167,global,2,25066,-12196,64265,12981,-7074,57995
1460,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,737,250,1667,income,2,952,-806,2606,844,-519,2323
1461,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1163,58,3173,income,2,1746,-814,4125,1454,-367,3904
1462,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,440,154,1002,NA,NA,NA,NA,NA,440,154,1002
1463,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,705,43,1894,global,5,13619,-740,27942,7162,-5,26154
1464,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,603,172,1522,global,4,32516,-4020,67689,16560,135,62940
1465,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,169,-12,523,global,1,35397,-32552,103726,17783,-20606,91662
1466,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,1358,-4722,8392,income,1,5059,-4840,14604,3209,-4839,13499
1467,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,743,147,1906,global,2,79250,-26789,196464,39996,-15174,176939
1468,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,1251,263,3218,NA,NA,NA,NA,NA,1251,263,3218
1469,MKD,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10556,-7911,30333,10556,-7911,30333
1470,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,35,13,80,global,2,607,-496,1734,321,-338,1581
1471,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,45,11,116,NA,NA,NA,NA,NA,45,11,116
1472,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,62,20,155,global,2,24363,-12878,63052,12212,-9681,58220
1473,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,52,21,121,global,3,972,-750,2715,512,-428,2360
1474,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,35,14,80,global,2,1749,-697,4282,892,-277,3917
1475,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,45,16,101,NA,NA,NA,NA,NA,45,16,101
1476,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,47,3,131,global,5,13163,-1505,26262,6605,-3,25087
1477,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,73,29,160,global,4,33489,390,68011,16781,30,62554
1478,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,11,-1,31,global,1,33361,-29488,102916,16686,-20231,90357
1479,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,95,-278,609,global,1,5170,-5226,14925,2633,-3254,13515
1480,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,77,27,173,global,2,84602,-34610,199053,42339,-16177,180534
1481,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,83,17,211,NA,NA,NA,NA,NA,83,17,211
1482,MLI,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9637,-9250,30003,9637,-9250,30003
1483,MLT,EURO A,Middle East & North Africa,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,2940,31,7885,income,2,581,-519,1642,1761,-399,6716
1484,MLT,EURO A,Middle East & North Africa,EURO,High income,gn,carbapenems,BSI,whoc,2,3229,-666,9834,NA,NA,NA,NA,NA,3229,-666,9834
1485,MLT,EURO A,Middle East & North Africa,EURO,High income,gp,glycopeptides,BSI,income,3,4493,1242,10483,income,2,24007,-14521,64861,14250,-8859,57974
1486,MLT,EURO A,Middle East & North Africa,EURO,High income,gp,penicillins,BSI,whoc,2,6062,1386,14942,income,3,1017,-767,2772,3539,-429,13181
1487,MLT,EURO A,Middle East & North Africa,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,365,-1031,2098,global,2,1738,-825,4214,1051,-963,3851
1488,MLT,EURO A,Middle East & North Africa,EURO,High income,gn,carbapenems,COL/INF,whoc,5,2569,-2482,9872,NA,NA,NA,NA,NA,2569,-2482,9872
1489,MLT,EURO A,Middle East & North Africa,EURO,High income,gp,glycopeptides,COL/INF,income,3,3349,-219,9283,income,5,13128,921,27441,8239,94,25242
1490,MLT,EURO A,Middle East & North Africa,EURO,High income,gp,penicillins,COL/INF,whoc,2,2986,883,7364,income,4,32945,-2876,69511,17966,735,62627
1491,MLT,EURO A,Middle East & North Africa,EURO,High income,gp,glycopeptides,IAI,income,1,843,-16,2339,income,1,34479,-33580,106511,17661,-23652,96127
1492,MLT,EURO A,Middle East & North Africa,EURO,High income,gn,carbapenems,RTI,global,1,6711,-22193,38597,global,1,5044,-4337,14859,5878,-15767,32495
1493,MLT,EURO A,Middle East & North Africa,EURO,High income,gp,penicillins,SSI,whoc,1,3609,557,8990,income,2,83386,-30293,190961,43498,-8854,172881
1494,MLT,EURO A,Middle East & North Africa,EURO,High income,gp,penicillins,SSTI,whoc,1,6161,1226,15391,NA,NA,NA,NA,NA,6161,1226,15391
1495,MLT,EURO A,Middle East & North Africa,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10661,-8330,30690,10661,-8330,30690
1496,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gn,3g cephalosporins,BSI,global,3,21,8,44,global,2,618,-436,1775,320,-273,1534
1497,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gn,carbapenems,BSI,wbregion,2,39,-21,140,NA,NA,NA,NA,NA,39,-21,140
1498,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,BSI,global,3,36,11,83,global,2,23398,-14960,62019,11717,-10030,55872
1499,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,BSI,wbregion,1,33,10,77,wbregion,1,11772,-12978,34274,5902,-9548,30899
1500,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,21,8,44,wbregion,2,1806,-599,4291,913,-215,4053
1501,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gn,carbapenems,COL/INF,global,9,26,9,57,NA,NA,NA,NA,NA,26,9,57
1502,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,COL/INF,global,3,28,0,81,global,5,13432,151,26495,6730,1,24381
1503,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,46,18,98,global,4,32398,-3580,69091,16222,16,63294
1504,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,IAI,global,1,7,0,19,global,1,34134,-35463,108755,17071,-26056,95087
1505,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gn,carbapenems,RTI,wbregion,1,54,-173,345,wbregion,1,5308,-4453,15076,2681,-3013,13575
1506,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,SSI,global,3,46,15,102,global,2,83764,-32635,194768,41905,-15950,176465
1507,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,SSTI,global,1,49,11,111,NA,NA,NA,NA,NA,49,11,111
1508,MMR,SEARO D,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10228,-9279,30866,10228,-9279,30866
1509,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,1692,614,3727,income,2,584,-453,1659,1138,-352,3229
1510,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,7136,150,19823,NA,NA,NA,NA,NA,7136,150,19823
1511,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,3002,915,6996,global,2,23629,-15651,63732,13315,-9638,54492
1512,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,2405,853,5234,income,2,944,-813,2617,1674,-528,4638
1513,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,3875,311,10527,income,2,1775,-603,4057,2825,-252,8456
1514,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,1427,524,3082,NA,NA,NA,NA,NA,1427,524,3082
1515,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,2317,52,6575,global,5,13088,-1393,27378,7702,-264,25371
1516,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,1983,531,4709,global,4,31964,-2631,67450,16974,417,61209
1517,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,561,-1,1583,global,1,34004,-31300,102084,17282,-22467,92647
1518,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,4354,-15009,27304,income,1,4926,-5958,15280,4640,-10966,21825
1519,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,2414,415,6527,global,2,84121,-33548,202970,43267,-16229,184674
1520,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,4050,936,9972,NA,NA,NA,NA,NA,4050,936,9972
1521,MNE,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10087,-8495,29894,10087,-8495,29894
1522,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,118,44,259,global,2,604,-454,1722,361,-287,1516
1523,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,BSI,whoc,1,107,38,237,NA,NA,NA,NA,NA,107,38,237
1524,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,BSI,global,3,205,62,482,global,2,25651,-12277,65999,12928,-6721,59148
1525,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,BSI,whoc,1,185,54,428,whoc,1,12481,-10867,35045,6333,-7572,31661
1526,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,117,43,253,wbregion,2,1848,-716,4292,983,-331,3938
1527,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,COL/INF,global,9,147,51,331,NA,NA,NA,NA,NA,147,51,331
1528,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,159,-9,454,global,5,13178,-695,27943,6669,-21,25245
1529,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,262,96,567,global,4,32914,-3879,69348,16588,88,62901
1530,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,IAI,global,1,38,-2,106,global,1,32754,-35401,97359,16396,-26507,86875
1531,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,RTI,wbregion,1,350,-1009,2096,wbregion,1,5177,-5394,15074,2764,-3809,13579
1532,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSI,global,3,258,89,573,global,2,85892,-28326,197094,43075,-10196,178118
1533,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSTI,global,1,279,64,678,NA,NA,NA,NA,NA,279,64,678
1534,MNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10115,-10307,29749,10115,-10307,29749
1535,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,22,9,52,global,2,558,-585,1554,290,-378,1427
1536,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,28,7,71,NA,NA,NA,NA,NA,28,7,71
1537,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,38,13,85,global,2,25453,-14158,63578,12746,-7662,57267
1538,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,33,13,74,global,3,1012,-589,2740,523,-364,2423
1539,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,86,34,196,global,2,1823,-626,4193,954,-286,3855
1540,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,28,10,62,NA,NA,NA,NA,NA,28,10,62
1541,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,30,0,82,global,5,13743,-26,27950,6886,0,25206
1542,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,46,18,101,global,4,33573,-1779,68309,16809,16,63303
1543,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,7,0,21,global,1,34456,-34559,102718,17232,-19599,91744
1544,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,52,-209,344,global,1,5024,-4895,15187,2538,-3279,13444
1545,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,49,18,108,global,2,86560,-27727,198479,43304,-11438,182027
1546,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,52,12,121,NA,NA,NA,NA,NA,52,12,121
1547,MOZ,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9840,-9282,29340,9840,-9282,29340
1548,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,61,24,124,global,2,586,-446,1649,324,-278,1512
1549,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,78,20,175,NA,NA,NA,NA,NA,78,20,175
1550,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,107,37,228,global,2,23768,-16807,62643,11937,-10216,56883
1551,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,91,35,174,global,3,1008,-797,2920,549,-495,2505
1552,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,61,25,119,global,2,1798,-724,4282,929,-384,3887
1553,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,76,28,161,NA,NA,NA,NA,NA,76,28,161
1554,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,81,-1,212,global,5,13430,-746,26180,6756,-8,24380
1555,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,126,49,265,global,4,33933,-1338,68824,17030,45,63881
1556,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,20,-1,52,global,1,33873,-36011,105345,16946,-25912,93065
1557,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,168,-498,1030,global,1,5090,-5035,14574,2629,-3231,13498
1558,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,134,51,275,global,2,81767,-35232,199469,40951,-13209,178475
1559,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,145,36,335,NA,NA,NA,NA,NA,145,36,335
1560,MRT,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9962,-9034,30524,9962,-9034,30524
1561,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,819,291,1774,income,2,594,-448,1659,706,-307,1684
1562,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,BSI,income,1,3459,140,8995,NA,NA,NA,NA,NA,3459,140,8995
1563,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,BSI,global,3,1446,472,3208,global,2,23266,-13391,62448,12356,-9059,55503
1564,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,BSI,income,2,1157,417,2456,income,2,902,-910,2679,1029,-614,2578
1565,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,COL/INF,whoc,1,818,312,1763,income,2,1746,-675,4340,1282,-271,3782
1566,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,COL/INF,income,1,692,252,1503,NA,NA,NA,NA,NA,692,252,1503
1567,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1103,39,2890,global,5,13020,-1933,27411,7062,-32,25075
1568,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,COL/INF,global,7,1693,627,3600,global,4,34148,543,68277,17921,621,62723
1569,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,IAI,global,1,269,-15,727,global,1,34441,-32236,101702,17355,-21490,93446
1570,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,RTI,income,1,2024,-7416,13257,income,1,5248,-3962,14328,3636,-6033,14125
1571,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSI,global,3,1806,650,4111,global,2,87460,-32213,200042,44633,-9870,189755
1572,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSTI,global,1,1944,418,4779,NA,NA,NA,NA,NA,1944,418,4779
1573,MUS,AFRO D,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9828,-10675,29995,9828,-10675,29995
1574,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,19,7,41,global,2,591,-498,1652,305,-319,1514
1575,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,26,6,64,NA,NA,NA,NA,NA,26,6,64
1576,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,35,11,79,global,2,23731,-15913,62472,11883,-8061,56829
1577,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,29,11,63,global,3,962,-578,2570,496,-361,2322
1578,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,76,28,161,global,2,1863,-656,4284,969,-178,3907
1579,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,25,9,53,NA,NA,NA,NA,NA,25,9,53
1580,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,27,1,73,global,5,13013,-769,26239,6520,-1,23695
1581,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,40,14,86,global,4,32290,-824,68556,16165,14,63271
1582,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,6,-1,19,global,1,35610,-31152,102796,17808,-22541,92853
1583,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,50,-160,289,global,1,5212,-3824,14868,2631,-2626,13275
1584,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,43,15,96,global,2,83243,-30143,195688,41643,-11335,183946
1585,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,47,11,115,NA,NA,NA,NA,NA,47,11,115
1586,MWI,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10428,-9589,30412,10428,-9589,30412
1587,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,667,253,1441,income,2,592,-476,1686,629,-290,1630
1588,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,BSI,whoc,1,606,215,1371,NA,NA,NA,NA,NA,606,215,1371
1589,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,BSI,global,3,1166,381,2770,global,2,24331,-14925,62383,12748,-8250,56512
1590,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,BSI,whoc,1,1089,337,2658,whoc,1,12204,-10678,34230,6646,-6688,30471
1591,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1475,-10,4256,income,2,1839,-537,4334,1657,-240,4276
1592,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,COL/INF,income,1,564,214,1219,NA,NA,NA,NA,NA,564,214,1219
1593,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,890,-27,2479,global,5,13385,-1659,27623,7137,-113,25487
1594,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,COL/INF,wbregion,1,1489,568,3275,global,4,33253,-1302,69723,17371,519,60979
1595,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,IAI,global,1,221,-9,603,global,1,34048,-32444,101942,17135,-21247,89093
1596,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,RTI,income,1,1733,-5991,11102,income,1,4998,-4590,14830,3366,-5554,14036
1597,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSI,global,3,1455,483,3299,global,2,84464,-33479,188172,42960,-6671,175032
1598,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSTI,global,1,1612,342,4504,NA,NA,NA,NA,NA,1612,342,4504
1599,MYS,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9899,-10282,29724,9899,-10282,29724
1600,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,349,119,801,income,2,589,-564,1688,469,-341,1556
1601,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,BSI,income,1,1473,41,4371,NA,NA,NA,NA,NA,1473,41,4371
1602,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,BSI,global,3,611,188,1448,global,2,24218,-17741,64658,12414,-9999,56969
1603,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,BSI,income,2,492,159,1163,income,2,966,-659,2605,729,-421,2369
1604,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,COL/INF,whoc,1,1347,448,3175,income,2,1724,-758,4238,1535,-343,3911
1605,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,COL/INF,income,1,293,103,655,NA,NA,NA,NA,NA,293,103,655
1606,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,474,-4,1379,global,5,13154,-1900,27215,6814,-119,24215
1607,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,COL/INF,global,7,720,247,1592,global,4,32947,-739,67016,16834,223,62055
1608,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,IAI,global,1,113,-1,339,global,1,34181,-35737,105742,17147,-23838,96444
1609,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,RTI,income,1,978,-3802,5716,income,1,5257,-4608,14871,3117,-4164,12953
1610,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSI,global,3,766,249,1839,global,2,80438,-38058,194107,40602,-16522,176877
1611,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSTI,global,1,833,185,2259,NA,NA,NA,NA,NA,833,185,2259
1612,NAM,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10151,-10541,30578,10151,-10541,30578
1613,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,16,7,33,global,2,581,-463,1612,298,-348,1468
1614,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,21,6,50,NA,NA,NA,NA,NA,21,6,50
1615,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,28,10,61,global,2,23048,-19233,61546,11538,-13451,55919
1616,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,24,10,49,global,3,991,-634,2605,507,-406,2345
1617,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,16,6,33,global,2,1825,-694,4277,920,-243,3879
1618,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,20,8,43,NA,NA,NA,NA,NA,20,8,43
1619,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,21,1,55,global,5,13362,-347,28893,6692,0,26379
1620,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,33,13,67,global,4,32423,-5479,69074,16228,11,64717
1621,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,5,-1,13,global,1,33655,-28588,103691,16830,-21365,91657
1622,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,46,-124,264,global,1,5043,-5444,15430,2545,-3571,13350
1623,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,35,13,74,global,2,84267,-42415,198958,42151,-19053,178343
1624,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,38,9,94,NA,NA,NA,NA,NA,38,9,94
1625,NER,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9943,-9554,28750,9943,-9554,28750
1626,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,86,35,172,global,2,587,-506,1672,337,-380,1541
1627,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,111,25,268,NA,NA,NA,NA,NA,111,25,268
1628,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,151,53,345,global,2,23396,-15320,63582,11773,-10149,57513
1629,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,129,51,261,global,3,1026,-652,2767,578,-432,2480
1630,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,86,36,174,global,2,1760,-664,4124,923,-312,3835
1631,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,110,40,236,NA,NA,NA,NA,NA,110,40,236
1632,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,119,7,313,global,5,13291,-775,27474,6705,2,24949
1633,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,179,72,378,global,4,32471,-2001,68410,16325,67,61706
1634,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,28,-1,78,global,1,35908,-30303,103755,17968,-18006,96338
1635,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,235,-747,1460,global,1,4887,-4594,14347,2561,-2961,12925
1636,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,190,72,392,global,2,84688,-27814,201875,42439,-11465,181135
1637,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,204,51,480,NA,NA,NA,NA,NA,204,51,480
1638,NGA,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9910,-9684,29634,9910,-9684,29634
1639,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gn,3g cephalosporins,BSI,global,3,127,48,265,global,2,604,-563,1706,365,-347,1536
1640,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,BSI,global,4,164,40,380,NA,NA,NA,NA,NA,164,40,380
1641,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,BSI,global,3,224,67,521,global,2,24646,-15628,63146,12435,-8627,56813
1642,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,BSI,global,5,189,71,396,global,3,1020,-756,2803,604,-444,2505
1643,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,126,48,261,global,2,1810,-730,4157,968,-324,3845
1644,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,COL/INF,global,9,160,54,360,NA,NA,NA,NA,NA,160,54,360
1645,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,COL/INF,global,3,174,9,466,global,5,13293,-322,27188,6733,6,24906
1646,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,COL/INF,global,7,261,99,560,global,4,31381,-2966,67117,15821,86,60227
1647,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,IAI,global,1,42,1,122,global,1,34281,-34013,108943,17162,-22300,91939
1648,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,RTI,global,1,339,-1161,2034,global,1,5184,-5049,14495,2761,-2840,13230
1649,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,SSI,global,3,277,99,629,global,2,86399,-28787,201724,43338,-8347,182439
1650,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,SSTI,global,1,297,71,750,NA,NA,NA,NA,NA,297,71,750
1651,NIC,AMRO D,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10031,-10758,29665,10031,-10758,29665
1652,NIU,WPRO B,NA,WPRO,NA,gn,3g cephalosporins,BSI,global,3,2992,1155,6160,global,2,605,-475,1677,1799,-327,5530
1653,NIU,WPRO B,NA,WPRO,NA,gn,carbapenems,BSI,whoc,1,2702,979,5851,NA,NA,NA,NA,NA,2702,979,5851
1654,NIU,WPRO B,NA,WPRO,NA,gp,glycopeptides,BSI,global,3,5282,1658,12083,global,2,24365,-14122,62455,14824,-8117,56657
1655,NIU,WPRO B,NA,WPRO,NA,gp,penicillins,BSI,whoc,1,4751,1366,11442,whoc,1,11890,-11136,36300,8320,-7698,32123
1656,NIU,WPRO B,NA,WPRO,NA,gn,3g cephalosporins,COL/INF,global,5,4096,1040,10291,global,2,1754,-899,4091,2925,-349,8212
1657,NIU,WPRO B,NA,WPRO,NA,gn,carbapenems,COL/INF,global,9,3727,1381,7869,NA,NA,NA,NA,NA,3727,1381,7869
1658,NIU,WPRO B,NA,WPRO,NA,gp,glycopeptides,COL/INF,global,3,3853,-10,10320,global,5,13004,-567,26793,8429,-92,24625
1659,NIU,WPRO B,NA,WPRO,NA,gp,penicillins,COL/INF,global,7,6153,2400,13307,global,4,33391,-7785,70748,19772,1559,64318
1660,NIU,WPRO B,NA,WPRO,NA,gp,glycopeptides,IAI,global,1,993,-123,2841,global,1,34062,-36730,102471,17528,-24501,89911
1661,NIU,WPRO B,NA,WPRO,NA,gn,carbapenems,RTI,global,1,7083,-26121,48535,global,1,4881,-4621,14255,5982,-19979,38792
1662,NIU,WPRO B,NA,WPRO,NA,gp,penicillins,SSI,global,3,6533,2274,14039,global,2,82583,-30191,200340,44558,-12198,180381
1663,NIU,WPRO B,NA,WPRO,NA,gp,penicillins,SSTI,global,1,7152,1599,16945,NA,NA,NA,NA,NA,7152,1599,16945
1664,NIU,WPRO B,NA,WPRO,NA,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9947,-9773,28885,9947,-9773,28885
1665,NLD,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,7153,472,20269,income,2,581,-455,1714,3867,-382,17212
1666,NLD,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,7555,-2095,24167,NA,NA,NA,NA,NA,7555,-2095,24167
1667,NLD,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,10656,3236,23625,income,2,22865,-15142,63190,16760,-9011,57503
1668,NLD,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,14724,3409,37388,income,3,1036,-628,2819,7880,-333,30644
1669,NLD,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,877,-2241,4437,global,2,1744,-941,4197,1311,-1734,4324
1670,NLD,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,6379,-6013,24422,NA,NA,NA,NA,NA,6379,-6013,24422
1671,NLD,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,8287,472,23295,income,5,12983,-1843,27557,10635,-759,26016
1672,NLD,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,7152,2076,16734,income,4,32183,-5337,67089,19667,1394,61966
1673,NLD,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,2034,-101,6121,income,1,34985,-30201,103397,18509,-21325,88641
1674,NLD,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,17324,-55150,90585,global,1,5075,-4210,15378,11199,-35050,76750
1675,NLD,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,8872,1686,23212,income,2,78776,-43199,195137,43824,-25141,175358
1676,NLD,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,14459,3488,35075,NA,NA,NA,NA,NA,14459,3488,35075
1677,NLD,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9527,-9278,27464,9527,-9278,27464
1678,NOR,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,11775,179,33222,income,2,586,-513,1741,6180,-476,27756
1679,NOR,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,12109,-3438,38242,NA,NA,NA,NA,NA,12109,-3438,38242
1680,NOR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,17909,5090,42927,income,2,22330,-15548,61437,20119,-10860,55379
1681,NOR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,24216,5686,62429,income,3,980,-681,2691,12598,-381,51033
1682,NOR,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,1293,-3830,7594,global,2,1732,-674,4240,1513,-2703,5956
1683,NOR,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,9632,-11898,37639,NA,NA,NA,NA,NA,9632,-11898,37639
1684,NOR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,13641,695,37509,income,5,13323,333,27060,13482,484,32958
1685,NOR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,11582,3209,28227,income,4,33434,249,67242,22508,2505,60951
1686,NOR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,3345,99,9794,income,1,35553,-29529,95631,19449,-18127,86802
1687,NOR,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,22594,-100836,167180,global,1,5029,-4728,15207,13812,-70189,133127
1688,NOR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,14276,2111,36933,income,2,83507,-31720,200204,48892,-18635,182941
1689,NOR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,23656,5590,60680,NA,NA,NA,NA,NA,23656,5590,60680
1690,NOR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9866,-8938,28783,9866,-8938,28783
1691,NPL,SEARO D,South Asia,SEARO,Low income,gn,3g cephalosporins,BSI,global,3,36,13,80,global,2,615,-483,1740,326,-297,1534
1692,NPL,SEARO D,South Asia,SEARO,Low income,gn,carbapenems,BSI,global,4,46,10,122,NA,NA,NA,NA,NA,46,10,122
1693,NPL,SEARO D,South Asia,SEARO,Low income,gp,glycopeptides,BSI,global,3,63,20,149,global,2,24078,-14116,65257,12071,-7591,57247
1694,NPL,SEARO D,South Asia,SEARO,Low income,gp,penicillins,BSI,global,5,53,20,117,global,3,984,-747,2851,519,-450,2511
1695,NPL,SEARO D,South Asia,SEARO,Low income,gn,3g cephalosporins,COL/INF,global,5,50,10,130,global,2,1780,-622,4148,915,-228,3805
1696,NPL,SEARO D,South Asia,SEARO,Low income,gn,carbapenems,COL/INF,global,9,45,16,105,NA,NA,NA,NA,NA,45,16,105
1697,NPL,SEARO D,South Asia,SEARO,Low income,gp,glycopeptides,COL/INF,global,3,49,3,137,global,5,13263,-1371,27196,6656,-2,25262
1698,NPL,SEARO D,South Asia,SEARO,Low income,gp,penicillins,COL/INF,global,7,74,28,172,global,4,33029,-2694,66582,16551,24,62519
1699,NPL,SEARO D,South Asia,SEARO,Low income,gp,glycopeptides,IAI,global,1,12,-1,37,global,1,35849,-29378,104243,17930,-20156,93924
1700,NPL,SEARO D,South Asia,SEARO,Low income,gn,carbapenems,RTI,global,1,91,-291,571,global,1,4930,-4785,14417,2510,-3119,12872
1701,NPL,SEARO D,South Asia,SEARO,Low income,gp,penicillins,SSI,global,3,78,27,180,global,2,84243,-28743,197197,42161,-14541,180471
1702,NPL,SEARO D,South Asia,SEARO,Low income,gp,penicillins,SSTI,global,1,85,19,224,NA,NA,NA,NA,NA,85,19,224
1703,NPL,SEARO D,South Asia,SEARO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10146,-10955,31139,10146,-10955,31139
1704,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,155,58,349,income,2,608,-492,1659,381,-347,1504
1705,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,BSI,whoc,1,139,46,334,NA,NA,NA,NA,NA,139,46,334
1706,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,BSI,global,3,272,87,654,global,2,23929,-16706,65190,12101,-11438,59054
1707,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,BSI,whoc,1,248,73,606,whoc,1,11984,-11182,34792,6116,-8029,31363
1708,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,348,26,925,income,2,1797,-712,4180,1072,-317,3843
1709,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,COL/INF,income,1,130,48,301,NA,NA,NA,NA,NA,130,48,301
1710,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,210,4,626,global,5,12875,-2857,27815,6543,-317,25027
1711,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,COL/INF,wbregion,1,343,127,788,global,4,32391,-3125,66025,16367,102,60854
1712,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,IAI,global,1,51,0,155,global,1,33080,-34659,103362,16565,-24197,90767
1713,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,RTI,income,1,387,-1306,2396,income,1,5007,-5351,15025,2697,-3348,13165
1714,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSI,global,3,338,118,840,global,2,81548,-32383,196179,40943,-16538,180377
1715,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSTI,global,1,366,86,954,NA,NA,NA,NA,NA,366,86,954
1716,NRU,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10466,-8906,31705,10466,-8906,31705
1717,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,BSI,income,3,4300,1627,8868,income,2,602,-544,1685,2451,-359,7810
1718,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,BSI,income,3,5107,1369,12989,NA,NA,NA,NA,NA,5107,1369,12989
1719,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,BSI,income,3,7545,2464,16663,income,2,24256,-15950,63430,15900,-9315,57208
1720,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,BSI,income,5,6415,2409,13023,income,3,999,-820,2718,3707,-468,11902
1721,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,COL/INF,income,1,594,-1510,3322,wbregion,2,1793,-677,4441,1194,-1151,4123
1722,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,COL/INF,income,8,7001,1084,16660,NA,NA,NA,NA,NA,7001,1084,16660
1723,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,COL/INF,income,3,5650,-166,16062,income,5,13246,-1162,27208,9448,-426,25152
1724,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,COL/INF,whoc,1,9564,3706,19482,income,4,32776,-1965,68851,21170,2786,60803
1725,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,IAI,income,1,1411,-75,3929,income,1,35681,-33346,99935,18546,-21306,90323
1726,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,RTI,wbregion,1,10801,-40422,67720,wbregion,1,5046,-5012,15160,7923,-27634,53148
1727,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,SSI,income,3,9554,3307,20922,income,2,83795,-50616,203015,46675,-24606,184443
1728,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,SSTI,income,1,10349,2383,24755,NA,NA,NA,NA,NA,10349,2383,24755
1729,NZL,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10376,-9794,29672,10376,-9794,29672
1730,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,BSI,income,3,1094,430,2340,income,2,609,-500,1621,852,-322,2105
1731,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,BSI,income,3,1281,323,3337,NA,NA,NA,NA,NA,1281,323,3337
1732,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,BSI,income,3,1909,660,4355,income,2,23934,-12672,63364,12921,-8232,58854
1733,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,BSI,income,5,1630,624,3506,income,3,1021,-626,2733,1325,-346,3144
1734,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,COL/INF,income,1,160,-397,796,global,2,1831,-729,4473,996,-478,3912
1735,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,COL/INF,whoc,1,919,361,1942,NA,NA,NA,NA,NA,919,361,1942
1736,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,COL/INF,income,3,1447,70,4106,income,5,13476,-443,28158,7461,46,25568
1737,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,COL/INF,income,7,2260,877,4843,income,4,32038,-3199,67758,17149,824,60205
1738,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,IAI,income,1,355,-9,980,income,1,34490,-32703,94462,17423,-22132,87036
1739,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,RTI,global,1,2924,-7843,18543,global,1,5127,-5123,15219,4026,-6677,16442
1740,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSI,income,3,2392,840,5288,income,2,80388,-36027,194280,41390,-20487,176576
1741,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSTI,income,1,2579,561,6580,NA,NA,NA,NA,NA,2579,561,6580
1742,OMN,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10288,-9885,29451,10288,-9885,29451
1743,PAK,EMRO D,South Asia,EMRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,51,19,111,global,2,610,-471,1743,330,-307,1525
1744,PAK,EMRO D,South Asia,EMRO,Lower middle income,gn,carbapenems,BSI,global,4,65,17,149,NA,NA,NA,NA,NA,65,17,149
1745,PAK,EMRO D,South Asia,EMRO,Lower middle income,gp,glycopeptides,BSI,global,3,91,27,205,global,2,24492,-13943,60021,12291,-7762,55240
1746,PAK,EMRO D,South Asia,EMRO,Lower middle income,gp,penicillins,BSI,global,5,76,28,161,global,3,1040,-664,2668,558,-332,2404
1747,PAK,EMRO D,South Asia,EMRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,51,19,105,global,2,1822,-614,4271,936,-299,3872
1748,PAK,EMRO D,South Asia,EMRO,Lower middle income,gn,carbapenems,COL/INF,global,9,64,22,138,NA,NA,NA,NA,NA,64,22,138
1749,PAK,EMRO D,South Asia,EMRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,68,3,176,global,5,12945,-1629,26650,6506,-5,24774
1750,PAK,EMRO D,South Asia,EMRO,Lower middle income,gp,penicillins,COL/INF,global,7,105,37,226,global,4,32641,-5249,69059,16373,32,61970
1751,PAK,EMRO D,South Asia,EMRO,Lower middle income,gp,glycopeptides,IAI,global,1,17,0,47,global,1,35080,-30721,104133,17548,-21092,91524
1752,PAK,EMRO D,South Asia,EMRO,Lower middle income,gn,carbapenems,RTI,global,1,128,-474,726,global,1,4949,-4650,14468,2538,-3579,12808
1753,PAK,EMRO D,South Asia,EMRO,Lower middle income,gp,penicillins,SSI,global,3,112,38,252,global,2,83727,-29384,194066,41920,-10109,177737
1754,PAK,EMRO D,South Asia,EMRO,Lower middle income,gp,penicillins,SSTI,global,1,120,25,289,NA,NA,NA,NA,NA,120,25,289
1755,PAK,EMRO D,South Asia,EMRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9778,-11075,28491,9778,-11075,28491
1756,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,BSI,income,3,997,397,2175,income,2,606,-461,1691,801,-340,1939
1757,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,BSI,income,3,1160,270,2813,NA,NA,NA,NA,NA,1160,270,2813
1758,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,BSI,income,3,1760,575,3862,income,2,23401,-17121,62544,12581,-9986,58142
1759,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,BSI,income,5,1479,614,3192,income,3,1036,-723,2764,1258,-448,2940
1760,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,COL/INF,income,1,141,-354,787,global,2,1803,-508,4223,972,-411,3791
1761,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,COL/INF,income,8,1585,385,4042,NA,NA,NA,NA,NA,1585,385,4042
1762,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,COL/INF,income,3,1298,-36,3747,income,5,13333,-1275,28064,7316,-259,25267
1763,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,COL/INF,income,7,2049,832,4348,income,4,33254,-3920,70328,17651,697,64755
1764,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,IAI,income,1,327,-3,860,income,1,34163,-30153,102906,17245,-22505,92716
1765,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,RTI,global,1,2279,-8592,14496,global,1,5219,-4447,15196,3749,-7188,14914
1766,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSI,income,3,2203,805,5237,income,2,82792,-35320,202018,42497,-15037,180058
1767,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSTI,income,1,2317,450,5707,NA,NA,NA,NA,NA,2317,450,5707
1768,PAN,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9904,-10471,29532,9904,-10471,29532
1769,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,527,210,1101,income,2,584,-464,1623,556,-339,1504
1770,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,2210,135,5992,NA,NA,NA,NA,NA,2210,135,5992
1771,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,923,284,2122,global,2,24242,-13385,63142,12582,-7780,56489
1772,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,748,290,1601,income,2,957,-776,2747,852,-526,2424
1773,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1186,93,3299,income,2,1771,-720,4317,1478,-305,3976
1774,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,445,179,934,NA,NA,NA,NA,NA,445,179,934
1775,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,708,24,2011,global,5,13511,-1004,27590,7110,-65,25598
1776,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,1096,426,2459,global,4,32238,-4527,68423,16667,311,63446
1777,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,170,-12,504,global,1,33989,-36186,106334,17079,-20679,91354
1778,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,1341,-4268,8898,income,1,4988,-4320,15066,3165,-4320,13526
1779,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,1170,388,2512,global,2,85131,-33538,201943,43151,-15424,189101
1780,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,1271,302,3368,NA,NA,NA,NA,NA,1271,302,3368
1781,PER,AMRO D,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10245,-10783,30256,10245,-10783,30256
1782,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,134,55,267,global,2,561,-553,1601,348,-372,1456
1783,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,BSI,whoc,1,122,47,256,NA,NA,NA,NA,NA,122,47,256
1784,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,BSI,global,3,239,78,522,global,2,24263,-14590,62178,12251,-8747,57078
1785,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,BSI,whoc,1,220,66,474,whoc,1,11222,-11168,34058,5721,-8035,30468
1786,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,134,56,269,wbregion,2,1707,-845,4293,921,-319,3895
1787,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,COL/INF,global,9,170,65,334,NA,NA,NA,NA,NA,170,65,334
1788,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,175,-2,462,global,5,13369,-234,26470,6772,-4,24679
1789,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,299,123,592,global,4,31710,-4102,68506,16005,104,62014
1790,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,IAI,global,1,46,-1,125,global,1,32752,-32554,95474,16399,-19786,88116
1791,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,RTI,wbregion,1,336,-1192,2054,wbregion,1,4853,-4534,15389,2594,-3028,13433
1792,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSI,global,3,296,112,590,global,2,82656,-28469,194230,41476,-13982,177341
1793,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSTI,global,1,316,70,744,NA,NA,NA,NA,NA,316,70,744
1794,PHL,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9687,-9744,28449,9687,-9744,28449
1795,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,BSI,income,3,2214,807,4929,income,2,564,-573,1655,1389,-403,4104
1796,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gn,carbapenems,BSI,whoc,1,1970,683,4434,NA,NA,NA,NA,NA,1970,683,4434
1797,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gp,glycopeptides,BSI,income,3,3879,1287,9114,income,2,22159,-13082,62673,13019,-8228,55233
1798,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gp,penicillins,BSI,whoc,1,3561,1074,8750,whoc,1,11271,-12161,34761,7416,-8416,31318
1799,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,COL/INF,income,1,362,-791,1844,wbregion,2,1808,-829,4307,1085,-799,3972
1800,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gn,carbapenems,COL/INF,income,8,3591,745,9160,NA,NA,NA,NA,NA,3591,745,9160
1801,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gp,glycopeptides,COL/INF,income,3,3041,104,8100,income,5,13860,-507,27808,8451,20,25696
1802,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gp,penicillins,COL/INF,income,7,4568,1620,10048,income,4,33602,-1482,69244,19085,1547,63159
1803,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gp,glycopeptides,IAI,income,1,722,-30,2028,income,1,36327,-29843,107678,18525,-19535,96137
1804,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gn,carbapenems,RTI,wbregion,1,5193,-20506,35698,wbregion,1,4793,-6079,14572,4993,-15120,28858
1805,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gp,penicillins,SSI,income,3,4909,1681,11377,income,2,79501,-31241,188622,42205,-13843,170420
1806,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gp,penicillins,SSTI,income,1,5265,1215,13560,NA,NA,NA,NA,NA,5265,1215,13560
1807,PLW,WPRO B,East Asia & Pacific,WPRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10038,-9220,28979,10038,-9220,28979
1808,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,152,57,337,global,2,597,-479,1704,374,-332,1554
1809,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,BSI,whoc,1,135,49,314,NA,NA,NA,NA,NA,135,49,314
1810,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,BSI,global,3,263,84,639,global,2,22952,-16499,59178,11607,-11182,55169
1811,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,BSI,whoc,1,240,66,572,whoc,1,12177,-9540,34185,6208,-6390,31641
1812,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,151,57,339,wbregion,2,1848,-707,4341,1000,-221,3929
1813,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,COL/INF,global,9,190,67,419,NA,NA,NA,NA,NA,190,67,419
1814,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,198,6,567,global,5,13334,5,27334,6766,6,25055
1815,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,336,123,747,global,4,33541,-2216,68792,16939,119,63899
1816,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,IAI,global,1,51,-1,145,global,1,32413,-38368,105306,16232,-26433,89042
1817,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,RTI,wbregion,1,390,-1425,2505,wbregion,1,4971,-4889,15073,2681,-3019,12896
1818,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSI,global,3,336,118,757,global,2,82453,-31151,203559,41395,-10775,184881
1819,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSTI,global,1,361,67,951,NA,NA,NA,NA,NA,361,67,951
1820,PNG,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10255,-9026,28709,10255,-9026,28709
1821,POL,EURO B,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,income,3,1273,508,2689,income,2,610,-485,1615,942,-290,2362
1822,POL,EURO B,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,income,3,1515,352,3760,NA,NA,NA,NA,NA,1515,352,3760
1823,POL,EURO B,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,2195,713,5276,income,2,24870,-13092,65283,13533,-6902,58137
1824,POL,EURO B,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,income,5,1892,732,4136,income,3,1023,-547,2805,1458,-325,3515
1825,POL,EURO B,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,income,1,159,-493,952,global,2,1781,-689,4256,970,-549,3861
1826,POL,EURO B,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,income,8,2096,387,5618,NA,NA,NA,NA,NA,2096,387,5618
1827,POL,EURO B,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,1726,11,4641,income,5,13258,-1326,26623,7492,-169,24881
1828,POL,EURO B,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,income,7,2626,999,5600,income,4,32492,-819,67088,17559,893,61436
1829,POL,EURO B,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,430,3,1192,income,1,34468,-32305,100649,17449,-21286,89074
1830,POL,EURO B,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,3366,-10111,20786,global,1,5056,-4622,14857,4211,-7716,17411
1831,POL,EURO B,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,income,3,2802,994,6339,income,2,84795,-25668,193769,43799,-10000,178022
1832,POL,EURO B,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,income,1,3035,681,8251,NA,NA,NA,NA,NA,3035,681,8251
1833,POL,EURO B,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10010,-8980,29334,10010,-8980,29334
1834,PRK,SEARO D,East Asia & Pacific,SEARO,Low income,gn,3g cephalosporins,BSI,NA,NA,NA,NA,NA,global,2,573,-502,1651,573,-502,1651
1835,PRK,SEARO D,East Asia & Pacific,SEARO,Low income,gp,glycopeptides,BSI,NA,NA,NA,NA,NA,global,2,23247,-13972,61395,23247,-13972,61395
1836,PRK,SEARO D,East Asia & Pacific,SEARO,Low income,gp,penicillins,BSI,NA,NA,NA,NA,NA,wbregion,1,11238,-12943,33517,11238,-12943,33517
1837,PRK,SEARO D,East Asia & Pacific,SEARO,Low income,gn,3g cephalosporins,COL/INF,NA,NA,NA,NA,NA,wbregion,2,1765,-652,4228,1765,-652,4228
1838,PRK,SEARO D,East Asia & Pacific,SEARO,Low income,gp,glycopeptides,COL/INF,NA,NA,NA,NA,NA,global,5,13372,-584,26905,13372,-584,26905
1839,PRK,SEARO D,East Asia & Pacific,SEARO,Low income,gp,penicillins,COL/INF,NA,NA,NA,NA,NA,global,4,32150,-709,66245,32150,-709,66245
1840,PRK,SEARO D,East Asia & Pacific,SEARO,Low income,gp,glycopeptides,IAI,NA,NA,NA,NA,NA,global,1,35123,-33269,101452,35123,-33269,101452
1841,PRK,SEARO D,East Asia & Pacific,SEARO,Low income,gn,carbapenems,RTI,NA,NA,NA,NA,NA,wbregion,1,4835,-5414,16008,4835,-5414,16008
1842,PRK,SEARO D,East Asia & Pacific,SEARO,Low income,gp,penicillins,SSI,NA,NA,NA,NA,NA,global,2,83066,-34930,192567,83066,-34930,192567
1843,PRK,SEARO D,East Asia & Pacific,SEARO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9782,-11151,29272,9782,-11151,29272
1844,PRT,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,2826,52,7900,income,2,591,-502,1664,1708,-401,6428
1845,PRT,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,3059,-786,9897,NA,NA,NA,NA,NA,3059,-786,9897
1846,PRT,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,4187,1363,9605,income,2,23748,-16199,62976,13968,-9453,56883
1847,PRT,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,5788,1593,14237,income,3,991,-651,2600,3389,-487,11870
1848,PRT,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,360,-783,1931,global,2,1782,-771,4251,1071,-780,3898
1849,PRT,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,2520,-1818,8975,NA,NA,NA,NA,NA,2520,-1818,8975
1850,PRT,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,3247,223,8435,income,5,13032,-479,26354,8140,-27,24586
1851,PRT,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,2773,837,6476,income,4,33264,-1926,69421,18019,694,62178
1852,PRT,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,797,11,2230,income,1,35120,-32345,102080,17958,-21211,90729
1853,PRT,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,5160,-23145,35961,global,1,4869,-5464,14785,5014,-16411,30111
1854,PRT,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,3372,575,8722,income,2,81749,-39690,195898,42561,-19474,177658
1855,PRT,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,5678,1323,13941,NA,NA,NA,NA,NA,5678,1323,13941
1856,PRT,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9530,-10214,29058,9530,-10214,29058
1857,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,233,82,509,income,2,584,-558,1669,408,-335,1516
1858,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,995,52,2641,NA,NA,NA,NA,NA,995,52,2641
1859,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,412,117,969,global,2,24643,-13454,65582,12528,-6425,59242
1860,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,327,123,758,income,2,970,-835,2618,649,-460,2407
1861,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,515,40,1341,income,2,1735,-799,4349,1125,-365,3970
1862,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,197,70,436,NA,NA,NA,NA,NA,197,70,436
1863,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,313,20,910,global,5,13370,-2506,26899,6841,-83,25327
1864,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,485,161,1118,global,4,32342,-1325,65575,16414,155,60656
1865,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,75,-2,221,global,1,33936,-32334,99801,17006,-20965,86522
1866,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,637,-1853,4074,income,1,4755,-5150,14499,2696,-4047,12614
1867,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,517,163,1167,global,2,82532,-34017,191226,41524,-17013,177826
1868,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,560,131,1414,NA,NA,NA,NA,NA,560,131,1414
1869,PRY,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10127,-9879,29961,10127,-9879,29961
1870,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,BSI,income,3,6155,2287,13550,income,2,610,-535,1697,3382,-339,11413
1871,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,BSI,income,3,7168,1643,18475,NA,NA,NA,NA,NA,7168,1643,18475
1872,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,BSI,income,3,10818,3308,25708,income,2,23887,-15670,61611,17353,-8454,55865
1873,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,BSI,income,5,9095,3459,20703,income,3,998,-709,2680,5046,-403,16972
1874,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,COL/INF,income,1,820,-2305,4587,global,2,1718,-667,4323,1269,-1820,4400
1875,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,COL/INF,whoc,1,5145,1897,10845,NA,NA,NA,NA,NA,5145,1897,10845
1876,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,COL/INF,income,3,8193,306,22140,income,5,13630,-58,28311,10912,174,26582
1877,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,COL/INF,income,7,12584,4543,28064,income,4,32061,-3239,67991,22322,1468,62256
1878,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,IAI,income,1,1996,29,5716,income,1,32785,-37034,96345,17391,-25921,89021
1879,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,RTI,global,1,17690,-47477,100287,global,1,5129,-4874,14533,11410,-32090,79476
1880,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSI,income,3,13321,4562,30431,income,2,81263,-29695,201524,47292,-15070,185086
1881,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSTI,income,1,14620,3422,39855,NA,NA,NA,NA,NA,14620,3422,39855
1882,QAT,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9685,-8735,29801,9685,-8735,29801
1883,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,812,303,1776,income,2,586,-513,1660,699,-358,1690
1884,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,3481,196,9356,NA,NA,NA,NA,NA,3481,196,9356
1885,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,1436,453,3537,global,2,24332,-13269,62386,12884,-7624,55713
1886,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,1149,427,2467,income,2,964,-850,2627,1057,-530,2586
1887,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1837,110,4977,income,2,1786,-745,4448,1812,-393,4634
1888,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,684,261,1441,NA,NA,NA,NA,NA,684,261,1441
1889,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1067,55,2819,global,5,13351,-1068,27650,7209,-35,25834
1890,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,957,295,2265,global,4,31627,-608,69293,16292,292,61407
1891,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,281,-9,860,global,1,33901,-30689,102126,17091,-20883,91341
1892,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,2319,-6622,14394,income,1,5048,-4568,15596,3684,-5633,14923
1893,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,1140,184,3018,global,2,83707,-30524,199239,42423,-9914,180683
1894,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,1943,378,4949,NA,NA,NA,NA,NA,1943,378,4949
1895,ROU,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9905,-9215,28260,9905,-9215,28260
1896,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,1160,418,2484,income,2,593,-482,1704,877,-355,2235
1897,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,4941,345,13466,NA,NA,NA,NA,NA,4941,345,13466
1898,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,2045,638,4724,global,2,24990,-13461,62927,13517,-7146,54951
1899,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,1651,613,3641,income,2,977,-853,2770,1314,-451,3253
1900,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,2658,285,7607,income,2,1849,-654,4460,2253,-323,6049
1901,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,975,363,2115,NA,NA,NA,NA,NA,975,363,2115
1902,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1590,32,4501,global,5,13161,-510,26403,7375,-43,24593
1903,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,1333,393,3103,global,4,32656,-5364,69771,16994,257,64068
1904,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,383,-10,1128,global,1,33784,-33558,104007,17083,-21572,86963
1905,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,3060,-8948,18750,income,1,5062,-4656,15313,4061,-7568,16398
1906,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,1676,337,4380,global,2,80411,-40406,192098,41044,-12679,176803
1907,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,2742,539,7018,NA,NA,NA,NA,NA,2742,539,7018
1908,RUS,EURO C,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9626,-10422,29860,9626,-10422,29860
1909,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,32,12,70,global,2,602,-515,1705,317,-380,1543
1910,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,40,10,95,NA,NA,NA,NA,NA,40,10,95
1911,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,56,19,133,global,2,24245,-11633,64034,12151,-7531,57919
1912,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,47,18,100,global,3,1046,-700,2725,547,-433,2491
1913,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,124,45,276,global,2,1772,-618,4132,948,-271,3818
1914,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,40,15,86,NA,NA,NA,NA,NA,40,15,86
1915,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,43,0,121,global,5,12843,-2260,27398,6443,-5,24526
1916,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,66,25,147,global,4,32479,223,68737,16272,25,61954
1917,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,10,-1,28,global,1,34493,-34881,110399,17251,-24743,93542
1918,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,78,-281,472,global,1,4926,-5474,15590,2502,-3602,13332
1919,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,71,26,160,global,2,86956,-29666,206487,43513,-13626,186601
1920,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,76,16,182,NA,NA,NA,NA,NA,76,16,182
1921,RWA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10314,-8732,28932,10314,-8732,28932
1922,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,BSI,income,3,1169,449,2390,income,2,591,-540,1661,880,-371,2149
1923,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,BSI,income,3,1373,263,3186,NA,NA,NA,NA,NA,1373,263,3186
1924,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,BSI,income,3,2050,695,4721,income,2,23786,-16941,63630,12918,-9997,57476
1925,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,BSI,income,5,1732,652,3721,income,3,1026,-836,2822,1379,-478,3260
1926,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gn,3g cephalosporins,COL/INF,income,1,165,-472,850,global,2,1698,-762,4182,932,-566,3756
1927,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,COL/INF,whoc,1,982,386,2041,NA,NA,NA,NA,NA,982,386,2041
1928,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,COL/INF,income,3,1532,-51,4128,income,5,13165,-1383,27320,7348,-251,25136
1929,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,COL/INF,income,7,2408,941,5089,income,4,33190,-3434,67667,17799,876,63531
1930,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,IAI,income,1,375,-50,1050,income,1,35693,-28196,100890,18034,-20753,90593
1931,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gn,carbapenems,RTI,global,1,3470,-8313,20136,global,1,4792,-4726,14982,4131,-6611,17059
1932,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSI,income,3,2567,929,5506,income,2,81749,-28162,190476,42158,-8668,176343
1933,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gp,penicillins,SSTI,income,1,2795,633,6579,NA,NA,NA,NA,NA,2795,633,6579
1934,SAU,EMRO E,Middle East & North Africa,EMRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9546,-10486,29576,9546,-10486,29576
1935,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,234,85,518,global,2,605,-469,1684,420,-313,1531
1936,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gn,carbapenems,BSI,global,4,303,64,783,NA,NA,NA,NA,NA,303,64,783
1937,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gp,glycopeptides,BSI,global,3,407,120,929,global,2,22560,-15777,61575,11484,-10863,56318
1938,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gp,penicillins,BSI,global,5,349,123,782,global,3,1008,-750,2693,678,-442,2341
1939,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,233,83,500,global,2,1771,-769,4285,1002,-382,3787
1940,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gn,carbapenems,COL/INF,global,9,294,98,682,NA,NA,NA,NA,NA,294,98,682
1941,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,320,19,925,global,5,13109,-1154,27081,6714,-23,25211
1942,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gp,penicillins,COL/INF,global,7,485,167,1049,global,4,33540,-184,68057,17013,165,63361
1943,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gp,glycopeptides,IAI,global,1,79,-3,230,global,1,35483,-29222,101440,17781,-17011,91931
1944,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gn,carbapenems,RTI,global,1,575,-2117,3580,global,1,5075,-4718,14756,2825,-3399,13328
1945,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gp,penicillins,SSI,global,3,516,170,1173,global,2,86253,-28943,199906,43384,-8069,179857
1946,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gp,penicillins,SSTI,global,1,553,118,1385,NA,NA,NA,NA,NA,553,118,1385
1947,SDN,EMRO D,Sub-Saharan Africa,EMRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10141,-10250,29526,10141,-10250,29526
1948,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,62,21,137,global,2,581,-554,1637,322,-390,1423
1949,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,81,16,213,NA,NA,NA,NA,NA,81,16,213
1950,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,110,31,268,global,2,23079,-16931,61415,11595,-9966,56264
1951,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,93,34,205,global,3,973,-714,2654,533,-377,2404
1952,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,62,22,137,global,2,1810,-785,4474,936,-264,4063
1953,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,78,26,183,NA,NA,NA,NA,NA,78,26,183
1954,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,84,0,234,global,5,13205,-37,27553,6644,0,24667
1955,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,129,45,279,global,4,32300,-1970,70475,16215,39,63922
1956,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,20,-1,57,global,1,34590,-34799,101895,17305,-25519,92246
1957,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,172,-616,1051,global,1,4868,-6048,15367,2520,-3751,13324
1958,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,136,45,326,global,2,81283,-35728,202400,40709,-10261,185472
1959,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,144,33,378,NA,NA,NA,NA,NA,144,33,378
1960,SEN,AFRO D,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10291,-7277,29943,10291,-7277,29943
1961,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,BSI,income,3,5695,2400,11879,income,2,569,-468,1657,3132,-305,10281
1962,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,BSI,income,3,6681,1498,15378,NA,NA,NA,NA,NA,6681,1498,15378
1963,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,BSI,income,3,10032,3218,22391,income,2,23615,-16172,64784,16824,-10404,56553
1964,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,BSI,income,5,8504,3453,18009,income,3,1008,-698,2802,4756,-473,15314
1965,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gn,3g cephalosporins,COL/INF,income,1,832,-2289,4548,wbregion,2,1782,-627,4394,1307,-1600,4438
1966,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,COL/INF,income,8,9354,1767,23023,NA,NA,NA,NA,NA,9354,1767,23023
1967,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,COL/INF,income,3,7819,186,20892,income,5,13355,-1299,27316,10587,-598,25746
1968,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,COL/INF,whoc,1,12715,5363,25511,income,4,33048,-1794,69111,22881,2349,63189
1969,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,IAI,income,1,1878,-72,5116,income,1,35145,-37877,103211,18512,-23435,93390
1970,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gn,carbapenems,RTI,wbregion,1,13401,-57015,84369,wbregion,1,5197,-4601,14790,9299,-40983,70720
1971,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,SSI,income,3,12486,4793,28140,income,2,83080,-39187,204442,47783,-13791,176132
1972,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gp,penicillins,SSTI,income,1,13336,2802,31386,NA,NA,NA,NA,NA,13336,2802,31386
1973,SGP,WPRO A,East Asia & Pacific,WPRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9407,-9565,29002,9407,-9565,29002
1974,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,216,80,469,global,2,578,-461,1589,397,-299,1448
1975,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,BSI,whoc,1,195,68,442,NA,NA,NA,NA,NA,195,68,442
1976,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,BSI,global,3,384,124,897,global,2,23285,-14756,66272,11834,-9587,59411
1977,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,BSI,whoc,1,346,99,857,whoc,1,11990,-11898,35520,6168,-8017,32282
1978,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,216,83,478,wbregion,2,1734,-863,4245,975,-358,3701
1979,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,COL/INF,global,9,270,94,622,NA,NA,NA,NA,NA,270,94,622
1980,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,283,-14,737,global,5,13259,-988,26525,6771,-25,24614
1981,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,481,177,1056,global,4,32160,-3286,67507,16321,158,62101
1982,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,IAI,global,1,72,2,229,global,1,33713,-34799,101101,16892,-20256,90030
1983,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,RTI,wbregion,1,528,-1781,3340,wbregion,1,5105,-4500,14870,2816,-3145,13009
1984,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSI,global,3,472,166,1064,global,2,84908,-31728,191500,42690,-11585,173300
1985,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSTI,global,1,507,99,1237,NA,NA,NA,NA,NA,507,99,1237
1986,SLB,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10776,-9804,29990,10776,-9804,29990
1987,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,27,10,56,global,2,585,-492,1589,306,-320,1470
1988,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,34,8,84,NA,NA,NA,NA,NA,34,8,84
1989,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,46,16,109,global,2,23307,-16132,61243,11677,-9249,55522
1990,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,40,15,81,global,3,1013,-723,2769,526,-472,2499
1991,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,27,10,54,global,2,1816,-838,4277,922,-311,4007
1992,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,34,12,71,NA,NA,NA,NA,NA,34,12,71
1993,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,36,0,97,global,5,13136,-1164,26839,6586,-5,25466
1994,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,56,21,115,global,4,33065,-3178,67606,16560,19,62802
1995,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,9,0,25,global,1,34827,-33436,101770,17418,-25542,94773
1996,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,64,-247,405,global,1,4904,-4504,14678,2484,-3098,13268
1997,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,59,20,125,global,2,83691,-34779,196040,41875,-12285,176644
1998,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,63,15,152,NA,NA,NA,NA,NA,63,15,152
1999,SLE,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10242,-7455,27624,10242,-7455,27624
2000,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gn,3g cephalosporins,BSI,global,3,351,137,745,global,2,593,-522,1702,472,-329,1552
2001,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,BSI,global,4,452,112,1061,NA,NA,NA,NA,NA,452,112,1061
2002,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,BSI,global,3,623,202,1520,global,2,23721,-12780,63151,12172,-7217,57553
2003,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,BSI,global,5,525,196,1137,global,3,994,-813,2699,759,-440,2422
2004,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,350,133,761,global,2,1776,-720,4208,1063,-386,3777
2005,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,COL/INF,global,9,448,157,996,NA,NA,NA,NA,NA,448,157,996
2006,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,COL/INF,global,3,478,14,1300,global,5,13189,-648,27840,6834,-13,24613
2007,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,COL/INF,global,7,727,272,1631,global,4,32568,-2557,67023,16648,237,61223
2008,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,IAI,global,1,117,0,348,global,1,33343,-35788,99441,16730,-25407,88238
2009,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gn,carbapenems,RTI,global,1,858,-2776,5303,global,1,5065,-4778,14652,2962,-3760,13450
2010,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,SSI,global,3,775,283,1774,global,2,83792,-30045,196265,42283,-12392,179310
2011,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,penicillins,SSTI,global,1,835,175,2049,NA,NA,NA,NA,NA,835,175,2049
2012,SLV,AMRO B,Latin America & Caribbean,PAHO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9632,-10410,29110,9632,-10410,29110
2013,SMR,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,9446,464,25242,income,2,597,-496,1672,5021,-424,21598
2014,SMR,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,9805,-2125,30738,NA,NA,NA,NA,NA,9805,-2125,30738
2015,SMR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,13936,4629,34836,income,2,23172,-15037,63527,18554,-8551,55935
2016,SMR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,19257,5233,48362,income,3,1022,-735,2619,10140,-487,39539
2017,SMR,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,1209,-3115,6167,global,2,1771,-518,4242,1490,-2298,5187
2018,SMR,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,8330,-6982,32810,NA,NA,NA,NA,NA,8330,-6982,32810
2019,SMR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,10910,300,29715,income,5,13463,-215,27148,12187,-130,28845
2020,SMR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,9163,2708,21848,income,4,32514,-956,66298,20838,1900,59348
2021,SMR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,2586,-220,7934,income,1,32629,-33231,102307,17608,-23851,88593
2022,SMR,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,20380,-59973,122395,global,1,4996,-4541,14740,12688,-46453,93819
2023,SMR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,11310,2062,29058,income,2,82166,-35072,199286,46738,-13716,178520
2024,SMR,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,18864,4270,47481,NA,NA,NA,NA,NA,18864,4270,47481
2025,SMR,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10722,-9566,30063,10722,-9566,30063
2026,SOM,EMRO D,Sub-Saharan Africa,EMRO,Low income,gn,3g cephalosporins,BSI,NA,NA,NA,NA,NA,global,2,580,-482,1618,580,-482,1618
2027,SOM,EMRO D,Sub-Saharan Africa,EMRO,Low income,gp,glycopeptides,BSI,NA,NA,NA,NA,NA,global,2,24264,-14940,66393,24264,-14940,66393
2028,SOM,EMRO D,Sub-Saharan Africa,EMRO,Low income,gp,penicillins,BSI,NA,NA,NA,NA,NA,global,3,1021,-739,2581,1021,-739,2581
2029,SOM,EMRO D,Sub-Saharan Africa,EMRO,Low income,gn,3g cephalosporins,COL/INF,NA,NA,NA,NA,NA,global,2,1723,-643,4206,1723,-643,4206
2030,SOM,EMRO D,Sub-Saharan Africa,EMRO,Low income,gp,glycopeptides,COL/INF,NA,NA,NA,NA,NA,global,5,13254,378,26459,13254,378,26459
2031,SOM,EMRO D,Sub-Saharan Africa,EMRO,Low income,gp,penicillins,COL/INF,NA,NA,NA,NA,NA,global,4,32216,-1716,65118,32216,-1716,65118
2032,SOM,EMRO D,Sub-Saharan Africa,EMRO,Low income,gp,glycopeptides,IAI,NA,NA,NA,NA,NA,global,1,33716,-34399,100130,33716,-34399,100130
2033,SOM,EMRO D,Sub-Saharan Africa,EMRO,Low income,gn,carbapenems,RTI,NA,NA,NA,NA,NA,global,1,5040,-5451,14823,5040,-5451,14823
2034,SOM,EMRO D,Sub-Saharan Africa,EMRO,Low income,gp,penicillins,SSI,NA,NA,NA,NA,NA,global,2,83842,-37691,201203,83842,-37691,201203
2035,SOM,EMRO D,Sub-Saharan Africa,EMRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9933,-9097,28631,9933,-9097,28631
2036,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,1341,529,2805,income,2,586,-472,1732,963,-318,2472
2037,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,5571,329,15758,NA,NA,NA,NA,NA,5571,329,15758
2038,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,2367,808,5145,global,2,23302,-13334,63493,12834,-9253,57728
2039,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,1910,717,4032,income,2,968,-691,2599,1439,-447,3516
2040,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,3072,184,8015,income,2,1815,-770,4260,2444,-436,6998
2041,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,1128,460,2291,NA,NA,NA,NA,NA,1128,460,2291
2042,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1809,111,4892,global,5,13364,-1334,27429,7587,-29,24743
2043,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,1596,490,3500,global,4,32739,-1532,67143,17168,459,61498
2044,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,459,-1,1292,global,1,35238,-32741,100745,17849,-18867,89493
2045,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,3278,-12749,22021,income,1,5287,-4761,15364,4282,-9191,18781
2046,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,1912,335,5010,global,2,83387,-37971,201560,42649,-19970,184440
2047,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,3212,770,7794,NA,NA,NA,NA,NA,3212,770,7794
2048,SRB,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10244,-9963,31224,10244,-9963,31224
2049,STP,AFRO D,NA,AFRO,NA,gn,3g cephalosporins,BSI,global,3,76,28,156,global,2,563,-477,1657,320,-361,1456
2050,STP,AFRO D,NA,AFRO,NA,gn,carbapenems,BSI,global,4,99,24,230,NA,NA,NA,NA,NA,99,24,230
2051,STP,AFRO D,NA,AFRO,NA,gp,glycopeptides,BSI,global,3,134,41,306,global,2,23961,-13853,61171,12047,-7326,56550
2052,STP,AFRO D,NA,AFRO,NA,gp,penicillins,BSI,global,5,114,44,235,global,3,995,-760,2686,555,-514,2431
2053,STP,AFRO D,NA,AFRO,NA,gn,3g cephalosporins,COL/INF,whoc,1,76,29,157,global,2,1734,-690,4218,905,-371,3796
2054,STP,AFRO D,NA,AFRO,NA,gn,carbapenems,COL/INF,global,9,96,35,209,NA,NA,NA,NA,NA,96,35,209
2055,STP,AFRO D,NA,AFRO,NA,gp,glycopeptides,COL/INF,global,3,104,10,272,global,5,13521,-373,27699,6812,7,25729
2056,STP,AFRO D,NA,AFRO,NA,gp,penicillins,COL/INF,global,7,159,59,338,global,4,32609,-3066,69135,16384,57,63254
2057,STP,AFRO D,NA,AFRO,NA,gp,glycopeptides,IAI,global,1,25,1,70,global,1,34629,-28445,100080,17327,-18788,89745
2058,STP,AFRO D,NA,AFRO,NA,gn,carbapenems,RTI,global,1,211,-563,1281,global,1,5261,-4430,14710,2736,-2486,13061
2059,STP,AFRO D,NA,AFRO,NA,gp,penicillins,SSI,global,3,168,59,364,global,2,81884,-34322,193918,41026,-15339,179982
2060,STP,AFRO D,NA,AFRO,NA,gp,penicillins,SSTI,global,1,180,41,419,NA,NA,NA,NA,NA,180,41,419
2061,STP,AFRO D,NA,AFRO,NA,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9563,-9959,29570,9563,-9959,29570
2062,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,405,158,867,income,2,600,-600,1721,503,-383,1542
2063,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,1723,65,4536,NA,NA,NA,NA,NA,1723,65,4536
2064,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,722,235,1647,global,2,24080,-14686,62978,12401,-9230,55518
2065,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,575,218,1250,income,2,960,-729,2719,767,-444,2415
2066,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,916,118,2502,income,2,1781,-688,4144,1348,-265,3921
2067,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,341,134,728,NA,NA,NA,NA,NA,341,134,728
2068,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,548,12,1570,global,5,12714,-918,26146,6631,-75,24040
2069,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,837,326,1876,global,4,32668,-5374,67858,16753,221,62582
2070,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,133,-3,357,global,1,36349,-31759,105289,18241,-20907,95493
2071,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,1003,-3722,6180,income,1,5159,-4793,14932,3081,-4229,13454
2072,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,896,323,1949,global,2,82250,-32195,206845,41573,-13254,180480
2073,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,967,232,2391,NA,NA,NA,NA,NA,967,232,2391
2074,SUR,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9732,-8207,29750,9732,-8207,29750
2075,SVK,EURO B,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,income,3,1651,656,3504,income,2,620,-399,1658,1136,-223,3124
2076,SVK,EURO B,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,income,3,1905,471,4705,NA,NA,NA,NA,NA,1905,471,4705
2077,SVK,EURO B,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,2919,958,6843,income,2,23137,-16066,59263,13028,-9792,55116
2078,SVK,EURO B,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,income,5,2450,950,5263,income,3,1034,-559,2597,1742,-339,4602
2079,SVK,EURO B,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,income,1,215,-593,1218,global,2,1773,-830,4321,994,-653,3985
2080,SVK,EURO B,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,income,8,2625,521,6358,NA,NA,NA,NA,NA,2625,521,6358
2081,SVK,EURO B,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,2221,51,5936,income,5,12960,-749,27317,7590,-70,25368
2082,SVK,EURO B,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,income,7,3400,1315,7416,income,4,32433,-1728,65535,17917,1199,61901
2083,SVK,EURO B,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,549,6,1471,income,1,35228,-26946,99995,17889,-17691,91731
2084,SVK,EURO B,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,4559,-14464,26143,global,1,5104,-4333,14608,4832,-10498,21066
2085,SVK,EURO B,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,income,3,3606,1301,8130,income,2,81801,-37719,203782,42703,-10404,180020
2086,SVK,EURO B,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,income,1,3960,858,9576,NA,NA,NA,NA,NA,3960,858,9576
2087,SVK,EURO B,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10147,-9823,29640,10147,-9823,29640
2088,SVN,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,3148,4,8428,income,2,595,-539,1691,1872,-435,6960
2089,SVN,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,3543,-831,11004,NA,NA,NA,NA,NA,3543,-831,11004
2090,SVN,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,4662,1511,10483,income,2,24827,-16206,65065,14744,-9349,57349
2091,SVN,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,6539,1763,15592,income,3,1052,-638,2820,3796,-349,12656
2092,SVN,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,362,-944,2069,global,2,1827,-460,4376,1094,-791,3925
2093,SVN,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,2612,-2394,10302,NA,NA,NA,NA,NA,2612,-2394,10302
2094,SVN,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,3500,70,9262,income,5,13670,-1946,28385,8585,-356,25986
2095,SVN,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,3109,929,7143,income,4,32676,-3781,67912,17893,616,61121
2096,SVN,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,847,-51,2458,income,1,36105,-30431,107104,18476,-20448,93442
2097,SVN,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,7236,-23966,42780,global,1,4797,-4878,14581,6017,-18002,34137
2098,SVN,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,3762,619,9557,income,2,83982,-33375,204413,43872,-12517,179506
2099,SVN,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,6300,1402,15406,NA,NA,NA,NA,NA,6300,1402,15406
2100,SVN,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9365,-11423,29832,9365,-11423,29832
2101,SWE,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,BSI,whoc,1,6712,47,18632,income,2,587,-533,1689,3649,-507,15825
2102,SWE,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,BSI,whoc,2,7220,-1727,23605,NA,NA,NA,NA,NA,7220,-1727,23605
2103,SWE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,BSI,income,3,10274,3172,24628,income,2,23354,-14577,62737,16814,-9572,55697
2104,SWE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,BSI,whoc,2,13884,3065,32539,income,3,969,-826,2852,7426,-522,29043
2105,SWE,EURO A,Europe & Central Asia,EURO,High income,gn,3g cephalosporins,COL/INF,whoc,1,855,-2035,4648,global,2,1737,-885,4139,1296,-1608,4438
2106,SWE,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,COL/INF,whoc,5,5714,-5579,21016,NA,NA,NA,NA,NA,5714,-5579,21016
2107,SWE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,COL/INF,income,3,7961,392,22142,income,5,13140,-775,26382,10551,88,25995
2108,SWE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,COL/INF,whoc,2,6682,1998,15253,income,4,33272,-2068,69187,19977,1438,64692
2109,SWE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,IAI,income,1,1922,29,5635,income,1,34533,-34338,101574,18228,-18766,89480
2110,SWE,EURO A,Europe & Central Asia,EURO,High income,gn,carbapenems,RTI,global,1,14596,-44949,88351,global,1,5115,-4489,14436,9856,-35212,72251
2111,SWE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSI,whoc,1,8205,1795,21743,income,2,84048,-25938,197598,46127,-7952,178728
2112,SWE,EURO A,Europe & Central Asia,EURO,High income,gp,penicillins,SSTI,whoc,1,13823,3400,35608,NA,NA,NA,NA,NA,13823,3400,35608
2113,SWE,EURO A,Europe & Central Asia,EURO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,9429,-9721,30137,9429,-9721,30137
2114,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,203,78,429,global,2,602,-477,1639,403,-303,1528
2115,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,264,66,615,NA,NA,NA,NA,NA,264,66,615
2116,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,356,115,815,global,2,24102,-16875,60994,12229,-9147,56301
2117,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,302,113,624,global,3,1019,-768,2836,661,-451,2548
2118,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,780,291,1690,global,2,1806,-662,4318,1293,-218,3936
2119,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,256,94,558,NA,NA,NA,NA,NA,256,94,558
2120,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,268,-1,740,global,5,13189,-393,27648,6729,-20,24891
2121,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,418,160,881,global,4,32001,-3195,65354,16209,132,61627
2122,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,68,-1,181,global,1,33581,-35399,100755,16824,-22944,91716
2123,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,539,-1557,3178,global,1,5142,-4792,15235,2841,-3374,13474
2124,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,450,160,956,global,2,82266,-38160,200356,41358,-19610,183151
2125,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,468,108,1114,NA,NA,NA,NA,NA,468,108,1114
2126,SWZ,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9663,-10156,29359,9663,-10156,29359
2127,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gn,3g cephalosporins,BSI,income,3,1787,634,4003,income,2,597,-475,1736,1192,-310,3584
2128,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gn,carbapenems,BSI,income,3,2096,477,5514,NA,NA,NA,NA,NA,2096,477,5514
2129,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gp,glycopeptides,BSI,income,3,3110,903,7528,income,2,24890,-13955,63255,14000,-8479,58428
2130,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gp,penicillins,BSI,income,5,2653,928,5969,income,3,996,-554,2742,1824,-351,5205
2131,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gn,3g cephalosporins,COL/INF,whoc,1,1771,640,3850,global,2,1786,-483,4158,1779,-187,4017
2132,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gn,carbapenems,COL/INF,income,8,2819,481,7441,NA,NA,NA,NA,NA,2819,481,7441
2133,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gp,glycopeptides,COL/INF,income,3,2378,80,6758,income,5,13511,-636,27498,7945,-45,25940
2134,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gp,penicillins,COL/INF,income,7,3667,1275,7979,income,4,34174,-1113,69112,18920,1174,64355
2135,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gp,glycopeptides,IAI,income,1,599,-28,1817,income,1,33852,-30309,98980,17226,-22253,90281
2136,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gn,carbapenems,RTI,global,1,4655,-15955,28856,global,1,5022,-5014,15070,4838,-12663,23932
2137,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gp,penicillins,SSI,income,3,3904,1303,8727,income,2,83061,-33139,198793,43482,-15375,184483
2138,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gp,penicillins,SSTI,income,1,4236,961,10808,NA,NA,NA,NA,NA,4236,961,10808
2139,SYC,AFRO D,Sub-Saharan Africa,AFRO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10377,-10530,30040,10377,-10530,30040
2140,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gn,3g cephalosporins,BSI,global,3,609,206,1307,global,2,593,-450,1604,601,-295,1535
2141,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gn,carbapenems,BSI,wbregion,1,-87,-2020,1605,NA,NA,NA,NA,NA,-87,-2020,1605
2142,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gp,glycopeptides,BSI,global,3,1087,314,2468,global,2,23370,-15888,61875,12229,-9365,54833
2143,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gp,penicillins,BSI,global,5,904,306,1939,global,3,1021,-673,2865,962,-488,2578
2144,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gn,3g cephalosporins,COL/INF,global,5,837,197,1979,global,2,1727,-711,4199,1282,-366,3798
2145,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gn,carbapenems,COL/INF,whoc,1,511,178,1114,NA,NA,NA,NA,NA,511,178,1114
2146,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gp,glycopeptides,COL/INF,global,3,788,7,2155,global,5,13470,-458,28193,7129,-8,25374
2147,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gp,penicillins,COL/INF,global,7,1260,430,2816,global,4,32188,-4417,68932,16724,263,60916
2148,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gp,glycopeptides,IAI,global,1,204,-6,590,global,1,33702,-34802,99367,16953,-24328,88904
2149,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gn,carbapenems,RTI,global,1,1648,-5887,10131,global,1,5132,-4351,15232,3390,-5107,14002
2150,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gp,penicillins,SSI,global,3,1340,431,3131,global,2,81539,-43021,195051,41439,-17849,172391
2151,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gp,penicillins,SSTI,global,1,1442,341,3778,NA,NA,NA,NA,NA,1442,341,3778
2152,SYR,EMRO E,Middle East & North Africa,EMRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9980,-8714,29423,9980,-8714,29423
2153,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,40,16,84,global,2,607,-426,1706,324,-325,1557
2154,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,51,12,133,NA,NA,NA,NA,NA,51,12,133
2155,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,70,23,145,global,2,25467,-12938,63337,12768,-6770,57641
2156,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,60,22,123,global,3,960,-695,2614,510,-396,2318
2157,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,40,15,79,global,2,1731,-714,4213,885,-350,3819
2158,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,51,18,107,NA,NA,NA,NA,NA,51,18,107
2159,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,53,2,142,global,5,13286,-1352,28278,6670,-2,24991
2160,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,83,30,176,global,4,33400,-1594,69501,16741,30,63508
2161,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,13,-1,37,global,1,33640,-31289,101452,16827,-20532,90201
2162,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,97,-341,589,global,1,5191,-4809,14848,2644,-3396,13655
2163,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,89,31,191,global,2,83430,-33498,200627,41760,-15589,180915
2164,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,94,21,223,NA,NA,NA,NA,NA,94,21,223
2165,TCD,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10249,-9230,29906,10249,-9230,29906
2166,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,27,10,55,global,2,578,-516,1700,302,-348,1491
2167,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,35,9,85,NA,NA,NA,NA,NA,35,9,85
2168,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,46,15,101,global,2,24344,-15173,63107,12195,-7165,56455
2169,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,40,16,84,global,3,977,-816,2693,508,-576,2443
2170,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,27,11,55,global,2,1771,-668,4256,899,-373,3901
2171,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,34,13,73,NA,NA,NA,NA,NA,34,13,73
2172,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,37,0,98,global,5,13215,-132,28246,6626,-1,24116
2173,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,55,22,115,global,4,32980,-2734,67721,16517,19,63344
2174,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,9,-1,24,global,1,35354,-35402,103968,17681,-24131,93845
2175,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,76,-208,404,global,1,5135,-5591,14951,2605,-3612,13400
2176,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,59,21,127,global,2,82216,-43969,194695,41138,-17747,182927
2177,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,63,16,146,NA,NA,NA,NA,NA,63,16,146
2178,TGO,AFRO D,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10507,-9592,30730,10507,-9592,30730
2179,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gn,3g cephalosporins,BSI,income,2,403,155,838,income,2,602,-456,1727,502,-305,1535
2180,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gn,carbapenems,BSI,whoc,1,1651,5,4543,NA,NA,NA,NA,NA,1651,5,4543
2181,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gp,glycopeptides,BSI,global,3,711,223,1672,global,2,22492,-16553,59516,11602,-11303,54816
2182,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gp,penicillins,BSI,income,2,571,204,1242,income,2,967,-758,2632,769,-424,2405
2183,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gn,3g cephalosporins,COL/INF,whoc,2,499,44,1347,whoc,2,1778,-686,4356,1138,-286,3980
2184,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gn,carbapenems,COL/INF,income,1,340,130,722,NA,NA,NA,NA,NA,340,130,722
2185,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gp,glycopeptides,COL/INF,global,3,550,49,1495,global,5,13442,-410,26164,6996,10,24496
2186,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gp,penicillins,COL/INF,wbregion,1,899,341,1866,global,4,32299,-3182,70845,16599,291,63095
2187,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gp,glycopeptides,IAI,global,1,133,-6,357,global,1,34778,-35425,101077,17456,-23652,90943
2188,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gn,carbapenems,RTI,whoc,1,1060,-3487,6123,whoc,1,5138,-4928,14521,3099,-4185,13087
2189,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gp,penicillins,SSI,global,3,893,308,1892,global,2,86751,-28910,206048,43822,-10843,187508
2190,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gp,penicillins,SSTI,global,1,952,202,2481,NA,NA,NA,NA,NA,952,202,2481
2191,THA,SEARO B,East Asia & Pacific,SEARO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9631,-10121,29026,9631,-10121,29026
2192,TJK,EURO B,Europe & Central Asia,EURO,Low income,gn,3g cephalosporins,BSI,wbregion,3,36,14,77,wbregion,2,572,-563,1612,304,-302,1473
2193,TJK,EURO B,Europe & Central Asia,EURO,Low income,gn,carbapenems,BSI,wbregion,1,63,22,143,NA,NA,NA,NA,NA,63,22,143
2194,TJK,EURO B,Europe & Central Asia,EURO,Low income,gp,glycopeptides,BSI,global,3,64,20,153,global,2,22890,-17850,62875,11477,-10855,55528
2195,TJK,EURO B,Europe & Central Asia,EURO,Low income,gp,penicillins,BSI,wbregion,4,53,19,113,wbregion,2,931,-743,2738,492,-547,2412
2196,TJK,EURO B,Europe & Central Asia,EURO,Low income,gn,3g cephalosporins,COL/INF,wbregion,1,5,-14,28,global,2,1773,-817,4321,889,-447,3870
2197,TJK,EURO B,Europe & Central Asia,EURO,Low income,gn,carbapenems,COL/INF,wbregion,3,44,-69,180,NA,NA,NA,NA,NA,44,-69,180
2198,TJK,EURO B,Europe & Central Asia,EURO,Low income,gp,glycopeptides,COL/INF,global,3,48,1,133,global,5,13312,-1027,26839,6680,0,24858
2199,TJK,EURO B,Europe & Central Asia,EURO,Low income,gp,penicillins,COL/INF,wbregion,2,42,13,98,global,4,31905,-4014,67598,15974,10,61725
2200,TJK,EURO B,Europe & Central Asia,EURO,Low income,gp,glycopeptides,IAI,global,1,12,0,33,global,1,33192,-33880,98681,16602,-23282,89586
2201,TJK,EURO B,Europe & Central Asia,EURO,Low income,gn,carbapenems,RTI,global,1,99,-288,592,global,1,5086,-4588,15338,2593,-3299,13393
2202,TJK,EURO B,Europe & Central Asia,EURO,Low income,gp,penicillins,SSI,wbregion,1,50,10,133,global,2,81498,-30790,194423,40774,-14095,178073
2203,TJK,EURO B,Europe & Central Asia,EURO,Low income,gp,penicillins,SSTI,wbregion,1,86,19,220,NA,NA,NA,NA,NA,86,19,220
2204,TJK,EURO B,Europe & Central Asia,EURO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9835,-8745,29352,9835,-8745,29352
2205,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,941,326,2043,income,2,579,-495,1652,760,-323,1786
2206,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,3972,399,10296,NA,NA,NA,NA,NA,3972,399,10296
2207,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,1677,521,4024,global,2,24107,-12619,64162,12892,-7045,56581
2208,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,1347,485,3059,income,2,952,-715,2674,1150,-496,2865
2209,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,2025,43,5493,income,2,1857,-687,4343,1941,-416,4863
2210,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,795,285,1769,NA,NA,NA,NA,NA,795,285,1769
2211,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1288,33,3388,global,5,13171,-1518,26896,7230,-158,24670
2212,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,1088,301,2471,global,4,32306,-2893,66708,16697,179,62939
2213,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,306,-27,901,global,1,36383,-29532,103870,18344,-21564,92625
2214,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,2611,-7194,16839,income,1,5446,-4268,15131,4028,-6055,15597
2215,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,1357,240,3404,global,2,82167,-36806,212996,41762,-21038,186102
2216,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,2244,541,5732,NA,NA,NA,NA,NA,2244,541,5732
2217,TKM,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10042,-9465,29611,10042,-9465,29611
2218,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gn,3g cephalosporins,BSI,global,3,66,27,140,global,2,589,-483,1761,328,-342,1548
2219,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gn,carbapenems,BSI,whoc,1,271,-3,766,NA,NA,NA,NA,NA,271,-3,766
2220,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,BSI,global,3,116,40,261,global,2,22792,-17187,62959,11454,-9885,57061
2221,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,BSI,wbregion,1,106,33,237,wbregion,1,11351,-10806,34133,5729,-7441,29690
2222,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,2,80,8,213,whoc,2,1765,-677,4183,922,-307,3838
2223,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gn,carbapenems,COL/INF,global,9,83,32,173,NA,NA,NA,NA,NA,83,32,173
2224,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,COL/INF,global,3,90,3,246,global,5,13298,-1259,26697,6694,-6,24611
2225,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,147,60,301,global,4,32888,-2373,68728,16518,53,63804
2226,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,IAI,global,1,22,0,59,global,1,35187,-34391,105604,17604,-22265,93804
2227,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gn,carbapenems,RTI,whoc,1,169,-497,974,whoc,1,5045,-4799,14860,2607,-3421,13335
2228,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,SSI,global,3,146,52,333,global,2,81176,-26324,193034,40661,-10445,174718
2229,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,penicillins,SSTI,global,1,160,38,392,NA,NA,NA,NA,NA,160,38,392
2230,TLS,SEARO B,East Asia & Pacific,SEARO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9604,-9042,30302,9604,-9042,30302
2231,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,465,169,1023,income,2,583,-509,1659,524,-333,1506
2232,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,BSI,whoc,1,420,140,931,NA,NA,NA,NA,NA,420,140,931
2233,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,BSI,global,3,825,257,1958,global,2,23362,-13193,63224,12093,-8056,57412
2234,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,BSI,whoc,1,750,225,1858,whoc,1,12004,-10468,35025,6377,-7425,31568
2235,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1062,84,3153,income,2,1778,-634,4181,1420,-321,3874
2236,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,COL/INF,income,1,393,144,844,NA,NA,NA,NA,NA,393,144,844
2237,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,607,2,1581,global,5,13346,-770,27236,6976,-55,24767
2238,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,COL/INF,wbregion,1,1038,386,2242,global,4,32203,-4666,69201,16620,319,64780
2239,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,IAI,global,1,157,-5,455,global,1,32609,-32353,103820,16383,-23818,93942
2240,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,RTI,income,1,1176,-3689,7125,income,1,4867,-4493,14054,3021,-4135,12683
2241,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSI,global,3,1025,349,2365,global,2,84452,-24743,196780,42738,-7858,182553
2242,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSTI,global,1,1127,232,2909,NA,NA,NA,NA,NA,1127,232,2909
2243,TON,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9909,-10300,28905,9909,-10300,28905
2244,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,BSI,income,3,1930,766,3952,income,2,600,-473,1698,1265,-337,3421
2245,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,BSI,income,3,2251,502,5628,NA,NA,NA,NA,NA,2251,502,5628
2246,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,BSI,income,3,3420,1085,7414,income,2,23421,-17885,64189,13421,-8567,56851
2247,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,BSI,income,5,2866,1155,5960,income,3,1027,-579,2707,1947,-292,5197
2248,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,COL/INF,income,1,249,-721,1382,global,2,1756,-774,4228,1002,-732,3907
2249,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,COL/INF,income,8,3152,469,7625,NA,NA,NA,NA,NA,3152,469,7625
2250,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,COL/INF,income,3,2581,136,7122,income,5,13352,-1732,27995,7966,2,24827
2251,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,COL/INF,income,7,3987,1532,8194,income,4,32402,-3130,69089,18194,1108,63181
2252,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,IAI,income,1,628,-14,1690,income,1,35734,-35224,102270,18181,-19294,90769
2253,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,RTI,global,1,5026,-16768,30142,global,1,5010,-4791,15418,5018,-12090,23967
2254,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSI,income,3,4268,1668,9138,income,2,82163,-24899,196344,43215,-5863,176484
2255,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSTI,income,1,4627,1083,11080,NA,NA,NA,NA,NA,4627,1083,11080
2256,TTO,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10387,-8707,28826,10387,-8707,28826
2257,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,284,100,601,global,2,578,-593,1691,431,-398,1571
2258,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,BSI,wbregion,1,-37,-873,821,NA,NA,NA,NA,NA,-37,-873,821
2259,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,BSI,global,3,503,156,1246,global,2,23561,-14998,61789,12032,-8602,55398
2260,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,BSI,global,5,423,157,890,global,3,994,-794,2664,709,-464,2437
2261,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,284,104,590,global,2,1778,-722,4204,1031,-328,3935
2262,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,COL/INF,whoc,1,240,90,501,NA,NA,NA,NA,NA,240,90,501
2263,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,389,12,1074,global,5,13006,-1863,26530,6697,-101,24648
2264,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,COL/INF,global,7,588,216,1270,global,4,32706,-1860,67769,16647,202,62357
2265,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,IAI,global,1,93,-6,249,global,1,35258,-32324,103359,17675,-22667,92967
2266,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gn,carbapenems,RTI,global,1,599,-2481,4274,global,1,4858,-4761,14422,2728,-3707,13224
2267,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,SSI,global,3,626,200,1355,global,2,85657,-32127,196559,43141,-13276,179913
2268,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gp,penicillins,SSTI,global,1,667,149,1754,NA,NA,NA,NA,NA,667,149,1754
2269,TUN,EMRO E,Middle East & North Africa,EMRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10207,-10308,31841,10207,-10308,31841
2270,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,BSI,income,2,646,220,1554,income,2,596,-501,1652,621,-327,1589
2271,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,BSI,income,1,2729,156,7448,NA,NA,NA,NA,NA,2729,156,7448
2272,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,BSI,global,3,1137,341,2758,global,2,23887,-13721,64449,12512,-7984,56979
2273,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,BSI,income,2,915,302,2164,income,2,940,-667,2613,928,-459,2485
2274,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1484,171,3957,income,2,1757,-868,4214,1620,-431,4126
2275,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,COL/INF,income,1,544,185,1213,NA,NA,NA,NA,NA,544,185,1213
2276,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,COL/INF,global,3,907,48,2590,global,5,12662,-2348,26728,6785,-91,24181
2277,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,COL/INF,wbregion,2,750,212,1852,global,4,32637,-2490,66466,16694,194,61752
2278,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,IAI,global,1,211,-18,658,global,1,35804,-31624,98951,18007,-19873,89576
2279,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gn,carbapenems,RTI,income,1,1587,-5942,10189,income,1,4809,-5405,14730,3198,-5846,13665
2280,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSI,wbregion,1,913,137,2337,global,2,83328,-27903,202097,42121,-12287,179396
2281,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,penicillins,SSTI,wbregion,1,1547,337,4106,NA,NA,NA,NA,NA,1547,337,4106
2282,TUR,EURO B,Europe & Central Asia,EURO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10385,-8740,29426,10385,-8740,29426
2283,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,245,94,522,income,2,611,-490,1780,428,-304,1458
2284,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,BSI,whoc,1,219,82,482,NA,NA,NA,NA,NA,219,82,482
2285,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,BSI,global,3,433,142,1064,global,2,23029,-12116,63507,11731,-8209,56384
2286,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,BSI,whoc,1,397,121,966,whoc,1,11326,-12738,35066,5862,-8190,30632
2287,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,548,64,1440,income,2,1818,-792,4444,1183,-408,3996
2288,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,COL/INF,income,1,206,82,438,NA,NA,NA,NA,NA,206,82,438
2289,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,326,10,1011,global,5,13204,-997,27170,6765,-26,24937
2290,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,COL/INF,wbregion,1,545,209,1156,global,4,33460,-836,68508,17003,208,62921
2291,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,IAI,global,1,79,-6,213,global,1,34475,-32500,100019,17277,-22178,89399
2292,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,RTI,income,1,671,-2130,3889,income,1,4857,-4700,14540,2764,-3469,13048
2293,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSI,global,3,541,190,1301,global,2,84425,-30273,207894,42483,-11110,184755
2294,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSTI,global,1,585,131,1473,NA,NA,NA,NA,NA,585,131,1473
2295,TUV,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9914,-11075,30226,9914,-11075,30226
2296,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,40,16,86,global,2,605,-472,1709,323,-315,1526
2297,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,52,13,128,NA,NA,NA,NA,NA,52,13,128
2298,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,71,23,163,global,2,24014,-14701,61488,12042,-7844,56605
2299,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,60,23,127,global,3,1018,-693,2740,539,-426,2477
2300,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,154,55,325,global,2,1729,-605,4235,941,-258,3726
2301,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,50,18,108,NA,NA,NA,NA,NA,50,18,108
2302,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,56,5,151,global,5,13353,-899,27630,6704,3,24871
2303,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,83,31,177,global,4,31827,-5530,69516,15955,13,61601
2304,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,13,-1,38,global,1,36956,-27228,107803,18484,-17686,95119
2305,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,102,-352,587,global,1,4873,-5285,14954,2488,-3684,13544
2306,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,88,33,201,global,2,82951,-27617,196106,41520,-10521,175277
2307,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,92,21,227,NA,NA,NA,NA,NA,92,21,227
2308,TZA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9714,-9764,29287,9714,-9764,29287
2309,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,BSI,global,3,27,10,58,global,2,595,-569,1684,311,-311,1454
2310,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,BSI,global,4,35,9,81,NA,NA,NA,NA,NA,35,9,81
2311,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,BSI,global,3,48,14,109,global,2,24026,-15479,61209,12037,-9322,56696
2312,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,BSI,global,5,40,15,83,global,3,1005,-615,2723,523,-370,2397
2313,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,3g cephalosporins,COL/INF,whoc,1,104,37,230,global,2,1789,-772,4184,946,-340,3782
2314,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,COL/INF,global,9,34,12,71,NA,NA,NA,NA,NA,34,12,71
2315,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,COL/INF,global,3,37,1,95,global,5,13374,-1161,26325,6705,-2,24673
2316,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,COL/INF,global,7,56,21,120,global,4,32489,-4234,68172,16272,18,61765
2317,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,IAI,global,1,9,0,24,global,1,36099,-33924,104157,18054,-21525,92089
2318,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gn,carbapenems,RTI,global,1,69,-244,450,global,1,5112,-4463,14739,2591,-2793,13481
2319,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSI,global,3,59,21,136,global,2,83295,-41478,201153,41677,-16569,179021
2320,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,penicillins,SSTI,global,1,65,13,160,NA,NA,NA,NA,NA,65,13,160
2321,UGA,AFRO E,Sub-Saharan Africa,AFRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10130,-8854,28820,10130,-8854,28820
2322,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gn,3g cephalosporins,BSI,wbregion,3,248,100,517,wbregion,2,598,-463,1703,423,-300,1549
2323,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,BSI,wbregion,1,438,151,981,NA,NA,NA,NA,NA,438,151,981
2324,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,BSI,global,3,438,138,984,global,2,23948,-14706,65343,12193,-6980,56944
2325,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,BSI,wbregion,4,365,147,782,wbregion,2,939,-795,2643,652,-474,2391
2326,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,247,98,508,global,2,1838,-773,4355,1042,-394,4027
2327,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,COL/INF,wbregion,3,289,-547,1386,NA,NA,NA,NA,NA,289,-547,1386
2328,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,COL/INF,global,3,329,-19,890,global,5,13347,-765,27841,6838,-45,25477
2329,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,COL/INF,wbregion,2,292,90,657,global,4,32529,-2434,68655,16410,79,62795
2330,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,IAI,global,1,81,-7,232,global,1,31384,-40605,101421,15732,-26860,92166
2331,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,RTI,global,1,618,-1968,4431,global,1,5066,-4351,14817,2842,-3399,13380
2332,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,SSI,wbregion,1,344,79,818,global,2,85462,-21899,203835,42903,-6083,184850
2333,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,SSTI,wbregion,1,574,124,1412,NA,NA,NA,NA,NA,574,124,1412
2334,UKR,EURO C,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10003,-9144,29445,10003,-9144,29445
2335,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,BSI,income,3,1192,453,2618,income,2,586,-516,1659,889,-323,2263
2336,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,BSI,income,3,1404,317,3523,NA,NA,NA,NA,NA,1404,317,3523
2337,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,BSI,income,3,2094,716,4847,income,2,23625,-15964,62558,12859,-9174,56300
2338,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,BSI,income,5,1780,685,3885,income,3,992,-711,2854,1386,-394,3352
2339,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gn,3g cephalosporins,COL/INF,income,1,158,-429,889,global,2,1826,-512,4352,992,-453,3799
2340,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,COL/INF,income,8,1895,388,5012,NA,NA,NA,NA,NA,1895,388,5012
2341,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,COL/INF,income,3,1629,-11,4461,income,5,13063,68,26220,7346,-11,24217
2342,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,COL/INF,income,7,2467,903,5333,income,4,32041,-3681,65918,17254,770,59359
2343,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,IAI,income,1,399,2,1166,income,1,36076,-29858,104703,18237,-20490,94651
2344,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gn,carbapenems,RTI,global,1,2771,-11909,19975,global,1,5074,-4459,14546,3923,-8666,16406
2345,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSI,income,3,2636,919,5999,income,2,83412,-29356,197959,43024,-14785,182299
2346,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gp,penicillins,SSTI,income,1,2881,645,7170,NA,NA,NA,NA,NA,2881,645,7170
2347,URY,AMRO B,Latin America & Caribbean,PAHO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,income,1,10433,-9013,30532,10433,-9013,30532
2348,USA,AMRO A,North America,PAHO,High income,gn,3g cephalosporins,BSI,income,3,7379,2584,15783,income,2,589,-492,1588,3984,-301,13858
2349,USA,AMRO A,North America,PAHO,High income,gn,carbapenems,BSI,income,3,8529,1866,21311,NA,NA,NA,NA,NA,8529,1866,21311
2350,USA,AMRO A,North America,PAHO,High income,gp,glycopeptides,BSI,whoc,3,12945,3836,31265,whoc,2,23121,-14649,65429,17016,-7019,55516
2351,USA,AMRO A,North America,PAHO,High income,gp,penicillins,BSI,income,5,11000,3926,24366,income,3,1020,-819,2885,6010,-448,20893
2352,USA,AMRO A,North America,PAHO,High income,gn,3g cephalosporins,COL/INF,income,1,1093,-2690,6047,global,2,1777,-558,4431,1435,-2031,5040
2353,USA,AMRO A,North America,PAHO,High income,gn,carbapenems,COL/INF,whoc,3,19366,1065,53247,NA,NA,NA,NA,NA,19366,1065,53247
2354,USA,AMRO A,North America,PAHO,High income,gp,glycopeptides,COL/INF,whoc,3,9844,420,26688,whoc,5,13260,-1381,27634,12121,-912,27526
2355,USA,AMRO A,North America,PAHO,High income,gp,penicillins,COL/INF,whoc,4,18234,6334,40164,whoc,4,32914,-1988,67454,25574,3164,62384
2356,USA,AMRO A,North America,PAHO,High income,gp,glycopeptides,IAI,whoc,1,2432,-30,6586,whoc,1,34017,-30630,97878,18224,-22936,89153
2357,USA,AMRO A,North America,PAHO,High income,gn,carbapenems,RTI,global,1,18844,-63222,110594,global,1,4651,-5114,14396,11747,-43828,88051
2358,USA,AMRO A,North America,PAHO,High income,gp,penicillins,SSI,whoc,2,18007,5806,41251,whoc,2,84545,-32300,194729,51276,-12807,180149
2359,USA,AMRO A,North America,PAHO,High income,gp,penicillins,SSTI,income,1,17714,4535,43052,NA,NA,NA,NA,NA,17714,4535,43052
2360,USA,AMRO A,North America,PAHO,High income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,whoc,1,9665,-8372,28803,9665,-8372,28803
2361,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gn,3g cephalosporins,BSI,wbregion,3,295,114,629,wbregion,2,620,-435,1630,457,-240,1514
2362,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,BSI,wbregion,1,516,185,1116,NA,NA,NA,NA,NA,516,185,1116
2363,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,BSI,global,3,520,177,1185,global,2,23630,-18181,61998,12075,-9248,55543
2364,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,BSI,wbregion,4,431,162,954,wbregion,2,977,-711,2663,704,-432,2401
2365,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,292,114,619,global,2,1784,-820,4397,1038,-426,4004
2366,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,COL/INF,wbregion,3,354,-526,1521,NA,NA,NA,NA,NA,354,-526,1521
2367,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,COL/INF,global,3,391,-12,1013,global,5,13379,-1003,27547,6885,-25,25183
2368,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,COL/INF,wbregion,2,339,102,770,global,4,32420,-1845,66308,16379,99,61316
2369,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,IAI,global,1,94,-9,270,global,1,35845,-30093,96768,17970,-16849,87344
2370,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gn,carbapenems,RTI,global,1,871,-2352,4707,global,1,4997,-5186,15067,2934,-3502,13614
2371,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,SSI,wbregion,1,416,98,1002,global,2,83771,-37348,197709,42093,-12869,177878
2372,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,penicillins,SSTI,wbregion,1,689,154,1648,NA,NA,NA,NA,NA,689,154,1648
2373,UZB,EURO B,Europe & Central Asia,EURO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10337,-8601,30056,10337,-8601,30056
2374,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,738,296,1526,income,2,609,-527,1672,674,-286,1623
2375,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,3159,60,8207,NA,NA,NA,NA,NA,3159,60,8207
2376,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,1312,416,2894,global,2,24317,-15763,63111,12815,-7743,56923
2377,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,1047,422,2168,income,2,949,-745,2648,998,-416,2417
2378,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,1653,178,4285,income,2,1797,-711,4427,1725,-382,4320
2379,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,622,249,1259,NA,NA,NA,NA,NA,622,249,1259
2380,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1025,42,2881,global,5,13244,-307,27882,7135,12,25605
2381,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,1526,632,3283,global,4,32768,-2414,69944,17147,559,62065
2382,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,246,-12,708,global,1,34126,-31586,101245,17186,-20186,89444
2383,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,1976,-5880,12924,income,1,4925,-4276,14793,3450,-5141,14078
2384,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,1628,603,3520,global,2,81665,-32895,199361,41647,-22259,180187
2385,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,1728,408,4292,NA,NA,NA,NA,NA,1728,408,4292
2386,VCT,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10230,-9657,29632,10230,-9657,29632
2387,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,BSI,income,2,1460,574,3015,income,2,619,-484,1736,1040,-369,2662
2388,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,BSI,income,1,6026,301,16470,NA,NA,NA,NA,NA,6026,301,16470
2389,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,BSI,global,3,2579,789,5970,global,2,23079,-15160,62521,12829,-8718,57096
2390,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,BSI,income,2,2068,739,4402,income,2,929,-844,2643,1499,-501,3868
2391,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,3360,348,9315,income,2,1763,-810,4236,2562,-461,7764
2392,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,COL/INF,income,1,1228,491,2526,NA,NA,NA,NA,NA,1228,491,2526
2393,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,COL/INF,global,3,1987,85,5456,global,5,13120,91,27222,7554,88,24614
2394,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,COL/INF,global,7,3024,1148,6481,global,4,32070,-2602,67128,17547,913,62280
2395,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,IAI,global,1,466,-47,1386,global,1,35266,-31101,99553,17866,-21266,92715
2396,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gn,carbapenems,RTI,income,1,3892,-13516,23081,income,1,5043,-4211,14390,4468,-9760,19111
2397,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSI,global,3,3214,1125,6887,global,2,83088,-31327,191273,43151,-12642,180156
2398,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,penicillins,SSTI,global,1,3492,666,8916,NA,NA,NA,NA,NA,3492,666,8916
2399,VEN,AMRO B,Latin America & Caribbean,PAHO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10224,-9438,30421,10224,-9438,30421
2400,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,106,42,232,global,2,589,-475,1702,347,-271,1469
2401,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,BSI,whoc,1,95,36,215,NA,NA,NA,NA,NA,95,36,215
2402,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,BSI,global,3,186,57,419,global,2,24651,-12664,64135,12419,-8791,59128
2403,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,BSI,whoc,1,168,52,389,whoc,1,12448,-10691,34848,6308,-7399,31321
2404,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,105,42,228,wbregion,2,1758,-792,4356,932,-384,3879
2405,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,COL/INF,global,9,133,49,286,NA,NA,NA,NA,NA,133,49,286
2406,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,140,0,391,global,5,13758,-442,28343,6949,-2,25738
2407,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,235,94,516,global,4,33165,-4440,68640,16700,81,62692
2408,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,IAI,global,1,35,-3,108,global,1,36725,-31961,107773,18380,-18193,94118
2409,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,RTI,wbregion,1,259,-983,1606,wbregion,1,4988,-4805,14922,2623,-3572,13049
2410,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSI,global,3,232,83,530,global,2,81670,-33850,197635,40951,-13157,179966
2411,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSTI,global,1,249,61,619,NA,NA,NA,NA,NA,249,61,619
2412,VNM,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9907,-9753,29407,9907,-9753,29407
2413,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,425,163,950,global,2,591,-406,1711,508,-234,1473
2414,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,BSI,whoc,1,385,141,873,NA,NA,NA,NA,NA,385,141,873
2415,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,BSI,global,3,754,248,1750,global,2,24380,-14365,62051,12567,-7765,57695
2416,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,BSI,whoc,1,681,221,1627,whoc,1,12155,-11235,36666,6418,-7356,31946
2417,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,3g cephalosporins,COL/INF,income,1,424,163,943,wbregion,2,1767,-574,4150,1095,-179,3849
2418,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,COL/INF,global,9,531,193,1221,NA,NA,NA,NA,NA,531,193,1221
2419,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,590,20,1674,global,5,13187,-1226,26568,6889,-69,24637
2420,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,COL/INF,wbregion,1,944,366,2066,global,4,32891,-4070,70108,16918,307,63737
2421,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,IAI,global,1,139,0,392,global,1,34642,-26063,105078,17390,-19085,91063
2422,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gn,carbapenems,RTI,wbregion,1,1183,-4035,7068,wbregion,1,4975,-4317,14534,3079,-4166,13129
2423,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSI,global,3,935,307,2050,global,2,88334,-29753,199196,44635,-9081,180895
2424,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,penicillins,SSTI,global,1,1014,223,2594,NA,NA,NA,NA,NA,1014,223,2594
2425,VUT,WPRO B,East Asia & Pacific,WPRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9784,-10210,30084,9784,-10210,30084
2426,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,266,101,585,income,2,592,-552,1635,429,-308,1495
2427,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,BSI,whoc,1,243,87,530,NA,NA,NA,NA,NA,243,87,530
2428,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,BSI,global,3,462,140,1099,global,2,25073,-13088,65316,12767,-6532,58881
2429,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,BSI,whoc,1,423,134,1005,whoc,1,12260,-10781,35711,6341,-7733,31817
2430,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,3g cephalosporins,COL/INF,income,3,594,70,1626,income,2,1765,-794,4313,1180,-372,3952
2431,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,COL/INF,income,1,224,87,483,NA,NA,NA,NA,NA,224,87,483
2432,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,356,11,918,global,5,13029,-359,26485,6693,-11,24544
2433,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,COL/INF,wbregion,1,593,234,1334,global,4,33392,-651,66331,16993,228,62396
2434,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,IAI,global,1,87,-2,271,global,1,35454,-27662,101189,17771,-21472,90364
2435,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gn,carbapenems,RTI,income,1,692,-2258,4282,income,1,5106,-4115,15069,2899,-3026,13474
2436,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSI,global,3,582,204,1336,global,2,85523,-34194,201860,43053,-17665,183796
2437,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,penicillins,SSTI,global,1,630,145,1537,NA,NA,NA,NA,NA,630,145,1537
2438,WSM,WPRO B,East Asia & Pacific,WPRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10046,-10055,28214,10046,-10055,28214
2439,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gn,3g cephalosporins,BSI,global,3,222,80,461,global,2,591,-414,1618,407,-276,1469
2440,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gn,carbapenems,BSI,wbregion,1,-15,-614,612,NA,NA,NA,NA,NA,-15,-614,612
2441,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gp,glycopeptides,BSI,global,3,394,116,930,global,2,24627,-12338,63101,12510,-7151,57352
2442,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gp,penicillins,BSI,global,5,331,120,695,global,3,1069,-745,2843,700,-434,2510
2443,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gn,3g cephalosporins,COL/INF,global,5,314,72,758,global,2,1787,-653,4305,1050,-182,3781
2444,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gn,carbapenems,COL/INF,wbregion,3,187,69,381,NA,NA,NA,NA,NA,187,69,381
2445,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gp,glycopeptides,COL/INF,global,3,297,4,868,global,5,13340,-922,27272,6819,-19,26120
2446,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gp,penicillins,COL/INF,global,7,458,170,956,global,4,32751,-841,69808,16605,164,63582
2447,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gp,glycopeptides,IAI,global,1,73,-5,209,global,1,32197,-34154,96339,16135,-22563,87708
2448,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gn,carbapenems,RTI,global,1,610,-1985,4039,global,1,5125,-4703,14520,2868,-3412,13021
2449,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gp,penicillins,SSI,global,3,482,173,1099,global,2,82814,-25485,193257,41648,-13353,170925
2450,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gp,penicillins,SSTI,global,1,531,117,1384,NA,NA,NA,NA,NA,531,117,1384
2451,YEM,EMRO D,Middle East & North Africa,EMRO,Low income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10686,-7527,30617,10686,-7527,30617
2452,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,BSI,income,2,522,194,1144,income,2,592,-496,1714,557,-314,1527
2453,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,BSI,income,1,2218,-34,6142,NA,NA,NA,NA,NA,2218,-34,6142
2454,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,BSI,global,3,908,293,2116,global,2,23723,-13453,62577,12315,-7750,54980
2455,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,BSI,income,2,739,262,1593,income,2,953,-760,2626,846,-465,2432
2456,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,3g cephalosporins,COL/INF,whoc,1,2032,736,4637,income,2,1775,-673,4299,1904,-294,4421
2457,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,COL/INF,income,1,440,170,941,NA,NA,NA,NA,NA,440,170,941
2458,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,COL/INF,global,3,730,37,1964,global,5,13599,-720,27677,7165,-9,25456
2459,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,COL/INF,global,7,1073,394,2296,global,4,32720,1797,66661,16897,406,61405
2460,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,IAI,global,1,170,-12,484,global,1,36200,-31302,103698,18185,-18918,93311
2461,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gn,carbapenems,RTI,income,1,1287,-4820,8136,income,1,5318,-4353,15202,3302,-4580,13701
2462,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSI,global,3,1146,399,2661,global,2,82600,-35435,201443,41873,-19077,175713
2463,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,penicillins,SSTI,global,1,1253,270,3339,NA,NA,NA,NA,NA,1253,270,3339
2464,ZAF,AFRO E,Sub-Saharan Africa,AFRO,Upper middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9991,-9407,29710,9991,-9407,29710
2465,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,global,3,39,15,88,global,2,610,-458,1647,325,-339,1502
2466,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,BSI,global,4,51,12,125,NA,NA,NA,NA,NA,51,12,125
2467,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,global,3,68,22,158,global,2,23853,-14563,62694,11961,-8940,55723
2468,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,global,5,58,23,127,global,3,999,-643,2760,529,-430,2422
2469,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,whoc,1,153,55,336,global,2,1705,-776,4031,929,-369,3707
2470,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,COL/INF,global,9,49,19,109,NA,NA,NA,NA,NA,49,19,109
2471,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,global,3,53,4,145,global,5,13467,-76,26065,6760,4,24305
2472,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,global,7,81,29,177,global,4,33612,-4033,71775,16847,27,66718
2473,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,global,1,13,0,39,global,1,34762,-29492,106234,17388,-20206,92533
2474,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,global,1,89,-335,632,global,1,5055,-4445,14629,2572,-3187,12896
2475,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,global,3,87,31,188,global,2,82135,-27949,188849,41111,-14787,174856
2476,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSTI,global,1,95,24,241,NA,NA,NA,NA,NA,95,24,241
2477,ZMB,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,9864,-9876,30632,9864,-9876,30632
2478,ZWE,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,BSI,NA,NA,NA,NA,NA,global,2,600,-471,1689,600,-471,1689
2479,ZWE,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,BSI,NA,NA,NA,NA,NA,global,2,23958,-16031,61974,23958,-16031,61974
2480,ZWE,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,BSI,NA,NA,NA,NA,NA,global,3,978,-821,2708,978,-821,2708
2481,ZWE,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,3g cephalosporins,COL/INF,NA,NA,NA,NA,NA,global,2,1706,-849,4086,1706,-849,4086
2482,ZWE,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,COL/INF,NA,NA,NA,NA,NA,global,5,12855,-1330,26510,12855,-1330,26510
2483,ZWE,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,COL/INF,NA,NA,NA,NA,NA,global,4,32540,-3720,71281,32540,-3720,71281
2484,ZWE,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,IAI,NA,NA,NA,NA,NA,global,1,32776,-38222,99998,32776,-38222,99998
2485,ZWE,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gn,carbapenems,RTI,NA,NA,NA,NA,NA,global,1,5073,-4745,15228,5073,-4745,15228
2486,ZWE,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,penicillins,SSI,NA,NA,NA,NA,NA,global,2,84000,-39280,197535,84000,-39280,197535
2487,ZWE,AFRO E,Sub-Saharan Africa,AFRO,Lower middle income,gp,glycopeptides,UTI,NA,NA,NA,NA,NA,global,1,10007,-10782,29435,10007,-10782,29435
